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Modern technology allows researchers to generate data at an ever increasing rate, 
outpacing the capacity of researchers to analyse it. Developing automated support 
systems for the collection, management and distribution of information is therefore an 
important step to reduce error rates and accelerate progress to enable high-quality 
research based on big data volumes. This thesis encompasses five articles, describing 
strategies for the creation of technical research platforms, as well as descriptions of the 
technical platforms themselves. 
The key conclusion of the thesis is that technical solutions for many issues have been 
available for a long time. These technical solutions are however overlooked, or simply 
ignored, if they fail to recognise the social dimensions of the issues they try to solve. 
The Molecular Methods database is an example of a technically sound but only 
partially successful solution in regards to social viability. Thousands of researchers 
have used the website to access protocols, but only a handful have shared their own 
work on MolMeth. Experiences from the Molecular Methods database and other 
projects have provided a foundation for studies supporting the development of the 
eB3Kit 
The eB3Kit is a portable, robust and scalable informatics platform for structured data 
management. Deploying the platform enables research groups to carry out advanced 
research projects with very limited means. With the eB3Kit researchers can integrate 
data from a wide variety of sources, including the local laboratory information 
management system and analyse it using the Galaksio interface. Galaksio provides user 
friendly access to the Galaxy workflow management system and provides eB3Kit users 
with access to tools developed by a far larger user community than the one actively 
developing the eB3Kit. Using a workflow management system improves 
reproducibility and enables bioinformaticians to prepare workflows without directly 
accessing ethically or commercially sensitive data.  Therefore, it is especially well-
suited for applications where researchers are worried about privacy and during disease 
outbreaks where persistent storage and analysis capacity must be established quickly. 
Keywords: bioinformatics, biobanking, scholarly communication, ethics, genetics, 
Galaxy, Galaksio, The Molecular Methods database. 
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Modern teknik gör det möjligt att generera mer data från experiment än någonsin 
tidigare. Inom livsvetenskaperna har denna utveckling gått så fort att forskare ofta 
genererar mer data än de klarar av att analysera. Det är därför viktigt att utveckla 
automatiserade stödsystem för provinsamling, informationshantering och 
dataöverföring för att forskare bättre ska kunna hantera stora datamängder. Denna 
avhandling omfattar fem delarbeten som beskriver strategier för att bygga tekniska 
informationsplattformar och två exempel på sådana plattformar. 
Den övergripande slutsatsen är att tekniska lösningar för många problem har funnits 
länge. Däremot har dessa lösningar ofta inte applicerats i praktiken då de varit 
fokuserade på tekniska aspekter utan att hantera de sociala dimensionerna som styr 
forskningen. The Molecular Methods database är ett sådant exempel. Tusentals forskare 
har använt hemsidan för att hitta laboratorieprotokoll men endast ett fåtal har valt att 
själva bidra med protokoll till hemsidan. Erfarenheterna från detta arbete och andra 
projekt har därefter legat till grund för studier till stöd för utvecklingen av eB3Kit inom 
ramen för B3Africa-projektet. 
eB3Kit är en portabel, robust och skalbar plattform för strukturerad hantering av 
data. Genom att använda plattformen kan forskargrupper genomföra omfattande 
forskningsprojekt med väldigt begränsade resurser. Plattformen gör det möjligt att 
integrera data från många olika källor och analysera dessa med hjälp av Galaksio. 
Galaksio är ett användargränssnitt utvecklat för att skapa en mer användarvänlig miljö 
vid hanteringen av bioinformatiska arbetsflöden. Gränssnittet är direkt kopplat till 
Galaxy workflow management system och innebär att forskare kan dra nytta av 
arbetsflöden utvecklade av långt fler forskare än de som använder eB3Kit. Genom att 
använda Galaxy ökar spårbarheten inom dataanalys och det är även möjligt för 
bioinformatiker att förbereda analysflöden utan att själva komma i kontakt med etiskt 
eller kommersiellt känsliga data. eB3Kit är därför väl lämpat för situationer där 
forskare behöver kunna ha kontroll över känsliga data eller snabbt etablera en 
provsamsamling och analysera data vid exempelvis sjukdomsutbrott. 
Keywords: bioinformatics, biobanking, scholarly communication, ethics, genetics, 
Galaxy, Galaksio, The Molecular Methods database. 
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Data integration och hantering: Att utveckla en informatikplattform 
för forskningsintegrerade biobanker 
Abstract 
 
 
For most researchers, science is a journey of increasing specialisation. As 
research grows more complex there is a need to build bridges between these 
specialisations. This thesis is therefore an interdisciplinary endeavour to 
provide a bioinformatics-based approach to unify knowledge from molecular 
biology, ethics and bioinformatics, so that researchers may enjoy the fruits of 
success from other fields while specialising within their own. 
In this age of specialization men who thoroughly know one field are often 
incompetent to discuss another. The great problems of the relations between 
one and another aspect of human activity have for this reason been discussed 
less and less in public. 
Richard Feynman (2 May 1956) at a Caltech YMCA lunch forum 
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Figure 1. The eB3Kit and the B3Africa project is described in depth in paper IV. 
The eB3Kit consists of separate software modules installed in a
virtual machine. The contribution of the author has been to participate 
in the writing of the initial proposal and manage work package 4
(bioinformatics) and design the bioinformatics module as well as its 
interactions with other software modules. As the server runs in a
virtual machine, it can be installed on practically any server with
sufficient power, but our preferred configuration is the above setup 
using a Mac Pro server and an external storage device connected by 
a Thunderbolt cable. This preferred setup is based on previous 
experience with the eBiokit bioinformatics platform where portability 
and robustness have been key factors to success by enabling
researchers to deal with harsh conditions and manage limitations in 
internet connectivity and maintenance. 24
)LJXUH The layered approach enabled by Galaksio and Galaxy. 32
Figure 3. The research cycle model adopted by the B3Africa project. The
eB3Kit provides an informatics platform covering the technical 
solutions necessary to manage information, samples and data 
analysis as well as share this information with external stakeholders 
on a secure platform (blue components). The social components of 
the B3Africa project (green) serves to integrate this technical capacity 
into the local research environment by providing training and 
expertise that allow researchers to use the technology, overcome 
ethical and legal barriers and make the most of their research. These
two components strengthen local research communities which can 
use the platform to innovate and produce new innovations or scientific 
discoveries (white). 41
Figure 4. Sources of traffic to www.molmeth.org. 47
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Figure 6. Scholarly communication as explained by Garvey & Griffith in 1972 
with an overlay of the academic process (marked 1-5) based on 
Roosendal and Guerts. To justify funding, promotion and recognition 
researchers are expected to contribute to scientific progress. As a 
researcher, it is, therefore, necessary to register discoveries (1), have 
them accepted by peers (2) and present the results to the wider 
research community (3) in a format accessible to future researchers 
(4).  Reward metrics may be straightforward (e.g., reward for 
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community) or implicit (e.g., being awarded a promotion based on a 
successful track record of conference presentations and publication 
of significant articles) but all four criteria are necessary to estimate 
scientific impact and justify the future allocation of resources (5). 54
Figure 7. The current status of scientific publishing. Publication in peer-
reviewed journals remains the only method to achieve certification, 
awareness and archiving, but search engines and scientific, social 
networks provide new channels for researchers to raise awareness of 
new articles. This makes scientists less reliant on the popularity of the 
journal to reach potential readers making it more attractive to publish 
raw data and methods, as long as the content is delivered in a 
citeable format. 55
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Figure 9. Hundreds of tools are available but hidden in the menu to the left and 
the history to the right expose all data generated by workflows. In the 
middle, a cramped space remains open to provide access to input 
parameters for each tool used. 61
Figure 10. Galaksio provides access to a clean workflow-centric view providing 
access annotated workflows describing necessary input data. Galaxy 
histories and a homepage are available in the menu to the left. 62
Figure 11. The layered approach. 63
Figure 12. View of the public Google Scholar profile of the author. Articles can 
be manually added, but the Google web crawler technology provides 
a high-quality aggregator collecting article, conference proceedings 
and abstracts into a single comprehensive view along with citation 
metrics (available at 
https://scholar.google.com/citations?user=KdTvA-wAAAAJ). 67
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performed within the organisation. In project one the chart indicates 
that a researcher specialised in applied science is the principal 
investigator and relying on automated support services using 
prepared workflows to generate results using prepared assays and 
data analysis workflows. In the second project, the bioinformatician or 
the molecular biologist would be the principal investigator as a new
experimental method is validated and a data analysis pipeline being
created using samples provided by the biobank rather than in a new 
research project. 78
Figure 14. Envisaged positive feedback loop for Galaxy usage by introducing a 
workflow-oriented user interface. 83
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As research projects grow larger and more interdisciplinary they also grow 
more complex and include more members producing material and co-authoring 
articles (Park et al., 2015; Papatheodorou et al., 2008; Weeks et al., 2004). This 
additional complexity makes it harder for researchers to complete a research 
cycle where a hypothesis is formulated, tested, and results presented for review 
by the research community as it is necessary to exchange a significant amount 
of information both within research groups and across the wider community to 
complete the cycle. 
As a result, researchers struggle to plan and organise their research in larger 
and larger groups consisting of experts from several different fields which 
require information to be shared in a formal and structured way to be 
meaningful (Fjällbrant, 2012; Fiore, 2008). At the same time, researchers find 
themselves in an hypercompetitive environment putting substantial pressure on 
researchers to produce research with limited time and incentives to store data 
persistently (Alberts et al., 2014; Teitelbaum, 2008) leading to significant loss 
of data each year (Glasziou et al., 2014). While many researchers have proven 
reluctant to commit to new and potentially disruptive technologies, the 
widespread adoption of social networking technologies for dissemination and, 
demonstrate that researchers are willing to commit to innovations for managing 
information provided that they provide tangible benefits at an acceptable cost 
of adoption. 
The Molecular Methods database (MolMeth, www.molmeth.org) is one 
such example of potentially disruptive technology (paper I). MolMeth is built 
to provide a platform for researchers to communicate experimental procedures 
based on ontologies within research groups and consortia (Klingström et al., 
2013). Upon completion of a project, or, when deemed suitable, protocols can 
be made publically available for dissemination to the wider research 
community. 
1 Introduction
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Paper II was devised to support the development of the Molecular Methods 
database. In 2013 we could conclude that even with the revised web page 
created based on paper I overall positive feedback did not convert into actual 
user engagement on the website. Many researchers are frustrated by the peer-
review system (Björk and Solomon, 2013; Harley and Acord, 2011; Akerman, 
2006) and positive about alternative means for dissemination. Based on user 
behaviour it was however clear that overall support of the concept was 
insufficient to commit the time and effort necessary to provide protocols. 
Lessons from the MolMeth project and the study of scholarly 
communication presented in paper II have been applied in the B3Africa project 
where the author has been head of work package 4 (WP4) which produces the 
bioinformatics module for the eB3Kit. The eB3Kit is a stand-alone platform 
which integrates a number of virtual machines into a complete system for 
managing large sample collections and all research tasks related to them. The 
software platform can be installed on any server, and when deployed it 
provides a robust and easy to handle solution for the IT-platform necessary to 
operate a biobank. To make it useful to the research community it is, however, 
necessary to combine the technical development with an understanding of the 
users, their needs, and motivations for using the platform. The B3Africa 
project and its bioinformatics component have therefore been developed based 
on valuable experience from other projects such as the eBiokit, H3Africa, 
BCNet, MolMeth and Goblet (paper IV). 
To create a solution that is integrated into the daily work of the biobank the 
eB3Kit is designed to provide a platform with structured data which allows 
researchers to formalise their information management and facilitate 
interdisciplinary collaboration where they more effectively distribute labour 
over time between experts. Modules such as the bioinformatics module and 
STATegra Experimental Management System (Hernández-de-Diego et al., 
2014) are therefore not limited to stand alone actions but communicate with 
each other to enhance communication within the project. In such a setting 
bioinformatics is not only an important component of analysis towards the end 
of a project but can also provide information for quality management and 
identification of pre-analytical variables that may be substantial discoveries 
themselves or serve as confounding factors in the analysis of samples retrieved 
from the biobank. 
As long as data is appropriately structured and accurately reflects the 
underlying biological system under investigation, more information is 
univocally positive for research. It is therefore natural that bioinformatics is a 
research field with strong connections to open data sharing going back as far in 
history as the research field itself (Ouzounis and Valencia, 2003).
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Unfortunately such open sharing, albeit scientifically beneficial, may interfere 
with individual interests or rights in regards to individual privacy or ownership 
rights for livestock, plants and pets. A technology platform supporting 
bioinformatics should, therefore, provide strong support for data access and 
sharing, but must do so in a manner that balances the individual rights of the 
people contributing data. Balancing the benefits of open sharing with 
individual rights is far from a straightforward task and bioethics has emerged 
as its field of research (Pellegrino, 1999).  To better implement a balance 
between safeguards and sharing there is close collaboration within the 
B3Africa project in regards to ethical and legal limitations of data sharing. 
Paper III provides a primer on the basics of ethical and legal management of 
data, and the eB3Kit will contain features that help researchers manage the 
issues while keeping as much data as possible available for open collaboration. 
To handle the complexity of projects, it is often necessary to divide research 
tasks based on the technology or expertise required to resolve them. This 
division of labour requires that researchers can share information between 
them and access proven solutions from outside their core area of competency.
These proven solutions are often provided in the form of services such as 
storage in biobanks or bioinformatics support or maintained by dedicated 
flagship platforms such as the ones hosted at the Science for Life Laboratory. 
Infrastructures can be developed as external infrastructures open to researchers 
from a broad range of institutions or internal infrastructures with staff scientists 
providing specialised services and development of new technologies applicable 
to research at the institute (Hyman, 2017). The eB3Kit bioinformatics module 
is based on the Galaxy Workflow management system but with a new layered 
DSSURDFKSURYLGLQJD³VHUYLFHOD\HU´WRUHVHDUFKELRORJLVWVZKRPDLQO\VHHNWR
apply pre-existing bioinformatics tools. Routine tasks can thereby be 
automated enabling research institutions to provide a more attractive working 
environment for bioinformaticians where they can focus on tasks to advance 
their careers in research which is often a challenge in the core services (Chang, 
2015) or develop new tools for other researchers to expand the capacity of the 
institution. 
The bioinformatics module which is called Galaksio (Esperanto for Galaxy) 
is developed by WP4 but can be installed independently of the eB3Kit and 
connected to any Galaxy server (paper V). Combined with other Galaxy 
integrations such as Pulsar and Cloudman this means that bioinformatics can 
be approached in layers based on the expertise of the user. Researchers who 
merely wish to apply bioinformatics tools can access the workflows in 
Galaksio; bioinformaticians can manage or create workflows in Galaxy and 
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workflow tasks can be sent to external computing clusters operated by trained 
administrators or computer scientists for demanding computations.  
The integrated environment with support for ethics, quality management 
and automated bioinformatics provides an informatics platform that can reduce 
the workload of researchers faced with the increasing complexity of research. 
The B3Africa project is focused on supporting the development of biobanks in 
Low and Medium-Income Countries (LMIC) by producing the eB3Kit (paper 
IV) but many lessons learned can be applied in other environments as well, and 
an eB3Kit will also be installed at Karolinska Institutet Biobank for specific 
research projects. 
The modular approach of the eB3Kit also makes it possible to install 
components of the kit separately in virtual machines. Such an approach is of 
particular importance for the bioinformatics component as it will allow local 
installations at larger servers located at the Swedish University of Agricultural 
Sciences (SLU) and Karolinska Institutet. Allowing researchers to automate 
routine tasks in biology and engage in international collaboration as workflows 
and tool setups can easily be exchanged within the network of researchers 
using Galaksio and Galaxy.  
1.1 The importance of biobanks and bioinformatics in 
Low and Medium-Income Countries 
Establishing a biobank allows institutions to create a more efficient supply 
chain in providing biospecimen for high-throughput experiments and 
longitudinal studies. By setting up a biobank, an institution can benefit from 
four major value drivers (Rogers et al., 2011). 
¾ The value of physical capital is optimised as necessary laboratory and 
storage equipment is handled by a single responsible body. Ensuring that 
samples are kept in a consistent manner over time, and economic benefits 
can be leveraged as duplication of work and infrastructure is avoided. 
¾ Human capital is leveraged as dedicated staff can be assigned to specific 
functions and trained to uphold strict control practices and reduce waste 
caused by inefficiencies or high defect rates. 
¾ Bioinformatics and information systems can be connected and centralised, 
allowing researchers to evaluate their data without relying on external 
stakeholders. The quality of analysis is also improved as the influence of 
patient data, potential confounding factors and other highly annotated 
metadata can be evaluated in the study. 
¾ Certification of operating procedures and best practices to improve the 
credibility of the institution. 
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Together these four value drivers make it possible for researchers to engage in 
research projects to collect highly annotated samples and perform credible 
research attractive for international collaborations and investments. If the 
biobank is established in a region permissive for investment by the 
pharmaceutical and medical companies economic benefits can reach tens of
millions of USD in reduced clinical trials costs (Rogers et al., 2011) as well as 
substantial cost savings for medical treatment by enabling the development of 
personalised medicine (Warnich et al., 2011; Compton, 2007). The economic 
potential by development in medical care driven by biobank based research has 
provided motivation for the H3Africa project (The H3Africa Consortium et al., 
2014). Providing 21 grants to selected researchers working at leading 
institutions chosen by the U.S. National Institutes of Health and UK-based 
Wellcome Trust (The H3Africa Consortium et al., 2014) to develop capacity at 
flagship institutions collecting and analysing samples from 50 000 to 75 000 
human participants. 
For researchers engaged in fundamental research or focusing on biological 
samples the economic benefits are likely to be less dramatic but still sufficient 
to generate significant returns. To strengthen research capacity in low and 
medium income countries several stakeholders therefore decided to join 
together and form the B3Africa consortium (described in paper IV). The 
consortium will develop the eB3Kit, a low-cost informatics platform providing 
researchers with the technical infrastructure necessary to manage governance, 
ethics, infrastructure, bioinformatics and data exchange (see figure 1) and 
provide researchers with the training to use it. 
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Figure 1. The eB3Kit and the B3Africa project is described in depth in paper IV. The eB3Kit 
consists of separate software modules installed in a virtual machine. The contribution of the 
author has been to participate in the writing of the initial proposal and manage work package 4 
(bioinformatics) and design the bioinformatics module as well as its interactions with other 
software modules. As the server runs in a virtual machine, it can be installed on practically any 
server with sufficient power, but our preferred configuration is the above setup using a Mac Pro 
server and an external storage device connected by a Thunderbolt cable. This preferred setup is 
based on previous experience with the eBiokit bioinformatics platform where portability and 
robustness have been key factors to success by enabling researchers to deal with harsh conditions 
and manage limitations in internet connectivity and maintenance.
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Providing the eB3Kit allows us to capitalise on existing research networks 
(IARC, 2016; Mulder et al., 2016) and establish an IT-infrastructure that 
supports the long-term management of samples and the resources necessary to 
analyse and share data. Such a platform can be rapidly deployed in regions 
with outbreaks of dangerous pathogens such as the recurring Ebola outbreaks 
in West Africa (Abayomi, Gevao, et al., 2016). It may also reduce the costs 
currently restricting the development biobanks for livestock, plant and 
environmental samples (Groeneveld et al., 2016). 
With its genetic diversity and a large number of local breeds adapted to 
harsh conditions, Africa is a unique region with high potential for the 
collection of biological (non-human) as well as human samples (Heymann, 
2017; Notter, 1999). When engaging in such projects, it is important that 
collaboration is conducted in a mutually beneficial manner to ensure that 
stakeholders are motivated to maintain a long-term and sustainable 
collaboration. In contrast, many previous projects have failed to become 
sustainable as samples were collected in Africa but contributed little or no 
tangible benefits to local communities (Abayomi, Gevao, et al., 2016; de Vries 
et al., 2015) are making future collaborations unlikely between involved 
partners. For biological (non-human) research the relative lack of support for 
biological samples collections in Europe (Directorate-General for Research and 
Innovation, 2016; Groeneveld et al., 2016) and sheer abundance of potential 
research topics provide additional incentives for supporting the development of 
strong local research communities. Since the capacity of each research centre is 
limited, comparative genomics and large-scale projects will need to rely on a 
large number of relatively small stakeholders collecting samples in each 
region. 
For biological biobanks, comparative genomics and longitudinal studies are 
central areas, and strong local research communities can collect, annotate and 
analyse samples in a manner allowing comparisons to be made across different 
regions and breeds. Thereby strengthening agricultural and environmental 
research in a wide variety of areas such as genomic selection for breeding 
(Hayes et al., 2013), conservation efforts (Blackburn, 2012), connecting 
nutritional values to genomics (Maurice-van Eijndhoven, 2014), interventions 
against epizootic diseases (Moen et al., 2015). Biological biobanks may also 
have significant implications for human health as animal models provide 
valuable insights into human health (Andersson, 2016) and the identification as 
well as prevention of zoonotic diseases (DiEuliis et al., 2016).  
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1.2 Managing pre-analytical variables in sample 
collections 
The research community is increasingly worried about issues regarding the 
validity and replicability of scientific findings (Baker, 2016), and 
pharmaceutical companies warn that billions are wasted each year on research 
based on erroneous results (Begley and Ellis, 2012; Prinz et al., 2011). Meta-
research to study how to better conduct research and the development of more 
stringent quality management methods to reduce pre-analytical variation are 
therefore increasingly important components of research (Kousta et al., 2016). 
As a result several standards for measuring and reporting sample handling and 
results such as SPREC (Betsou et al., 2010), BRISQ (Helen M. Moore et al., 
2011) and the recently approved Technical Standards on biobank samples from 
the European Committee for Standardisation(Neururer et al., 2016) have been 
suggested. 
It is yet too early to evaluate the implementation of the CEN/TS standards 
but neither SPREC nor BRISQ are widely cited in comparison to the number of 
biobanks related articles published (Astrin and Betsou, 2016). Suggesting that 
standards have so far seen limited application in biobanks even if quality 
management in biobanks is a recurring topic at the annual ESBB and Hands-on 
Biobanking conferences. 
Validation studies performed by the pharmaceutical company Amgen was 
only able to replicate results in 6 out of 53 high profile papers, despite 
collaborating with the original authors. It is highly worrisome that such a large 
number of secondary papers and expensive clinical trials are being based on 
questionable findings (Begley and Ellis, 2012). Further corroboration that 
much research and development relies on irreproducible findings is provided 
by an in-house survey at Bayer Healthcare, estimating that only 20-25 % of the 
tests were fully reproducible (Prinz et al., 2011) , as well as a wider survey 
performed by Nature among academic researchers (Baker, 2016). Combined, 
these findings suggest that the increasing rate of failure among phase II clinical 
trials in pharmaceutical research may very well be caused by an increasing 
number of pharmaceutical development projects being based on fundamentally 
flawed research (Arrowsmith, 2011). 
Reducing the influence of independent pre-analytical variables is an 
obvious step towards increasing the replicability of studies (Freedman et al., 
2015). The pre-analytical phase is according to ISO 15189 defined as a process 
WKDW VWDUWV ZLWK WKH FOLQLFLDQ¶V request and includes the examination request, 
preparation and identification of the patient, collection of the primary 
sample(s), transportation to, and within the laboratory, and end when the 
analytical examination begins (Doucet et al., 2016). Covering the entire pre-
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analytical phase for a biobank is an extensive undertaking as there is a high 
number of potentially relevant pre-analytical factors. A workshop sponsored by 
The College of American Pathologists Diagnostic Intelligence and Health 
Information Technology Committee suggested a list of 170 pre-analytical 
variables (Robb et al., 2014) and Neururer et. al. listed over 300 (Neururer et 
al., 2016). It is impossible for such an extensive list to be covered using 
informal means or manual record keeping and it is, therefore, necessary to 
invest in a Laboratory Information Management System (LIMS) suitable for 
storage as well as processing of samples when establishing a biobank 
(Hallmans and Vaught, 2011; Dangl et al., 2010). The efficiency of informatics 
management can be significantly improved by integrating data collection, 
LIMS, bioinformatics analysis, and ethics support in one package. Biobanks in 
high-income countries often have access to dedicated systems but with poor 
integration between the systems used by the biobank and its customers while 
biobanks in resource-limited environments often completely lack sufficient 
resources (Soo et al., 2017) and are restricted to record keeping using general 
software such as Microsoft Access databases and Excel spreadsheets, making 
sample management and recording a time consuming and error prone process 
(Mendy et al., 2015). 
This is especially problematic as the quality of a sample is dependent on its 
intended usage, meaning that the quality parameters of relevance to a sample 
collection may change over time as new technologies become available. 
Emerging technologies thereby introduce an element of uncertainty and a need 
for extensive record keeping covering not only variables of known importance 
but also potentially relevant pre-analytical variables. Current developments in 
long read sequencing techniques such as the MinION (Jain et al., 2016) and
PacBio (Rhoads and Au, 2015) are one such example as DNA fragment length 
is becoming increasingly important. With next generation sequencing (NGS) 
dominated by technologies producing reads shorter than 500 bp reads, DNA 
fragmentation in stored samples was a minor issue in comparison to purity, 
yield and amplification success. As long read sequencing technologies are now 
becoming increasingly popular and reaching read lengths above 100 kb the 
DNA fragmentation is suddenly emerging as a significant issue as current 
treatment methods in biobanks routinely shear samples to 5-35 kb depending 
on the methods and procedures used by the biobank (Malentacchi et al., 2015). 
Being able to track the processing history of samples is therefore critical for 
biobanks aiming to provide high-quality samples for long-read sequencing 
techniques as minor alterations to the process may significantly influence the 
quality of samples. Extensive record keeping and provenance of data are 
therefore essential for any biobank hoping to provide samples for future 
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technologies as well as currently established analytical techniques. The Janus 
biobank in Norway provide one compelling example of such administrative 
foresight with its collection of blood samples from 1973 to 2004 (Langseth et 
al., 2016) that has been retroactively evaluated as suitable for measurement of 
microRNA (Rounge et al., 2015), an analyte not discovered until 1993 (Lee et 
al., 1993; Wightman et al., 1993) and not widely recognised as being of 
importance until the early 2000s (Lagos-Quintana et al., 2001). 
Reproducibility has emerged as a minimum acceptable standard in the 
minds of most researchers, functioning as a proxy for replicability to determine 
if the appropriate scientific conduct has been observed (Peng, 2015). From a 
computational perspective, there are three main elements to a reproducible and 
replicable study: (i) the raw data from the experiment must be available, (ii) the 
statistical code and documentation to reproduce the analysis must be available, 
and (iii) a correct data analysis must be performed (Leek and Peng, 2015).  
In a biobank where samples are divided into aliquots and stored properly, 
reproducibility can be extended to cover most of the pre-analytical phase as 
well, allowing researchers to reproduce much of the processing and 
experimental phase of an experiment as well as the computational phase as 
long as sample aliquots are still available. While reproducibility ensures that a 
study has been documented appropriately, it does however not guarantee that 
the results are scientifically relevant. For results to be relevant, they must also 
be replicable, meaning that the results must be robust enough that other 
researchers targeting the same scientific question can generate consistent 
results using a similar setting. 
Various reporting standards and quality management standards are being 
advocated by different stakeholders for improving reproducibility and 
replicability in research, (Freedman et al., 2015; Freedman and Inglese, 2014; 
De Souza and Greenspan, 2013; Simera et al., 2010). There is, however, a 
considerable number of guidelines being authored with limited evaluation 
regarding whether they are being implemented in research (Simera et al., 
2008). The implementation of standards is costly and in a survey among 
members of the French biobanking organisation Club 3C-R with 48 responders 
and an 87 % response rate (di Donato, 2014). A majority of the respondents 
responded that certification had a negative or negligible impact on the financial 
performance of the biobank (70 % of the respondents) and a majority of the 
respondents did not see an increase in scientific collaborations for the biobank 
due to the adoption of standards (69 % of the respondents did not report any 
gains in this area). Despite the lack of economic gain 96 % of the respondents 
replied that they perceived that standardisation had improved the functions of 
the biobank. With improvements in training, documentation and traceability 
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being the most commonly cited benefits. In other words, standardisation does 
improve the overall quality of resources but does often not provide an 
immediate economic or socially beneficial impact to the people performing the 
work to implement them.  
This lack of alignment between the overall needs of the research 
community and incentives for individual stakeholders is a significant obstacle 
for improving quality in research and particularly pertinent in environments 
where funding is insufficient in environments lacking the digital platforms 
necessary to manage the increased administrative overhead. Providing a 
comprehensive IT platform for research integrated biobanks is therefore of 
vital importance to support the implementation of quality management tools in 
low and medium income countries (LMIC), fundamental research and for non-
human biological research. 
1.3 The role of bioinformatics in research 
Bioinformatics is a field of research with roots in the application of 
computational science to solve issues in biology, medicine and chemistry 
(Ouzounis and Valencia, 2003). As a consequence, there is an inherent conflict 
between the perspective of bioinformatics as a service providing the means for 
other research and bioinformatics as an independent field of research 
developing theoretical frameworks and new methods on its own. 
These two interpretations of bioinformatics are both viable but may cause 
significant friction unless recognised and actively managed. The Swedish 
University of Agricultural Sciences (SLU) and Uppsala University provide an 
informative example of this conflict of interest documented by external 
reviewers in the Quality and Renewal reports conducted by Uppsala University 
in 2007 and 2011. In 2007 Uppsala University conducted its first external 
Quality and renewal review (Nordgren and Uppsala universitet, 2007) 
combining a qualitative review by external experts with bibliometric data for 
each department. In the review, the Linnaeus Centre for bioinformatics was 
ranked as the top department in Life Science for citations per publication 
compared to the global average of the field in the bibliometric evaluation 
component.  
Due to its interdisciplinary nature, the centre was qualitatively evaluated by 
the biology panel as well as the information technology panel. Both panels 
described the centre as an internationally competitive research environment 
and of central strategic importance to the university, with the Information 
Technology panel adding that it could demonstrate how Uppsala University 
deals with the development of a promising new field. Recommendations for 
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further development was to develop an improved IT infrastructure (both 
panels) DQG WKDW ³WKH FHQWUH VKRXOG EH VHQVLWLYH WR WKH QHHGV WR WKH ORFDO
ELRORJLFDO FRPPXQLW\´ WKH ELRORJ\ SDQHO ,Q WKH IROORZLQJ VXUYH\ 4XDOLW\
and Renewal 2011 (Uppsala universitet, 2011), the centre had been shut down 
and researchers dispersed across Uppsala University and SLU. The biology 
review panel supported this decision as it ensured that bioinformaticians were 
available to assist researchers in other fields while it was heavily criticized by 
the information technology review panel as the field was under an immediate 
risk of becoming synonymous with software support for the short-term needs 
of biology projects, leading to a wasted strategic opportunity. 
Given the description of conflicting interests in the reports of both panels, it 
is clear that everyone was aware of the inherent conflict of interest between 
research and support in an interdisciplinary field like bioinformatics, despite 
this, it seems that no workable compromise could be reached. Similar concerns 
are also described in older documents such as the guidelines for the training of 
biologists for the 21st century provided by the US National Research Council 
(National Research Council (US) Committee on Undergraduate Biology 
Education to Prepare Research Scientists for the 21st Century, 2003), 
suggesting that even as influential stakeholders are well aware of the conflict, it 
is hard to manage in practice. 
Within the field of bioinformatics, there is also a significant difference 
between researchers trained in bioinformatics from a Life Science perspective 
and a Computer Science perspective. In Sweden, this is even reflected in the 
official government statistics as Statistics Sweden assign different codes to the 
degree depending on if the bioinformatics degree is obtained as a subfield of 
Computer and Information Sciences or Biological Sciences (Pettersson and 
Söder, 2016). With this added differentiation between computer-oriented and 
life science-oriented bioinformatics the field can be characterised in three 
different ways: 
¾ As an independent research subject pushing the boundaries of human 
knowledge by the progress of its own. 
¾ As a tool supporting the development of knowledge in other sub-fields of 
Life Science. 
¾ As an interface to computer science providing access to the computing 
resources necessary to understand the complex interdependencies, we see in 
living systems. 
When setting up research groups devoted to bioinformatics, it is therefore 
necessary to have a clear vision of how these different roles will be 
approached. As needs vary depending on the location, it is necessary for a 
system like the eB3Kit to provide a flexible approach so that a single technical 
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platform can support a wide variety of use cases. This is achieved by dividing 
workflow management into several layers where researchers with little 
bioinformatics training can use a simplified interface centred around 
workflows covering routine procedures while trained bioinformaticians can 
focus on more complex support tasks or their own research.  
A research centre looking to minimise its investment could, for example, 
remain largely dependent on prepared workflows available in the Galaksio 
environment, relying on the eB3Kit and Galaxy communities to provide 
workflows and obtain advanced bioinformatics support by collaborating with 
external partners. On the other hand research institutions with access to highly 
skilled bioinformaticians may use the platform to automate routine applications 
to maximise the time available for bioinformatics experts to develop new tools 
or perform their own research in bioinformatics. 
To capitalise on the potential networking effect of research groups working 
on a technical platform where workflows can be exchanged and reused, we 
decided to build the bioinformatics module on an already established workflow 
management platform in the form of the Galaxy Workflow management 
system (Goecks et al., 2010). Thereby not only connecting eB3Kit users with 
each other but also providing them with an existing user community allowing 
our users to both download and share their workflows with an already 
established community. 
A similarly layered approach is available in the intersection between 
bioinformatics and computer science. Most bioinformaticians are comfortable 
with high-level languages and have been slow to adopt new technology such as 
Hadoop based distributed computing systems (Oliphant, 2016). The Galaxy 
workflow management system can be augmented by several modules allowing 
researchers to run Galaxy workflows but send computation-intensive tasks to 
external computation resources using Cloudman (Afgan et al., 2010), Bioblend 
(Sloggett et al., 2013) and Pulsar (Afgan et al., 2015). A research group with 
trained bioinformaticians but limited skills in computer sciences can thereby 
develop new tools but only deal with advanced computing solutions when 
necessary and by connecting to systems hosted by external experts (figure 2).
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Figure 2. The layered approach enabled by Galaksio and Galaxy.
Resolving the question of if a specific research institution should treat 
bioinformatics as a service or as a research field is beyond the aims of this 
thesis. Instead, we have devised a technical solution based on available 
technology to accommodate research groups with expertise spanning from a 
lack of dedicated bioinformaticians to advanced institutions with qualified staff 
scientists or complete research centres dedicated to bioinformatics with a 
limited amount of time available to support other researchers. 
1.4 Approaching ELSI limitations in data sharing
From an informatics perspective, ethics and law are limitations to the efficient 
transfer of information. The extent of these constraints are under constant 
debate and revisions (Litton, 2017; Anon, 2015), but researchers must consider 
these limitations just like they do with limitations in connectivity, computing 
power or storage persistence.  
As ethical and legal considerations are an important limiting factor in data 
sharing (van Panhuis et al., 2014) there has been extensive collaboration 
between work package 1 (ethics) and work package 4 in the B3Africa project. 
This close collaboration is motivated by a number of factors regarding the 
33
implications of bioethics on the functions of the eB3Kit and its bioinformatics 
component: 
¾ There is no evidence that dedicated ethics experts provide an efficient and
consistent safeguard for the public (Scherzinger and Bobbert, 2017;
Nicholls et al., 2015; Abbott and Grady, 2011; Angell et al., 2006).
¾ Projects may be hijacked or mismanaged as it hard for people with little
own knowledge to evaluate the relative competence among researchers in a
field. Especially in a value-based research field like bioethics it is hard to
find the appropriate authority on relevant topics (Satel, 2015; Powers, 2005;
Crosthwaite, 1995).
¾ Fines and uncertain legal conditions make researchers unwilling to share
data without extensive reviews and legal negotiations (van Panhuis et al.,
2014).
¾ By exclusively relying on dedicated ELSI-experts it becomes hard, if not
impossible, to create innovative solutions supporting the management of
ELSI-questions (personal observation).
It is therefore important that at least a minority of practitioners of natural 
science are making an effort to engage in developing methods to deal with 
ethical and legal questions. This is especially important in data-intensive 
research (Dove et al., 2016) and it is evident from studies in the UK that 
academic chief investigators are prone to submit erroneous applications for 
ethical review (Angell and Dixon-Woods, 2009) and that dedicated ethics 
officers do not substantially improve the quality of submissions (Dixon-Woods 
et al., 2016). 
From the B3Africa project perspective there are two important objectives to 
achieve in regards to ethics and the management of personal data: 
¾ To promote sharing and collaboration to encourage efficient utilisation of
samples and data.
¾ To do this in an ethical, legal, and above all responsible manner that
maintains public trust and respect for the individual as well as communal
rights.
The article Legal & ethical compliance when sharing biospecimen (Klingstrom 
et al., 2017) provide an overview of key concepts on how extra-legal means 
bridge the gap between the national legal systems and advocate a bottom up-
approach where continuous collaboration creates a basis for mutual 
understanding and minimises the waste created when protective measures turn 
into unnecessary administration (Salman et al., 2014). These conclusions have 
contributed to the development of the B3Africa project and enable it to take a 
complementary approach to the establishment of cutting-edge biobanks funded 
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by British and American interests in the H3Africa project(Klingstrom et al., 
2016). 
The H3Africa project has generated significant documentation on ethical 
and legal frameworks in Africa applicable to major research centres funded, 
generating significant support at the locations supported by the project (de 
Vries et al., 2015; Adoga et al., 2014; The H3Africa Consortium et al., 2014). 
The B3Africa project follows a different approach as it targets smaller 
biobanks providing the IT infrastructure necessary to turn sample collections 
into operational biobanks with controlled storage of samples. Smaller research 
groups with lesser resources will, therefore, be exposed to the challenges of 
bridging national regulations of ethical and legal questions by the B3Africa 
project which must be reflected in the technical infrastructure as well as the 
capacity building components of the project. 
The European Union General Data Protection Regulation (EU-GDPR) will
significantly alter how digital data may be stored or processed within Europe 
and may also be of help to clarify regulations abroad. It provides, for the first 
time, a homogeneous implementation of binding law over a large number of 
countries. It should, however, be noted that despite the similarities between 
programming code (binary code) and DNA which is written in four letter code 
(quaternary code), the  EU-GDPR only covers digital data as the European 
Union does not possess legal competence over personal information in other 
forms than digital format. 
The EU-GDPR means that for data being transferred for analysis or storage 
we now, for the first time, have a resource with standardised terminology 
accepted by a large number of countries that will be applicable for all data 
handled within the EU. By connecting the technical solutions implemented in 
the eB3Kit to the legal concepts mentioned in the EU-GDPR it becomes easier 
for legal and ethics experts to evaluate applications within the EU and by 
comparison to the EU with other jurisdictions as well. 
1.5 Ontologies to manage data 
Formal ontologies became popular in the 1980s as a way of specifying content-
specific agreements for the sharing and reuse of knowledge in computer 
science (Gruber, 1995) and its philosophical roots go even further back to the 
17th century with philosophers investigating the concept of being (Lawson,
2004). The application of ontologies in computer science, and later 
bioinformatics, does however tend to be more pragmatic in its approach, using 
it to convert real-world knowledge into formal specifications that allow us to 
share conceptualisations that define objects, properties of objects, and 
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relationships between them in a manner that can be interpreted by computers 
(Smith, 2004; Chandrasekaran et al., 1999). Alternatively, using a less formal 
language, it provides us with the means to convert the ambiguous language we 
use in our normal life into strict definitions suitable for computations and data 
modelling. For a comprehensive practical review of different kinds of 
ontologies and their role in biomedical research Bogumil M. Konopka has 
produced a thorough review of the practical application of ontologies in Life 
Science (Konopka, 2015) along with a guide to different types of ontologies 
based on a classification scheme developed by Gómez-Pérez et al (Gomez-
Cabrero et al., 2014).
It should, however, be noted that despite the formalistic ambitions of the 
field. Many ontology-related terms may possess different meanings in different 
domains (Smith et al., 2006) and even highly successful ontologies such as 
Gene Ontology (Ashburner et al., 2000) and The Unified Medical Language 
System (UMLS) (Bodenreider, 2004) suffer from issues regarding internal 
inconsistencies and formal integrity (Geller et al., 2009; Ceusters et al., 2005; 
Smith et al., 2004). Given the difficulties of appropriately describing 
ontologies outside of their own formally defined domain a comprehensive 
description of the field is beyond the scope of the thesis, and we will instead 
focus on the three kinds of ontologies relevant to the MolMeth and eB3Kit 
projects. 
1.5.1 Formal is-a hierarchies 
Formal is-a hierarchies are familiar to most researchers in the form of 
taxonomies. A formal is-a hierarchy forms a tree where all instances of a 
subclass are also a member of the parent(s) of the subclass. Using taxonomies 
as an example, this means that if we know that an animal belongs to one of the 
13 subspecies of Canis lupus. Then we can also automatically infer that the 
animal belongs to the genus Canis, the family Candiae and all other higher 
levels associated with the class in its scientific classification. 
In molecular biology and bioinformatics, the Gene Ontology (GO) 
(Ashburner et al., 2000) is perhaps the most famous implementation of a 
formal is-a hierarchy with three separate ontologies that with increasing 
granularity describe the biological process, molecular function and cellular 
component of genes and their products.  
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1.5.2 Vocabularies, glossaries and thesauruses 
A vocabulary is a collection of words available within a domain. Such 
collections may seem primitive but can still provide value such as in the case 
of the 300-400 words long list that the director of Houghton Mifflins education 
division, William Spaulding, believed every American six-year-old should 
know. This vocabulary was then used to define the words Dr Seuss could use 
for the now famous children story about the Cat in the Hat (Nel, 2004). 
A glossary is a vocabulary where natural language definitions have been added 
to each term providing entries such as: 
Glossary ± The ontological classification of a dictionary. 
A Thesaurus is similar to a glossary but can include any number of 
semantic relations linking it to other resources, thus making it significantly 
larger and more complex to maintain than vocabularies and glossaries. For 
example, The Unified Medical Language System (UMLS) Metathesaurus 
published by the US National Institute of Health contain over two million 
concepts based on 150 electronic versions of classifications, code sets, thesauri, 
and lists of controlled terms in the biomedical domain according to its factsheet 
(National Institutes of Health, n.d.). Table 1 contains examples of the different 
kinds of non-hierarchical ontologies describe above.
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1.5.3 The EXACT definition of laboratory protocols 
Experiment ACTions (EXACT)(Soldatova et al., 2008) is a hierarchical 
ontology with additional non-hierarchical relations, thus possessing an overall 
formal is-a hierarchical structure but with additional relations attached to 
classes like in a Thesaurus. It aims to provide an exact representation of 
laboratory actions to support reproducible protocols using the EXACT/OBI 
ontology and the full automation of research using EXACT/EXPO in projects 
such as the robot scientist (King et al., 2009). In its second iteration the 
ontology depends on three top-level classes based on other existing ontologies: 
¾ EXACT2: descriptor of experimental actions which describes equipment 
and experimental conditions. 
¾ OBI:Process describing experimental actions, procedures and protocols. 
¾ IAO: information content entity which provides meta-information about 
the document title, author and license. 
In practice this allows the researcher (or computer) to read a protocol 
describing the exact actions taken by a researcher when performing a specific 
protocol such as in the example below. The first nine lines describe metadata 
and relevant starting conditions. After that, each experiment action (a subclass 
of OBI: a process called EXACT2: experimental action) is described together 
with all information necessary to describe the action. Creating an exact but 
very cumbersome representation of the experimental actions performed when 
executing a laboratory protocol in the following manner: 
 
Protocol 
DC title: partial protocol for the preparation of 
Saccharomyces cerevisiae competent cells 
DC author: Wayne Aubrey 
DC organisation: Aberystwth University 
status: draft 
DC submission date: 15 January 2008 
 
operating procedure: grow yeast culture 
pre-condition: sealed yeast colonies plate in cold room 
pre-condition: YPD media bottle in cold room 
experiment action: move 
object: YPD media bottle 
start location: in store 
end location: in laminar flow hood 
 
experiment action: move 
object: conical flask 
start location: in store 
end location: in laminar flow hood 
39
experiment action: move  
object: sealed yeast colonies plate   
start location: in cold room 
end location : in laminar flow hood 
experiment action: add 
component 1: YPD medium 
volume: 50ml 
start container: YPD media bottle 
end container: 500ml conical flask 
equipment: pipette 
experiment action: rename 
old name: 500ml conical flask 
new name: YPD conical flask 
experiment action: add  
component 1: single yeast colony 
volume: small volume 
precision: N/A 
start container: yeast single colonies plate 
end container: YPD conical flask 
equipment: inoculating loop 
experiment action: rename 
old name:YPD conical flask 
new name:yeast culture flask 
experiment action: incubate 
object: yeast culture flask 
equipment: shaking incubator 
rpm: 200 
temp: 30C 
time interval: 12-24h 
In a normal materials & methods article, the above text would perhaps, have 
been GHVFULEHG DV ´<HDVW FXOWXUHVZHUH WDNHQ IURPFROG VWRUDJH DQG D VLQJOH
yeast colony was added to a 500 ml conical flask and incubated for 12-24 h in 
D VKDNLQJ LQFXEDWRU  &  USP´ )RU D ZHEVLWH OLNH WKH 0ROHFXODU
Methods database, an ontology like EXACT, therefore, provides a potentially 
valuable back-end to categorise experimental actions and objects but requires
an adapted front-end to make the format more readable and convenient for 
human users. 
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1.5.4 Coordination among ontologies 
Ontologies suffer from the same weakness as standards in the sense that they 
depend on the acceptance of the community to become useful. To combat 
fragmentation of knowledge represented in ontologies two major efforts are 
ongoing in Life Science (Konopka, 2015). 
The Unified Medical Language System (UMLS) unifies a large number of 
GLIIHUHQW VRXUFH YRFDEXODULHV XVLQJ D ZRUG LQGH[ (DFK ZRUG RU ³SUHIHUUHG
WHUP´ LV WKHQ JLYHQ D ODUJH QXPEHU RI VHPDQWLF UHODWLRQVKLSV LQFOXGLQJ
synonyms) connecting the classifications, code sets, thesauri, and lists of 
controlled terms compiled in the UMLS Metathesaurus (Aronson, 2001; 
Schuyler et al., 1993). The Metathesaurus aims to create meaningful 
relationships between already existing vocabularies, meaning that it does not 
have an ambition of structuring data or reducing redundancy among 
overlapping vocabularies. 
The OBO Foundry is a collaborative development creating a more unified 
is-a hierarchy of terms covering all domains of scientific research (Smith et al., 
2007). Its overall aim is to pursue a strategy where ontologies are accepted into 
the foundry provided that they conform to the shared principles of the OBO 
Foundry. 
The eB3Kit relies on ontologies based on OBO principles (Brochhausen et 
al., 2013)  to federate and exchange data using the MIABIS (Merino-Martinez 
et al., 2016) and clinical data will to a great extent by local stakeholders using 
components of The Unified Medical Language System (UMLS). 
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The thesis aims to enable and to accelerate research cycles (see figure 3). This 
overall goal is achieved by helping researchers to more efficiently transfer and 
utilise information. The specific contributions presented in this thesis can be 
divided into three core components: 
¾ The development of the Molecular Methods database.
¾ The creation of the eB3Kit bioinformatics component.
¾ Investigations into the interaction between researchers and technology
platforms to evaluate how to address the needs of the end users.
Figure 3. The research cycle model adopted by the B3Africa project. The eB3Kit provides an 
informatics platform covering the technical solutions necessary to manage information, samples 
and data analysis as well as share this information with external stakeholders on a secure platform 
(blue components). The social components of the B3Africa project (green) serves to integrate this 
technical capacity into the local research environment by providing training and expertise that 
allow researchers to use the technology, overcome ethical and legal barriers and make the most of 
their research. These two components strengthen local research communities which can use the 
platform to innovate and produce new innovations or scientific discoveries (white). 
2 Aim of thesis
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3.1 Paper I: Workshop on laboratory protocol standards 
for the molecular methods database
The Molecular Methods Database was created in 2009 and initially funded by 
the EMERALD project (Beisvåg et al., 2011) as a central resource for methods 
and protocols focusing on microarray-based technologies. Throughout its 
lifetime the database has undergone several revisions changing the database 
from a software application to a web server and changing how the user 
interacts with the database (table 2). Since its third version which was created 
by the author based on the conclusions of paper I the protocol database has 
supported several European and Swedish research projects, hosting protocols 
used in numerous scientific publications (Daebeler et al., 2017; Medhat et al., 
2017; Allen et al., 2016; de Koning, 2016; Marikanty et al., 2016; Saxena et 
al., 2013; Librizzi et al., 2012) and more than 40 000 user sessions by external 
users have been logged since 2013 when Google Analytics was implemented 
on  the website. 
3 Summary of research & results from 
papers I - V
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Table 2. Iterations of MolMeth. Work on version 3 and 4 are covered in this thesis with data 
collected based on version 4. 
Version Features Reason for replacement Code platform 
1 Desktop application 
developed to exchange 
protocols and 
experience between 
laboratories. 
Rapid development of Ajax and Web 
applications made software solutions 
outdated as purely web based 
applications offer superior cross 
platform compatibility and freedom of 
movement. 
Unknown 
2 Web based platform 
with focus on semantic 
integration with other 
websites. 
Modern content management systems 
and other factors out-competed Ruby 
on Merb which made the situation 
unsustainable unless a full 
development team was to be recruited. 
Ruby on Merb 
3 Web based platform 
with focus on semantic 
integration with other 
websites. 
The migration to Drupal 7 reduced 
maintenance costs but the 
requirements devised by 
informaticians and ontologists created 
a learning curve that laboratory 
researchers were unwilling to commit 
to. A new interface built on the 
existing database was therefore 
necessary.  
Drupal 7 
4 Web based platform 
with semantic 
integration and large 
focus on user 
friendliness and search 
engine optimisation for 
maximum visibility. 
Current version, all technical 
objectives are achieved, and 
researchers find the website by 
searching for protocols of interest. A 
lack of sufficient incentives to publish 
protocols is however evident and 
restricts growth. 
Drupal 7 
 
Version 4 (2013-current) and version 3 (2012-2013) were supported by the 
Swedish biobanking infrastructure (www.BBMRI.se) and the EU FP7 project 
Affinomics (www.affinomics.org) producing antigen targets and novel binders 
for a variety of purposes. Antibodies are a fast moving area where major batch 
effects are known to occur, causing issues with reproducibility and the 
calibration of protocols (Baker, 2015). Researchers reliant on antibodies can 
therefore greatly benefit from the rapid dissemination of technical information 
about viable assays and the suitability of new batches of antibodies being 
produced. At the same time, the publication of research projects is taking 
longer and longer as more and more data is required for publication (Vale, 
2015), meaning that the feedback cycle for new technology or quality issues is 
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slowing down. Encouraging the public dissemination of technical data and the 
formation of loose collaborative networks with researchers alerting each other
of issues as well as troubleshooting methods by using a shared web portal was 
therefore deemed a potential solution to the issues.  
In biobanks, the research environment is more stable, but there are 
collaborative benefits in having similar workflows adapted at a large number of 
biobanks. National networks such as the national Biobank and Biomolecular 
Research Infrastructures (BBMRI) in Europe (Yuille et al., 2007) and the 
Canadian Tumour Repository Network (CTRNet) (Matzke et al., 2012) 
therefore often engage in training and support efforts to promote the 
development of biobanks abroad as well as on the national level (Matimba et 
al., 2016; Cohen et al., 2013). It was therefore deemed important by BBMRI.se 
to provide a technical platform where researchers could publish and compare 
protocols without constraints regarding pre-publication review and estimates of 
scientific impact required by peer-reviewed publications. Despite the 
significantly different challenges faced by the two projects, both projects made 
provisions to use MolMeth to create active user communities sharing technical 
information between experts to improve productivity and reduce error rates 
within the two fields. 
3.1.1 Description of the Molecular Methods database 
MolMeth relies on an open submission system where users may register on the 
site and immediately start publishing protocols. A commercially available anti-
spam system is used to categorise submissions as spam, or non-spam and 
administrators evaluate new protocols post-publication to conduct basic quality 
checking as well as re-categorising spam/non-spam if necessary. 
Registered users can comment and rate protocols which help users to find 
the highest rated protocols in each sector. Protocols are never removed from 
MolMeth, but a revisioning system is used to provide researchers with a simple 
but useful tool to update and manage protocols. 
Users can update any protocol they have submitted and also grant other 
members the right to edit protocols. When a protocol is edited, a revision is 
created. Each revision is saved with a timestamp and accessible by clicking the 
³UHYLVLRQ´ WDE DW WKH WRS RI Dprotocol. By referring to specific time stamps, 
users can ensure that they always cite the correct iteration of a protocol while 
still providing other researchers with access to both older and more updated 
versions of the protocol. Outdated or erroneous protocols can thereby be 
labelled as such, but older versions are still available to researchers who wish 
to access such content later.  
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3.1.2 Current status and sustainability 
MolMeth was first established in 2009 but has undergone several major 
overhauls where protocols have been re-curated, and user accessibility 
improved. Reading and posting protocols is free and all protocols are published 
using a Creative Commons 3 license, which means that all material can be 
freely distributed as long as it is properly cited. 
The two versions developed throughout the work of this doctoral project 
has been built using Drupal 7, an open source Content Management System 
(CMS) to ensure the longevity of the site as extensive documentation and 
commercial support is available for future development and maintenance. The 
website is currently being run on a hosted by the Swedish University of 
Agricultural Sciences, and backups of the site are being made daily. As the 
website relies on standard off the shelf software, there is a minimal need for the 
in-house development of new tools and software the as these are provided by 
the Drupal user community. 
3.1.3 Traffic and activity 
Rebasing MolMeth to Drupal 7 allowed provided support for integration with 
Google Analytics and systematic tracking of visitors started in 2013. During 
the four-year period between 13, May 2013 and 13 May 2017 almost 12 000 
sessions per year have been registered using Google Analytics. The by far most 
common way to find MolMeth is by search queries on search engines (65.4 %) 
with direct links (16.5 %) and referrals (14.0 %) providing most of the 
remaining visits (figure 4) 
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Figure 4. Sources of traffic to www.molmeth.org. 
MolMeth is designed to make information easily accessible using search 
engines like Google and users are expected to arrive immediately at the right 
protocol rather than visiting the front page. This is reflected in the user 
behaviour where the front page is only the third most visited page (table 3). 
Protocol popularity is very unevenly distributed and among the 584 unique 
URLs accessed by searchers the ten most influential pages have received 26.5 
% of the search engine hits (table 3). 
Table 3. During the period 13th May 2013 to 13 May 2017 a total number of 46 966 sessions 
by 38 760 different users were measured by Google Analytics. Of the 30 671 sessions with a 
measured target page, 26.5 % targeted one of the ten most popular web pages on MolMeth,
and the remainder were spread out among 584 valid URL:s at MolMeth. 
Target page Sessions Pages/session
/protocol/processing-blood-specimens 2 697 1.13
/protocol/collecting-plasma-whole-blood 2 092 1.15
/ (front page) 1 258 4.05
/protocol/situ-proximity-ligation-assay-pla-protocol-using-
duolink
1 196 1.16
/protocol/situ-proximity-ligations-assay-pla-protocol 890 1.22
/protocol/collecting-and-processing-saliva 868 1.26
/protocol/vivo-biotinylation-protocol-avitagged-proteins 844 1.25
65%
17%
14%
4%
Sources of traffic to 
MolMeth
Organic search Direct Referral Social networks
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Target page Sessions Pages/session 
/protocol/protocol-decontamination-instruments-reagents-
and-laboratory-areas-challenging-dna-analysis 
707 1.22 
/protocol/click-chemistry-antibody-dna-conjugation-
protocol 
700 1.23 
/protocol/collection-white-blood-cells 699 1.17 
Total number of sessions in top 10 8 138  
Total number of sessions in measurement 30 671  
Age distribution shows a strong bias towards younger researchers with 86 % of 
site visitors being 44 years old or younger (figure 5). The gender distribution is 
relatively equal with a slight overrepresentation of female visitors (53 %).   
 
Figure 5. Google Analytics was able to provide age data about 28.8 % of site visitors. 
The USA is the most common location for visitors to MolMeth (27.7 %) 
followed by Russia (9.6 %) and Sweden (4.3 %). Upon deeper analysis using 
Google Analytics, it is, however, clear that usage patterns in Sweden and 
Russia differ from normal usage patterns (table 4). In Sweden, this is related to 
a high number of partners providing direct links to the front page 
(www.molmeth.org) and high activity by partners at SLU and Karolinska 
Institutet to publish protocols. In Russia, a careful analysis (data not shown) 
show that the number of genuine visits most likely are only a few hundred 
while the rest are caused by various spamming programs manipulating Google 
analytics. This includes an attack directed via the social networking site Reddit 
0%
10%
20%
30%
40%
50%
18-24 25-34 35-44 45-54 55-64 65+
Age distribution 
49
which contributed almost half the visits generated by social media during the 
survey period.  
Table 4. Usage patterns across the globe. Web crawlers (mainly hosted in Russia or from an 
unknown location) disproportionally visits the front page compared to normal user behaviour. 
Country (100 % of total 
sessions)
Sessions Front page visits Percentage
United States 13022 1712 13.1%
Russia 4489 4 491 100.0%
Sweden 3469 2024 58.3%
United Kingdom 2648 388 14.7%
India 1851 60 3.2%
Germany 1764 280 15.9%
(not set) 1380 547 39.6%
Canada 1228 70 5.7%
France 1073 159 14.8%
Japan 1025 107 10.4%
Total top 10 31949 9838 30.8%
Total 46966
MolMeth hosts over 10 000 user sessions per year and its reliance on the 
Drupal content management system with limited customisation means that it 
can be operated at a very low cost to handle periods with limited or no funding. 
Based on user feedback the concept of an open protocol platform is also 
appreciated by researchers looking for support to find protocols and standard 
operating procedures. Generating the user engagement necessary to create a 
sustainable web 2.0 platform with an active user community publishing and 
discussing protocols have however been harder than anticipated. Attempts have 
been made to lower the threshold for publishing protocols on MolMeth by 
creating a simple uploading process sacrificing much of the structured data 
fields in favour of free text fields which can be filled in by copy and pasting 
from Word documents.  
3.1.4 Representation of protocols using the EXACT ontology 
The EXACT ontology (Soldatova et al., 2008) is closely related to the Robot 
Scientist project (King et al., 2009) and can in a controlled environment 
provide a perfect representation of laboratory protocols. In real life 
experiments using protocols and machine learning techniques, the ontology is 
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estimated to cover 85 % of the typical experimental actions described in 
previously unseen protocols (Soldatova et al., 2014).  
Both MolMeth and EXACT (Soldatova et al., 2014) have however been 
struggling to find a way to represent protocols in a manner accepted by 
biologists. Despite significant effort to simplify user interactions with the 
systems uptake of ontology-based protocols have failed to achieve significant 
traction among the intended user community. In MolMeth version 3 a
simplified annotator tool was created to help researchers separate metadata, 
information about preconditions/experimental conditions and the experimental 
actions described by the protocol (Trollvad et al., 2012). This annotation 
allowed MolMeth to represent all relevant information contained in the 
experiment actions of an EXACT protocol using approximately one-tenth of 
the number of lines used in an EXACT protocol (see table 5 for a comparison) 
provided that writers follow two simple rules: 
¾ Each sentence should only describe a single experimental action.
¾ Each sentence should begin with the verb describing the experimental
action.
Table 5. &omparison of EXACT, MolMeth V3 text and an example of a free text description. 
EXACT
MolMeth Free text
operating procedure: grow 
yeast culture
Protocol: Grow yeast cell 
culture
Materials and methods: Growth 
of yeast cell culture
pre-condition: sealed yeast 
colonies plate in cold room
reagent: sealed yeast colonies 
plate stored in cold room
Yeast cultures were taken from 
cold storage and a single yeast 
colony was added to a 500 ml 
conical flask and incubated for 
12-24 h in a shaking incubator
(30 C, 200 rpm)
pre-condition: YPD media 
bottle in cold room
reagent: YPD media
equipment: 500 ml conical flask
experiment action: move equipment: pipette
object: YPD media bottle equipment shaking incubator
start location: in store equipment: inoculating loop
end location: in laminar
flow hood
Add 50 ml YPD medium to a 
500 ml conical flask using a pipette
experiment action: move
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EXACT
MolMeth Free text
object: conical flask Transfer a single yeast colony from the plate to the 500 ml conical 
flask using the inoculating loop
start location: in store
end location: in laminar
flow hood
Incubate at 30 C for 12-24 h 
in shaking incubator at 200 rpm
experiment action: move 
object: sealed yeast 
colonies plate   
start location: in cold room
end location : in laminar
flow hood
experiment action: add
component 1: YPD 
medium
volume: 50ml
start container: YPD media 
bottle
end container: 500ml 
conical flask
equipment: pipette
experiment action: rename
old name: 500ml conical 
flask
new name: YPD conical 
flask
experiment action: add 
component 1: single yeast 
colony
volume: small volume
precision: N/A
start container: yeast single colonies plate
end container: YPD 
conical flask
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EXACT 
MolMeth Free text 
equipment: inoculating 
loop 
  
   
experiment action: rename   
old name:YPD conical 
flask 
  
new name:yeast culture 
flask 
  
   
   
experiment action: 
incubate 
  
object: yeast culture flask   
equipment: shaking 
incubator 
  
rpm: 200   
temp: 30C   
time interval: 12-24h   
The proposed annotation system did however not increase user engagement in 
any measurable manner, leading to the development of MolMeth version 4 
which allows researchers to copy and paste word documents into the website 
without any rewriting at all.  
3.1.5 Summary 
By comparing the initial plans for MolMeth outlined in paper I and research 
proposals the project has as of yet reached a point with a combination of 
achieved and unfulfilled objectives: 
¾ Create a platform to make protocols readily available ± achieved. 
¾ Create a platform that is sustainable in a technical and financial perspective 
± achieved. 
¾ Create a platform where structured data regarding laboratory information is 
made available ± objective removed to increase user-friendliness. 
¾ Create a platform with an active and sustainable user community ± 
unfulfilled. 
Even with a functional, technical solution and an acceptable number of traffic 
of visitors looking for information MolMeth has failed to establish an active 
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user community generating content on its own. To better understand the 
mechanisms behind such a community work on paper II was initiated. 
3.2 Paper II: Scholarly publication in the digital age, an
investigation into why novel publishing concepts 
have failed to disrupt the market of scientific journals. 
Paper II covers 42 different platforms for social networking aimed at 
researchers. Out of the 42 platforms, only six websites maintained active user 
communities that could be defined DV³DFWLYH´LQWKHVHQVHWKDWPHPEHUVJRWD
response from other members active on the site when publishing content. Of 
the six successful websites, three are focused on helping researchers to access 
articles of interest and advertise their articles (ResearchGate, Mendeley and 
Academia.edu) and one obtains members by requiring students participating in 
the International Genetically Engineered Machine (iGEM) competition to 
contribute protocols to the Wikipedia like web page OpenWetWare. The two 
remaining websites, Biostars and myExperiment are targeting 
bioinformaticians in line with traditions from programming and computer 
VFLHQFHUDWKHUWKDQ³ZHWZRUN´LQ/LIH6FLHQFH
Based on the evaluation in paper II we conclude that despite significant 
efforts the scholarly communication in Life Science remain highly similar to 
how it was conducted in the pre-digital era as devised by Garvey and Griffith 
(Garvey and Griffith, 1972) (figure 6) but with small modification to how 
researchers gain awareness of new publications (figure 7). 
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Figure 6. Scholarly communication as explained by Garvey & Griffith in 1972 with an overlay of 
the academic process (marked 1-5) based on Roosendal and Guerts. To justify funding, promotion 
and recognition researchers are expected to contribute to scientific progress. As a researcher, it is,
therefore, necessary to register discoveries (1), have them accepted by peers (2) and present the 
results to the wider research community (3) in a format accessible to future researchers (4).  
Reward metrics may be straightforward (e.g. UHZDUG IRU SXEOLVKLQJ LQ WKH µULJKW¶ MRXUQDOZLWK
high acceptance in the community) or implicit (e.g., being awarded a promotion based on a 
successful track record of conference presentations and publication of significant articles) but all 
four criteria are necessary to estimate scientific impact and justify the future allocation of 
resources (5). 
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Figure 7. The current status of scientific publishing. Publication in peer-reviewed journals 
remains the only method to achieve certification, awareness and archiving, but search engines and 
scientific, social networks provide new channels for researchers to raise awareness of new 
articles. This makes scientists less reliant on the popularity of the journal to reach potential 
readers making it more attractive to publish raw data and methods, as long as the content is 
delivered in a citeable format. 
Correlation between the journal impact factor and citation rate of an article is 
low (Bornmann and Leydesdorff, 2017) and seem to fall further as 
digitalisation of communication allows researchers to increasingly rely on 
searchers and social media rather than journal subscriptions to drive article 
readership, (Lozano et al., 2012) creating opportunities for alternative means of 
publication and lowering barriers of entry for new journals. Peer-reviewed 
articles are likely to remain a cornerstone of research, but even the decision of 
a single researcher to not pursue a traditional journal publication for his pre-
print (Coop, 2016) has been commented upon in Nature (Singh Chawla, 2017). 
Furthermore, citations are increasingly based on DOI numbers, and researchers 
in high-energy physics are already experimenting with citeable datasets 
(Herterich and Dallmeier-Tiessen, 2016). Historically high-energy physics has 
been at the forefront for previous developments in digital publication (Lozano 
et al., 2012) with the popularisation of preprints (Gentil-Beccot et al., 2010; 
Till, 2001) which are now accepted and even encouraged in Life Science 
(Callaway and Powell, 2016; NIH Grants, n.d.) as well. Suggesting that 
services such as Zenodo (www.zenodo.org) and Figshare 
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(www.figshare.com) which are currently seeing early adoption activity very 
well may have a bright future ahead of them.  
As the survey suggests life science researchers are unlikely to adopt new 
technology unless there are clear incentives to do so. Given the current focus 
on articles and citation rates it is therefore not surprising that the most 
successful websites have been websites which allow life scientists to boost 
their visibility and their efficiency by marketing their articles and find 
suggestions on articles to read, thereby reducing the time they have to spend 
finding information of relevance to them, and making communication faster. 
For a website like MolMeth this means that the barrier of entry to the 
scientific publication market has been reduced and that citeability and the 
ability of researchers to build awareness of their research are key factors to 
success. Obtaining DOI numbers and integrating a protocol website with 
established journals would, therefore, be key factors to success in the further 
development of MolMeth which is a development pattern currently followed 
by protocols.io (Teytelman et al., 2016). 
3.3 Paper III: Legal & ethical compliance when sharing 
biospecimen 
DNA is one of the most widely studied analytes and can be extracted from 
practically any sample commonly held in a biobank. Stored samples and 
derived data must, therefore, be treated with care in regards to privacy, or in 
the case of many biological samples, ownership rights.  This means that 
ethical, legal and social implications (ELSI) can be a significant barrier when 
engaging in collaborative projects (The Expert Advisory Group on Data 
Access, 2014; van Panhuis et al., 2014).  
Bioethics is an interdisciplinary subject (Silber, 1982) just like 
bioinformatics but its historical relationship to life science is complex as the 
roots of bioethics is not among natural scientists but among people trained in a 
philosophy who began to teach, write, and profoundly influence life science 
(Pellegrino, 1999). Bioethicists have always sought a normative role in medical 
and biological research (Pellegrino, 1999; Silber, 1982) and have  been 
successful in doing so as the field has achieved an almost extra-legal status 
with bioethicists functioning as experts in research ethics committees and 
institutional review boards (Abbott and Grady, 2011; Angell et al., 2006). 
Delegating research ethics to experts has however, despite significant resources 
being devoted to the task, not provided much of a tangible benefit to the 
research process (Dixon-Woods et al., 2016; Abbott and Grady, 2011) and also 
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risk alienating the researchers who conduct sensitive research but do not 
consider bioethics as being a part of their competence (Johnsson et al., 2014).  
Paper III was conceived as a collaboration between SLU Global 
Bioinformatics Centre and the Centre for Research Ethics & Bioethics at 
Uppsala University to provide better support for researchers who need to deal 
with ethical and legal compliance as their biobank grows. The resulting paper 
is a primer for active researchers who need help to deal with early stages of 
biobank planning and to understand common scientific discourse in bioethics 
papers.  
Key conclusions from the report and implications for the eB3Kit are: 
¾ To accommodate international collaboration, it is necessary to bridge the
gap between national legal frameworks. This is usually done by designating
experts and organisations who determine if material transfer agreements are
able to protect the rights of the donors in accordance with what they could
expect when giving their consent for samples to be stored for future usage.
± Standardised templates to encourage a more expedient review process has
previously been suggested in other projects (Thompson et al., 2014) and the
eB3Kit provides a standardised technology platform making not only
formatting but also the underlying security measures more standardised.
¾ Collaboration is substantially more likely to be accepted between nations
where the respective authorities have had the possibility to become familiar
ZLWKHDFKRWKHU¶VFXVWRPVDQGWUDGLWLRQV,GHQWLI\LQJVXFFHVVIXOSUHFHGHnts
by other researchers participating in collaborative projects can therefore
significantly reduce the time necessary to access samples. ± More mature
biobanks using the eB3Kit can serve as role models for other biobanks and
provide a template for biobank governance as well as applications to review
boards. By including ethics parameters in the data model, this data can be
spread more efficiently within networks of eB3Kit users (Merino et al.,
2016).
¾ Different institutions define terms such as consent, informed consent and
broad consent differently. This means WKDW DQ µLQIRUPHG FRQVHQW¶ DW RQH
institution may not be accepted as truly informed by another. Under such
circumstances, researchers are likely to face a situation where the strictest
interpretation in terms of data protection or privacy becomes the governing
one. ± Issues of terminology will be a significant challenge and the data
model developed by B3Africa (Merino et al., 2016) will need to provide a
mapped vocabulary to bridge the gap between terminologies and support
comparisons between applications.
¾ There is a conflict between reciprocity, anonymity and the right to not
know. Research must, therefore, be planned and conducted in accordance
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with what the donors could reasonably expect when donating their samples 
and giving their consent. ± eB3Kits will be deployed in biobanks at various 
levels of maturity and networks such as ESBB and BCNet (Mendy et al., 
2015) may be more suitable for this kind of early stage support even if the 
eB3Kit provides a comprehensive hands on training environment similar to 
how we use the eBiokit for bioinformatics training.  
Since the study was completed the European Union General Data Protection 
Regulation (GDPR) (European Union, 2016) has been published providing, for 
the first time, a legally binding set of regulations on data protection covering a 
large number of countries. From a technical perspective many of the terms 
used in the regulation are however still open for interpretation by expert bodies 
and there is also room for national legislation making the GDPR somewhat 
different in each country (Litton, 2017). The training requirements, even for 
researchers within the EU will therefore remain but the further development of 
the data model will benefit as it can be partially based on the GDPR. 
3.4 Paper IV: Supporting the development of biobanks in 
low and medium income countries 
Paper IV describes the work of the B3Africa consortium, and how social as
well as technical aspects are taken into account when building an informatics 
platform for research integrated biobanks. The project is based on experience 
from a several different projects contributing to the development of research 
infrastructure using technology and knowledge developed in several different 
projects concerning the development of biobanking and bioinformatics in 
Africa (Bendou et al., 2017; Hernández-de-Diego et al., 2017; Müller et al., 
2017; IARC, 2016; Merino-Martinez et al., 2016; Mulder et al., 2016; Mendy 
et al., 2015; Abayomi et al., 2013; Klingström, 2013; Norlin et al., 2012; 
Fuxelius et al., 2010). 
The overall aim is to provide a robust and sustainable technology platform 
for biobanks. Currently, active biobanks in low- and medium-income countries 
have mainly been created to support specific programmes targeting major 
health issues in the countries hosting the biobank. Consequently, biobanks are 
often ill-prepared to collaborate independently and maintain operations after 
the end of a project (Mendy et al., 2015), thus leading to the loss of valuable 
infrastructure and disassembly of the expert team necessary to run it (figure 8).
Figure 8. The life cycle of a biobank if sustainability is not achieved. 
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Research groups in resource-constrained settings were particularly vulnerable 
to loss of key personnel as they are reliant on a small number of individuals 
and lack the means to replace lost competencies quickly. An appropriately 
configured informatics system can in most cases negate these issues as data is 
stored in a structured manner and can be retrieved in a format accessible to 
non-specialists. This means that even if the data protection officer is lost her 
work can be retrieved and evaluated during future reviews and application, if 
the biobank core staff is lost samples will remain accessible and appropriately 
annotated in the freezers and if the bioinformatician leaves all workflows can 
not only be replicated but also re-used and applied to new datasets. Under ideal 
circumstances, a biobank operating eB3Kit should be able to hibernate to such 
an extent that even if all personnel leave the project, a researcher familiar with 
the eB3Kit should be able to activate the platform and retrieve data or ensure 
that precious or dangerous samples are still kept in the biobank. This means 
that the eB3Kit needs to contain structured data and the necessary tools to: 
¾ Support the collection of samples in compliance with the ethical and
regulatory framework.
¾ Ensure that samples are kept in compliance with the ethical and regulatory
framework.
¾ Allow staff to organise collections, studies and standard operating
procedures (SOP).
¾ Conduct sample acquisition and metadata management in each study.
¾ Track the processing and storage of samples.
¾ Handle the retrieval, retention, processing and destruction of samples and/or
data.
¾ Integrate and catalogue external data using MIABIS or other data transfer
formats.
¾ Support the retrieval of relevant data from all the above tasks to conduct
data analysis.
The bioinformatics module will have access to all data from the clinician¶s 
request to the start of the analytical examination, thus providing an 
unprecedented coverage of pre-analytical variables that may influence the 
analysis. This data access is provided in collaboration with the other work 
packages as well as built on the experience gained in paper I and III to ensure 
that relevant data is retrieved from the other components of the eB3Kit and
made available for data analysis with appropriate safeguards.  
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3.5 Paper V: Galaksio, a user-friendly workflow-centric 
front end for Galaxy  
Galaksio provides a workflow-centric graphical user interface (GUI) for data 
analysis in the eB3Kit and is described in paper V of the thesis. The aim of the 
tool within the context of the eB3Kit is to reduce the workload of 
bioinformaticians working at research integrated biobanks but can also be 
deployed independently as a user-friendly portal to any Galaxy server. 
Galaksio runs on a Python web server installed on the eB3Kit and connects to 
the Galaxy workflow management system using the Galaxy API. 
The Galaksio interface is created based on previous experience with Galaxy 
which has been installed in the eBiokit and used in several training & capacity 
building projects (Mulder et al., 2016; Atwood et al., 2015; Fuxelius et al., 
2010). During this work, it has become evident that the Galaxy workflow 
management can provide significant benefits when implemented as it allows 
workflows to be shared and ensures that data is handled reproducibly. A lack 
of stakeholder analysis has however created similar issues as with the MolMeth 
database in the sense that researchers acknowledge the overall benefits of the 
system but do not use it due to a lack of relevant incentives on a more personal 
level. 
Our in-house analysis concluded that a more layered approach would make 
the system more attractive for the users. Work related to bioinformatics can 
largely be separated into three distinct tasks: 
¾ Using bioinformatics tools or workflows. 
¾ Developing bioinformatics tools and workflows. 
¾ Creating and managing the infrastructure for data analysis. 
The graphical user interface provided by Galaxy provides enables the first two 
tasks but does not take into consideration that users completing the two tasks 
are likely to have significantly different backgrounds. Users developing 
workflows for others are likely to have bioinformatics training and even if 
there is no exact definition of what a bioinformatician needs to know (Vincent 
and Charette, 2015) bioinformaticians tend to prefer working in a command-
line environment due to its flexibility. Implementing tools in a graphical user 
interface with controlled input/out of data between tools limits this flexibility 
which means that bioinformaticians are unlikely to adopt Galaxy for their 
personal needs(Oliphant, 2016; Budd et al., 2015). Researchers looking to use 
pre-made workflows on the other hand come from a wide variety of 
backgrounds and in most cases this mean that they will have little or no 
experience of the tools they intend to use (Smith, 2013). Rich and flexible user 
options are therefore of limited value while a user-friendly graphical user 
interface is of high importance (Kumar and Dudley, 2007). 
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Despite these different user needs Galaxy provides the same interface to 
both user groups (figure 9) generating a far from optimal user experience for 
novice users using the graphical user interface. 
Figure 9. Hundreds of tools are available but hidden in the menu to the left and the history to the 
right expose all data generated by workflows. In the middle, a cramped space remains open to 
provide access to input parameters for each tool used. 
As the GUI is the dominant form of user access (Galaxy Questionnaire Results 
by Manuel Corpas & Rafael Jimenez, data not published) and crucial to 
automating bioinformatics tasks work package four have developed the 
Galaksio interface described in paper V (figure 10). Each workflow covers a 
dedicated task and Galaksio retrieves all the workflow data from the Galaxy 
server. All actions accessible to the user in Galaksio (see table 6) are directly 
sent to the Galaxy server using the Galaxy API and processed on the Galaxy 
server. Meaning that there should be no conflicts between Galaksio and other 
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Galaxy extensions such as Bioblend (Sloggett et al., 2013), Cloudman (Afgan 
et al., 2010) and Pulsar (Afgan et al., 2015). 
Figure 10. Galaksio provides access to a clean workflow-centric view providing access annotated 
workflows describing necessary input data. Galaxy histories and a homepage are available in the 
menu to the left. 
Table 6. Table of Galaksio features. 
Feature Category Implemented Planned
User sign-in/out Users X
User sign-up Users X
Workflow listing Workflows X
Workflow importing Workflows X
Workflow execution Workflows X
Workflow creation Workflows X
Simultaneous execution of workflows Workflows X
Recovering previous executions Workflows X
Help and description for tools in workflow Workflows X
Input selection and parameter configuration Workflows X
History selection History X
History creation History X
History deletion History X
Dataset uploading Dataset manipulation X
Dataset downloading Dataset manipulation X
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Feature Category Implemented Planned
Dataset deletion Dataset manipulation X
Dataset collection creation Dataset manipulation X
Dataset collection deletion Dataset manipulation X
Tool execution Tools X
The result is what we call a layered approach allowing users to work with 
bioinformatics at the level they are comfortable with. Researchers at the 
biobank using defined workflows use Galaksio, bioinformaticians can develop 
workflows and integrate tools using the default Galaxy interface or high-level 
programming languages such as Python through Bioblend and system 
administration is only burdened by the addition of a separate Python Web 
Server built using Flask (figure 11).
Figure 11. The layered approach. 
This means that a biobank lacking  dedicated bioinformaticians can still 
operate effectively using automated workflows and retrieve these from public 
Galaxy servers or by collaborations with the Galaxy community and other 
eB3Kit users. Furthermore, researchers using these automated workflows will 
have their work tracked by the eB3Kit and provenance data is exported from 
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Galaxy to the file management system of the eB3Kit. Meaning that even if a 
researcher leaves the biobank his or her work will remain reproducible. 
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The adoption of technology in research is hard to predict as the motivations 
underlying their implementation almost invariably constitute a wicked 
problem. Open sharing of data is a widely shared value in research and public 
databases like MolMeth can reach thousands of researchers each year even
without formal certification of the protocols through peer review. Getting 
researchers to engage and contribute is, however, a more difficult task, and
most entrepreneurs in social sharing of data have failed to propose a successful 
user proposition to motivate researchers to contribute. Likewise, proponents of 
best practice standards in a variety of subjects have found themselves 
struggling to reach widespread traction. With the eB3Kit it is possible to 
provide an out-of-the-box environment with integration between the 
components necessary to track, manage and share data. Which may be useful 
for quality management, large-scale research and beneficial to the careers of 
researchers using the sharing capacity to maximise the utilisation of their 
samples or results. 
4.1 Evaluating the results of MolMeth and social 
networking in research 
A lack of reproducibility is one of the major issues of research today, and 
numerous initiatives have been made to introduce new means of improving 
record keeping as well as improving reproducibility. It has however proven 
extremely difficult to make researchers embrace data sharing and open record 
keeping for laboratory methods. Based on discussions most people seem very 
interested in finding documented methods, but there has been a lack of 
incentives to motivate researchers into compiling their protocols into a 
shareable format. This problem is not unique to MolMeth and most of the 
social networks covered in paper II as well as published technology-oriented 
4 Discussion
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solutions based on the EXACT2 (Soldatova et al., 2014, p. 2), the BioAssay 
Template (BAT) (Clark et al., 2016) and several commercial workflow systems 
have failed as experimental biologists persist with notebooks and spreadsheets 
for personal usage (Kazic, 2015). 
This behaviour stands in stark contrast to openness as being one of the 
central values of science (Royal Society (Great Britain), 2012; Merton, 1942) 
which makes it somewhat surprising that technologies that enable the sharing 
of data and methods find it so hard to achieve widespread adoption. Empirical 
research (Anderson et al., 2007), as well as the results of the aforementioned 
projects, does, however, support our rather cynical view of researchers as 
rational rather than idealistic agents of science as outlined in paper II. There is 
a lack of solid empirical data on successful means to promote open sharing 
(Rowhani-Farid et al., 2017) but paper II provides a theoretical model that help 
us evaluate the rational incentives for researchers to share information. An 
important conclusion in paper II is that the journal, despite the common 
perception of a publish or perish culture (Harley and Acord, 2011; Fanelli, 
2010; Neill, 2008; Fuyuno and Cyranoski, 2006), probably is not an end in 
itself. Rather the journal has received its premier position in life science due to 
its unique ability to combine, registration, certification, awareness-building and 
archiving in a single unit of information. If this theory proves true, it is likely 
that ongoing initiatives attaching digital object identifiers (DOI) to laboratory 
protocols (Teytelman et al., 2016), datasets (Herterich and Dallmeier-Tiessen, 
2016) and genome reports (Smith, 2016) will become increasingly important in 
the coming decade. With DOI numbers, search engines and access to social 
networks researchers can register their findings and build awareness by other 
means than journal circulation and collect the relevant information using tools 
such as Google Scholar profiles which automatically aggregate publications as 
well as citation counts (figure 12). 
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Figure 12. View of the public Google Scholar profile of the author. Articles can be manually 
added, but the Google web crawler technology provides a high-quality aggregator collecting 
article, conference proceedings and abstracts into a single comprehensive view along with citation 
metrics (available at https://scholar.google.com/citations?user=KdTvA-wAAAAJ).
4.2 Wicked problems 
It is evident, but hard to explain, the discrepancy between the ideals of 
researchers and how they act in regards to open research. The existence of a 
normative dissonance between the ideals of researchers and their actions has 
previously been described in the empirical literature (Anderson et al., 2007) 
even if paper II provides a, to our knowledge, unique example of its practical 
implications for the development of technology platforms in research. 
Recognising this normative dissonance and its implications is a necessary 
step to evaluate the development of websites and standards for sharing data. 
When advocating open data sharing researchers tend to focus on the reduction 
of technical barriers and overall societal benefits (McKiernan et al., 2016; 
Voytek, 2016) which based on our conclusions is an idealistic but inefficient 
way of promoting open data sharing. Unfortunately, empirical data on studies 
on alternative means to promote data sharing are lacking and the only 
empirically tested method to successfully encourage open data sharing in 
KHDOWK DQG PHGLFDO UHVHDUFK LV E\ ³UHZDUGLQJ´ researchers with open data 
badges (Rowhani-Farid et al., 2017; Kidwell et al., 2016).
One way to approach this issue is by accepting the issue as an example of a 
³ZLFNHG´ SUREOHP (Rittel and Webber, 1973), meaning that the problem is 
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subjective and its solutions cannot be quantitatively evaluated as the issue, and 
its solutions must be assessed from the perspective of each stakeholder (see 
table 7 for a full list of the characteristics of a wicked problem as summarised 
and explained by Ritchey (Ritchey, 2013) based on Ritten and Webbers 
original work). 
Table 7.The criteria used to define a “wicked” problem.
Criteria Explanation
1. There is no definite
formulation of a wicked
problem.
³7KHLQIRUPDWLRQQHHGHGWRunderstand the problem depends 
XSRQRQH¶VLGHDIRUsolving it. This is to say: in order to 
describe a wicked problem in sufficient detail, one has to 
develop an exhaustive inventory for all the conceivable 
VROXWLRQVDKHDGRIWLPH´
2. Wicked problems have no
stopping rules.
In solving a tame problem, ³«WKHSUREOHP-solver knows 
when he has done his job. There are criteria that tell when the
solution or a solution has been found´. With wicked 
problems you never come to a ³final´, ³complete´ or ³fully 
correct´ solution - since you have no objective criteria for 
such. The problem is continually evolving and mutating. You
stop when you run out of resources, when a result is 
subjectively deemed ³good enough´ or when we feel ³we¶ve
GRQHZKDWZHFDQ«´
3. Solutions to wicked problems
are not true-or-false, but better or
worse.
The criteria for judging the validity of a ³solution´ to a 
wicked problem are strongly stakeholder dependent. 
However, the judgments of different stakeholders «´are
likely to differ widely to accord with their group or personal 
interests, their special value-sets, and their ideological 
predilections.´ Different stakeholders see different 
³solutions´ as simply better or worse.
4. There is no immediate and no
ultimate test of a solution to a
wicked problem.
³«DQ\VROXWLRQDIWHUEHLQJLPSOHPHQWHGZLOOJHQHUDWH
waves of consequences over an extended - virtually an 
unbounded - period of time. Moreover, the next day¶s
consequences of the solution may yield utterly undesirable 
repercussions which outweigh the intended advantages or the 
advantages accomplished hitherto.´
5. Every solution to a wicked
problem is a ³one-shot
operation´; because there is no
opportunity to learn by trial-and-
error, every attempt counts
significantly.
³«every implemented solution is consequential. It leaves 
³traces´ that cannot be undone«And every attempt to 
reverse a decision or correct for the undesired consequences 
poses yet another set of wicked problems « .´
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Criteria Explanation
6. Wicked problems do not have
an enumerable (or an
exhaustively describable) set of
potential solutions, nor is there a
well-described set of permissible
operations that may be
incorporated into the plan.
³There are no criteria which enable one to prove that all the 
solutions to a wicked problem have been identified and 
considered. It may happen that no solution is found, owing to 
logical inconsistencies in the µpicture¶ of the problem.´
7. Every wicked problem is
essentially unique.
³There are no classes of wicked problems in the sense that 
the principles of solution can be developed to fit all members 
of that class.´ «$OVR«´Part of the art of dealing with 
wicked problems is the art of not knowing too early which 
type of solution to apply.´
8. Every wicked problem can be
considered to be a symptom of
another [wicked] problem.
Also, many internal aspects of a wicked problem can be 
considered to be symptoms of other internal aspects of the 
same problem. A good deal of mutual and circular causality 
is involved, and the problem has many causal levels to 
consider. Complex judgements are required in order to
determine an appropriate level of abstraction needed to 
define the problem.
9. The causes of a wicked
problem can be explained in
numerous ways. The choice of
explanation determines the
nature of the problem¶s
resolution.
³There is no rule or procedure to determine the µcorrect¶
explanation or combination of [explanations for a wicked 
problem]. The reason is that in dealing with wicked problems
there are several more ways of refuting a hypothesis than
there are permissible in the [e.g. physical] sciences.´
10. [With wicked problems,] the
planner has no right to be wrong.
In ³hard´ science, the researcher is allowed to make 
hypotheses that are later refuted. Indeed, it is just such 
hypothesis generation that is a primary motive force behind 
scientific development (Ritchey, 1991). Thus one is not 
penalised for making hypothesis that turn out to be wrong. 
³In the world of«ZLFNHGSUREOHPVQRVXFKLPPXQLW\is
tolerated. Here the aim is not to find the truth, but to improve 
some characteristic of the world where people live. Planners 
are liable for the consequences of the actions they generate 
«´
7KHEDVLFTXHVWLRQRI³KRZVKRXOGUHVHDUFKHUVFRPPXQLFDWHWKHLUILQGLQJVDQG
LGHDV´ LV LQ LWVHOIDZLFNHGSUREOHPDQGSURYLGHVDQH[DPSOHRIKRZZLFNHG
problems lack a clear stop where an issue can be seen as solved (point 2 in 
table 7). Publication in peer-reviewed journals became the favoured option at a 
time when the number of publications and active researchers increased rapidly 
while two-way communication was limited by physical constraints (Harley and 
Acord, 2011). As society progresses, other opportunities and challenges 
present themselves. From a bioinformatics perspective, the most significant 
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trend is perhaps that high-throughput research and improving means of digital 
communication (Akerman, 2006) generate large datasets with complex data 
that cannot be adequately described within the confines of a journal article. 
Such datasets present not only a technical challenge but a social one as well as 
the publication of such datasets are significant achievements in their own right 
that must be recognised in the academic system. Furthermore they often 
represents major collaborative efforts and are likely to generate significant 
scientific impact by secondary research without the active involvement of the 
original data creators (Altman et al., 2015). 
Providing access to data sharing models and integration with internationally 
accepted ontologies through a federated framework is therefore not enough to 
encourage data sharing in the B3Africa project. We must also recognise that 
data is a valuable commodity and accept that even if openness is an important 
value in research (Anderson et al., 2007) we must also provide rational 
incentives for researchers to share their data as they are unlikely to do so 
otherwise (Stephan, 2012). This complexity was underestimated at the start of 
the MolMeth project and even if more systematic reviews provide a more clear 
formulation of potential barriers that prevent sharing (van Panhuis et al., 2014) 
it is largely dependent on the individual stakeholder which obstacles are 
relevant in each particular case. Accepting the complexity of wicked problems 
also makes it less surprising that around 90 % of all attempts to develop social 
networks for researchers have failed. Most attempts fail, but a few provide 
solutions that are sufficiently adapted to specific demographics that they 
become sustainable as they do not only contribute to the abstract concept of 
scientific benefit but also provide benefits to the individuals using the network. 
As Digitial Object Identifier numbers (DOI-number) provided by CrossRef 
are becoming a de facto standard for citeability in research (Lammey, 2016) 
alternative resources for publishing scientific material become more attractive. 
Based on the model proposed in paper II, citeability is a key factor, meaning 
that journal publications are likely to face increased competition from citeable 
resources such as citeable datasets (Herterich and Dallmeier-Tiessen, 2016), 
preprints and published protocols provided that they have a DOI attached to 
them. Protocols.io (Teytelman et al., 2016) is a recently announced website 
with the support of private equity that can serve as a valuable test for the 
citeability hypothesis as each protocol is given a DOI. Evaluating its 
development may, therefore, provide valuable insights on future developments 
in data sharing platforms with implications for websites such as MolMeth and 
the development of communities communicating using data models supported 
by the eB3Kit. 
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4.3 Improving quality in study design and data analysis 
Errors preventing the reproducibility of research can roughly be divided into 25 
% study design, 50 % failure during the sample processing and 25 % poor 
statistics and data reporting (Freedman et al., 2015). Study design and data 
analysis are therefore concepts closely related to each other with ad hoc post-
processing an important sources of errors. 
To consult a statistician after a study is initiated is all too often like asking a 
veterinarian to examine your dead dog, the post-mortem may be interesting, 
but it will not help the dog. If used appropriately the eB3Kit will contribute to 
improving the quality of research. Studies on human-machine interactions 
show that there is a significant bias against automated methods in favour of 
KXPDQ³hands on´PDQDJHPHQWXQOHVVWKHHUURUUDWHRIWKHPDFKLQHLVvery low 
(Lee and See, 2004). With automated workflows for data analysis and a 
provenance system tracking samples throughout the system, bioinformaticians 
can provide workflows with support for automatic testing of confounding 
factors influencing the study and workflows to evaluate the statistical power 
and suitability of a workflow using simulated data before initiating an 
experiment. 
Furthermore, the reproducibility of an automated workflow management 
system like the eB3Kit bioinformatics module can be extended to include the 
entire process from sample to final results as long as the biobank provide 
persistent storage of samples. Most research institutions are essentially 
collections of independent laboratories, each run by principal investigators who 
head a team of trainees. This scheme has ancient roots and a track record of 
success (Hyman, 2017) but also makes it hard to create sustainable 
environments where data and samples are made available for follow-up
research (Dangl et al., 2010). This is especially true in low and medium income 
countries where successful researchers often leave the country as grants dry up,
or new positions at more attractive locations become available (Adewole et al., 
2014; Kasper and Bajunirwe, 2012; Dodani, 2005). 
A quality infrastructure is, however, no guarantee for quality research 
unless appropriate management practices are in place (Simeon-Dubach et al., 
2012; Grizzle et al., 2011; H. M. Moore et al., 2011; Compton, 2007). The 
bioinformatics module provides an automated infrastructure for reproducible
data analysis which in combination with training provided by BCNet, 
H3Africa, H3Bionet and other organisations will provide the means for 
continuous quality management and maximise the likelihood of generating 
replicable results. 
Currently 19-50 % of the current medical literature contains statistical flaws 
(Thiese et al., 2015; Ercan et al., 2007) and experiences in biobanking suggest 
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that review by external experts evaluating the standardisation and 
documentation of procedures can have a significant positive influence on 
reproducibility (di Donato, 2014; Freedman and Inglese, 2014; Matzke et al., 
2012). Aims to standardise data analysis are however in direct contradiction to 
current training practices in bioinformatics ZKLFKDUHKHDYLO\GHSHQGHQWRQ³RQ
GHPDQG WUDLQLQJ´. Meaning that each bioinformatician assembles his or her 
unique training program in the form of short workshops and web open courses 
(Atwood et al., 2015; Leek and Peng, 2015). Despite the fact that the need for 
comprehensive training programs at the university level for quantitative 
biology and bioinformatics have been known for a long time (Atwood et al., 
2015; National Research Council (US) Committee on Undergraduate Biology 
Education to Prepare Research Scientists for the 21st Century, 2003). 
The bioinformatics module of the eB3Kit can contribute to this solution by 
allowing experts to create automated workflows accessed through the Galaksio 
interface. These automated workflows provide several benefits compared to the 
ad hoc analysis used by researchers today. 
¾ Clearly defined start and end points forcing the researchers to consider their 
study design to be compatible with the statistical methods available. 
¾ Pre-defined workflows provide a comprehensive framework for updating 
existing knowledge. As new tools are developed, they replace legacy tools 
in workflows. Researchers can compare new workflows versus old 
workflows simply by retrieving original raw data from the eB3Kit and 
compare the output of new workflows with the legacy output. 
¾ Provenance is maintained as the entire process from study design to data 
analysis is maintained within the same system supporting retrospective 
evaluation of analysis decisions.  
An ideal study is from a statistical perspective a study where all potential 
outcomes are explored prior to data collection. Such an ideal study would 
provide a complete data set with information recording observed variables, 
heterogeneity within the population, biases in sample collection and a 
statistical data plan regarding where power levels have guided the size of the 
studied population and a priori decision has been made regarding statistical 
significance and tests of association. 
Such planning does, however, require significant work, and as with other 
SUHYLRXVO\GHVFULEHG³ZLFNHG´problems, it is not surprising that the research 
community consistently fails to achieve such a high level of quality. The 
eB3Kit bioinformatics component can here make a significant contribution by 
UHGXFLQJWKHWKUHVKROGWRDGRSWVXFKSUDFWLFHVE\SURYLGLQJ³DSSURpriate data 
PDQDJHPHQWE\GHVLJQ´DQGDFFHVVWRZRUNIORZVWKDWFDQEHXVHGWRVLPXODWH
experimental results. Thereby strengthening research applications and 
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contributing to more efficient usage of resources by supporting funding 
applications that include feasibility tests using simulated data in workflows. 
4.4 The automation of research and reliance on 
specialists 
As research moves further and further away from the one gene-one enzyme era 
(Bussard, 2005; Beadle and Tatum, 1941) into the Omics era (Gomez-Cabrero 
et al., 2014; Tan et al., 2009a). Researchers are pushed into an environment 
where we are forced to deal with challenges requiring knowledge in a wide 
variety of fields ranging from law and ethics to functional biology, molecular 
biology and bioinformatics. Ideally, this would be met by a corresponding 
increase in the knowledge of the researchers. Unfortunately, this is unlikely to 
happen as the margin effect of knowledge acquisition declines over time and 
research shows that domain knowledge in one field does not greatly accelerate 
how we deal with challenges in other areas unless they are closely related 
(Hambrick and Oswald, 2005; Hambrick and Engle, 2002). 
Collaboration in interdisciplinary teams allows researchers to focus on their 
own core skills but places high demands on trust and collaboration. 
Communication between fields, or even subfields, is not always 
straightforward with tacit as well as tangible norms favouring specialisation 
and distribution of credit to principal investigators (Fiore, 2008). Leading to 
situations like the one described for the Linnaeus Centre for Bioinformatics in 
the introduction as stakeholder could not reconcile their respective aims. It is 
therefore not surprising that work in interdisciplinary fields tends to deviate 
into the establishment of new research fields with dedicated university 
programs and career tracks (Canuel et al., 2015; Wightman and Hark, 2012; 
Tan et al., 2009b). As the field matures, the interdisciplinary field is provided 
with more and more specialists educated in the field, providing the subject with 
its distinct specialisation, potentially alienating it from the research 
communities it originated. One way to enable specialisation of researchers 
while maintaining support to researchers in related fields is by the continuous 
automation of tasks. Reviewers of the Galaksio article (paper V), as well as 
informal discussions with peers, have however revealed that many researchers 
raise concerns regarding the costs and benefits of automation related to the 
quality of work and the importance of researchers learning new skills. 
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4.4.1 Automation versus training more people in bioinformatics 
Automation is a global trend, and in research, it both accelerates research and 
allows researchers to focus on their own fields of research. With modern NGS 
technology most sequencing can be performed in a highly automated process 
only requiring extracted DNA and (comparatively) little technical knowledge 
of the user. The trend of automation is in other words already well established 
in life science and can easily be inferred from concepts related to the division 
of labour which is a core concept of modern economy. The original theory of 
division of labour state that “The division of labour, however, so far as it can 
be introduced, occasions, in every art, a proportionable increase of the 
productive powers of labour” (Smith, 1786) and it applies to research as well. 
When applied to research and bioinformatics can be exemplified in the 
following way: 
¾ Alternative A is to hire a person who has been trained in accordance with a 
recognised curriculum where secondary and tertiary education has prepared 
the person to work in bioinformatics. 
¾ Alternative B is to hire a person who possesses a marketable skill in another 
research subject but is willing to undergo training to become a 
bioinformatician. As the person possess a marketable skill, the alternative 
cost of having an employment using that skill must be covered while 
learning to become a bioinformatician 
To obtain a marketable skill for a research subject in Sweden (i.e. be eligible 
for a position as a PhD student) requires ten years of primary school, three 
years of secondary school and at least five years of tertiary education. The 
economic value of such a degree in the private sector is approximately 325 000 
to 360 000 SEK per year (37 500 - 41 600 USD at current conversion rate) 
which is roughly equivalent to a first-year American postdoc and significantly 
less than a graduate working in the private sector (Stephan, 2012). To become 
proficient in a subject like bioinformatics specialisation often occurs at the 
secondary school level (Wightman and Hark, 2012) suggesting that an 
additional 3-8 years of education is a reasonable estimate of the time necessary 
to retrain a biologist into a competent bioinformatician with sufficient 
programming skills. 
This means that to FRQYHUWD³UHVHDUFKELRORJLVW´LQWRD³ELRLQIRUPDWLFLDQ´
we extend the education time of a researcher by 17-44 % while reducing their 
active years as a researcher by 3-8 years. Even at the lower end of the training 
estimate, such training implies an alternative cost of ~1 000 000 MSEK that 
must be covered by the employer or the researcher. 
There are however three significant counterpoints towards this line of 
reasoning: 
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¾ A biologist retrained into a bioinformatician is a more versatile researcher
than a pure expert on bioinformatics.
¾ $VLJQLILFDQWSDUWRIWKLVWLPHPD\EHVSHQWE\³OHDUQLQJRQWKHMRE´RUbe
equivalent to the time the bioinformatician needs to learn another subject.
¾ Expertise in one field provides general skills that make it easier to transition
into another field.
Even if a researcher, in theory, is more versatile, it is hard, if not impossible, to 
maintain a competitive level of expertise in a field without working actively in 
it as skills quickly become obsolete or atrophy (Bapna et al., 2013; Allen and 
Velden, 2002). Attending a standardised curriculum equivalent to an 
undergraduate program also means that the researcher will return to the school 
bench and thereby reduce the time spent applying previously obtained 
theoretical skills in an applied environment which is an important part of skills 
development (Boshuizen, 2003),QFRPSDULVRQ³OHDUQLQJRQWKHMRE´SURYLGHV
better opportunities to maintain practical skills in their main subject but does 
not fit well with the ideals of standardisation described in the previous section 
and still requires a significant investment of time and effort.  
The final argument is based on optimism towards how academic education 
provides generalisable skills to the student. Such optimism is widespread, and 
SLU is, for example, deducting points from tertiary education level courses 
when included in a PhD degree. Unfortunately, evidence overwhelmingly 
supports a less optimistic truth where obtaining domain knowledge in one area 
does not significantly strengthen the ability to acquire domain knowledge in an 
unrelated field (Hambrick and Oswald, 2005; Hambrick and Engle, 2002).  
Furthermore, it can be argued that given the lack of trained 
bioinformaticians and ad-hoc nature of training, many potential 
bioinformaticians are already being recruited from the biomedical community. 
So even if it is possible to find skilled researchers who can be trained on the 
job with limited negative side effects, this is a resource that is already being 
heavily utilised. Meaning that even with significant investments in 
bioinformatics education the shortage of bioinformaticians will remain which 
makes automation a necessity. 
4.4.2 Does automated bioinformatics reduce quality? 
Automation always implies a loss of controlled compared to production in the 
hands of a skilled artisan. Despite this downside automation and simplification 
have a history of improving quality over the long term as machines, when 
properly configured and provided with the appropriate raw materials, provide 
superior quality products as they are able to repeat step after step without rest 
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or boredom. When evaluating statistics literature it is clear that human 
intervention is a common source of error with solutions suggested being 
primarily about increased peer-review, more education and semi-automated 
checklists checking for common errors (Lang and Altman, 2015; Peng, 2015; 
McNutt, 2014; Nolan, 2000). 5HVHDUFKHUV PD\ WKHUHIRUH SUHIHU ³Drtisan 
statistics´DVWKH\DUHPDLQO\ZRUULHGDERXWPLVVLng on important results due to 
false negatives. From a community perspective, however, automation of data 
analysis provides significant benefits in regards to data provenance, 
comparability and reproducibility as well as reducing the risk of inappropriate 
ad-hoc processing of data. Systems such as Galaxy which provides modular 
workflows and saving data in every step may therefore be an acceptable 
compromise between the personal incentives of a researcher and the needs of 
the community as the system enables researchers to extract data and analyse it 
using customised workflows when deemed necessary (Goecks et al., 2010). 
The strongest argument in favour of automation may however be the simple 
realisation that bioinformatics has been heavily automated ever since its 
inception and even a single human genome would be impossible to analyse 
without the automation of routine tasks (Ewing et al., 1998) many cutting edge 
projects have published guidelines advising researchers to rely on FASTQ files 
with automatically assigned Phred-quality scores rather than the more 
expansive sequence read format (SRF) when working with large volumes of 
data (Van der Auwera et al., 2013; Clarke et al., 2012). When advancing 
automation from a per-tool basis to a per-workflow basis we must therefore 
realise that bioinformatics is already heavily automated and should realise that 
it is more relevant to discuss how we automate bioinformatics rather than if we 
should do it and draw inspiration from how increased automation has affected 
other information-heavy fields such as healthcare while doing so (Nolan, 
2000). 
As with all wicked problems no specific solution can be considered optimal 
for all stakeholders. Rather each proposed solution must be treated as a 
simulation where an unknown number of subjects evaluate the proposition and 
by their actions communicate the approval or avoidance of the proposition. In 
this context, we believe that automation and division of labour is a highly 
attractive solution for research integrated biobanks operating in a resource-
constrained setting. These biobanks often have valuable sample collections, a 
need for an improved informatics infrastructure and can benefit from 
standardised solutions in molecular biology and bioinformatics as their novelty 
lies in their samples and study design rather than the creation of novel 
algorithms or hardware solutions.  
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It has recently been proposed that to sustain the wealth of a nation the key is to 
maintain a high level of productivity among its skilled workers (Malmberg et 
al., 2017). These results are consistent with my conclusion that it would be 
hugely beneficial for the research community if researchers are enabled to 
focus on their core areas of competence (where they are skilled) rather than 
constantly expand outside their field of expertise as it allows them to maximise 
their productivity. Unfortunately, modern research is highly competitive 
(Edwards and Roy, 2017; Lawrence, 2009) with incentives pushing researchers 
WRZDUGV D ³RQH SURMHFW RQH UHVHDUFKHU´ DSSURDFK SUHIHUULQJ WHPSRUDU\ VWDII
performing ad-hoc solutions. Rather than making long-term investments in 
staff scientists who can specialise within key fields and support a large number 
of projects within a research institution (Hyman, 2017; Stephan, 2012). 
As the academic reward system is unlikely to change quickly it is necessary 
to adapt any technical solutions to this reality. One way to do this is to adopt a 
matrix model for researchers similar to the one employed by many companies 
to create cross-functional teams (Barlett and Ghoshal, 1990). Research 
integrated biobanks using the eB3Kit provide a perfect fit for such an academic 
model as the infrastructure facilitates the transfer of information when 
necessary and automation of tasks when possible.  
The common perception of research is skewed in favour of major landmark 
projects such as the Human Genome Organization (HUGO) project where 
scientific knowledge in a large number of fields is pushed forward at 
breakneck speed. Most research projects, however, are not the HUGO project, 
and overly ambitious research projects are undone due to delays, the loss of 
core members and unexpected results leading to ad hoc solutions drastically 
increasing the risk of errors. By recognising our limitations and focus on 
providing novelty within our own area of expertise we can greatly increase 
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research quality, reduce time to publication and resolve many of the conflicts 
we see today between research and supporting tasks.  
In a traditional matrix organisation employees are divided into permanent 
groups by their competence/function but assigned to work in cross-functional 
teams led by project managers, creating a matrix structure as the organisational 
structure is displayed in a pattern where employees report both vertically to 
their function manager and horizontally to their project managers. Research 
organisations could adopt similar structures for interdisciplinary research 
projects (see figure 13) to improve how we distribute workloads. In such an 
organisation, novel research should mainly be carried out by principal 
investigators who are the ones generating novel results by innovating within 
their field, while using automated systems or validated methods to handle tasks 
outside their area of competence. This means that an expert in a subject like 
bioinformatics may spend significant time helping researchers running 
standardised and validated workflows but also engage in the development of 
workflows on his own and make them available to colleagues as automated 
workflows in Galaksio as soon as they can be considered validated (see figure 
13).  
 
Figure 13. A matrix model dividing researchers into three functions (applied biology, molecular 
biology and bioinformatics) with two projects being performed within the organisation. In project 
one the chart indicates that a researcher specialised in applied science is the principal investigator 
and relying on automated support services using prepared workflows to generate results using 
prepared assays and data analysis workflows. In the second project, the bioinformatician or the 
molecular biologist would be the principal investigator as a new experimental method is validated 
and a data analysis pipeline being created using samples provided by the biobank rather than in a 
new research project. 
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Open sharing of data is a widely shared value in research and open databases 
like MolMeth can reach thousands of researchers each year even without 
formal peer review. Getting researchers to engage and contribute more actively 
have however proven to be a difficult task and most entrepreneurs aiming to 
encourage the social sharing of data have failed to achieve traction among the 
research community. Likewise proponents of best practice standards in a 
variety of subjects have found themselves struggling to reach widespread 
traction. 
The aims of the B3Africa project are in light of these findings a highly 
ambitious project as we aim to produce an informatics platform which 
significantly alters how our users manage their day-to-day work. Our 
combination of technical solutions and development of soft skills does,
however, provide strong incentives that may motivate researchers to use the 
platform as intended. That this approach has a good chance of becoming 
successful is not only supported by internal beliefs but also by the external 
advisory committee and feedback at conferences. At the 2017 Annual General 
meeting professor Ames Dhai, director of the Steve Biko Centre for Bioethics 
at the University of Witwatersrand in South Africa made the following 
assessment of the Be3Africa project: 
¾ B3 Africa provides for meaningful research infrastructure partnerships
because not only does it make provision for infrastructure, but also for
the development of human capital and training and capacity building
programs towards African intellectual leadership
¾ Currently, biobanks in Africa serve rather as collection centres for
biological materials with progress in the bioinformatics aspect being
non-existent or at a very nascent stage. With its focus on making robust
the bioinformatics infrastructure and building capacity of African
scientists in this discipline, it responds to an African need, fosters
sustainability and reduces a dependency on well-resourced regions.
Integration of bioinformatics with a platform for biobanking is not an obvious 
decision for most biobanks in Europe as biobanks tend to operate as 
independent organisations. The evaluations of the eB3Kit do however show 
that fears of exploitation or the discovery of compromising errors are 
significant obstacles to sharing data or samples. Unpopular results are often 
challenged and relevant data questioning the scientific basis for widely 
supported causes such as the distribution of vitamin A and deworming pills 
have been withheld for years due to fears that any minor errors in data-
handling may lead to the entire project being discredited and ignored (Hawkes, 
2012)6XFKIHDUVFRPELQHGZLWKWKHREYLRXVULVNVRIUHVXOWVEHLQJ³VFRRSHG´
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by researchers with superior analytics capacity make it hard to convince 
researchers to share data openly 
It should also be noted that many of the characteristics of research 
integrated biobanks can be extended to research institutions active in 
agricultural science and applied biology (such as the Swedish University of 
Agricultural science) as well. We may have cutting-edge facilities covering 
some aspects of molecular biology and bioinformatics, but overall our strength 
lies in the extensive knowledge possessed by researchers engaged in the study 
of the land, the animals and the plants surrounding us. With unique access to 
research facilities and research stations such as Lövsta and Grimsö we can 
obtain samples along with phenotype data in a manner matched by few other 
universities. Despite these advantages advances in Next Generation 
Sequencing and other ±omics technologies have created a significant strain on 
our ability to manage the information collected and generated by modern 
research. A more stringent division of labour would therefore not only benefit 
research integrated biobanks in low- and medium income countries but can 
also contribute to significantly increase the research productivity of SLU. 
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A natural progression of this thesis will be to incorporate the eB3Kit and the 
Galaksio interface in the daily research at SLU. The eB3Kit is developed to 
work on a community level with researchers sharing workflows in Galaxy and 
creating new tools using the BiobankApps catalogue (Müller et al., 2017). 
Such tool-oriented articles are often rewarded with high citations rates (Park et 
al., 2015; Van Noorden et al., 2014) making it an attractive way of advancing 
your career as a young researcher.  
Research automation can in itself also become a key strategic area for SLU 
and its aspirations to engage in an increased number of international 
collaborations. By adopting the division of labour within the university, we get 
the opportunity to build robust and reliable structures to exchange not only 
results but methodological knowledge in a scalable manner. This can, in turn, 
be used to strengthen collaboration with external actors through SLU Global 
and other research initiatives. The eB3Kit can thereby serve as a platform for 
innovation in several fields of biological and medical research as outlined 
below. 
6.1 Deployment of automated bioinformatics support 
A survey among PhD students at SLU made in anticipation of funding for the 
bioinformatics support infrastructure indicates that aid in data handling is a key 
priority to improve productivity. According to the survey, PhD students 
normally allocate 51-60 % of their time on data transformation and 
interpretation. In comparison they believe that roughly 31-40 % of the time is 
necessary while the remaining time is spent compensating for a lack of 
knowledge, tools or other issues.  
With a labour force of PhD students equivalent to 277 full-time positions 
this implies that PhD students at SLU spend 50 000-150 000 hours per year on 
6 Future prospects
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bioinformatics task that they could have allocated to other tasks if they had 
access to  better support and training. Given the wide variety of research tasks 
performed by PhD students, it is unlikely that such gains can ever be achieved 
by automation. The numbers do however provide some insight on how 
bioinformatics training and platforms can increase productivity of SLU 
employees. Deployment of automated bioinformatics support is therefore likely 
to be a cost efficient investment to increase productivity and should be 
combined with studies to evaluate the amount of time saved by PhD students 
and other categories of researchers at SLU.  
6.2 Deployment of Galaksio service interfaces for Galaxy 
servers 
The development of the Galaksio user interface is an important part of the 
B3Africa project but can be installed independently of the eB3Kit. To 
demonstrate this capability Galaksio instance connected to a PhenoMeNal 
Galaxy server (van Rijswijk et al., 2017), will be installed on Google cloud to 
demonstrate how researchers can create an easily accessible and scalable cloud 
computing environment for metabolomics.  
The Galaksio interface will also be highlighted in the Galaxy newsletter and 
is currently being considered for usage in connection with the main public 
Galaxy server (www.usegalaxy.org). The system is also under consideration 
for more specialised deployments creating easily accessible portals for 
bioinformatics projects. Promoting the usage of reproducible Galaxy 
workflows is at the heart of the Galaxy project (Goecks et al., 2010), but the 
user interface is not optimised for swift utilisation of workflows and reporting. 
Galaksio helps to resolve these issues and encouraging researchers to put 
together and publish comprehensive workflow packages may help to generate a 
positive feedback loop increasing overall usage of Galaxy (figure 14). 
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Figure 14. Envisaged positive feedback loop for Galaxy usage by introducing a workflow-
oriented user interface. 
6.3 Using structured databases and high-throughput 
technologies for replication studies 
In an ideal research environment positive as well as negative results 
accumulate in scientific articles until researchers feel confident enough to 
canonise theories as facts (Nissen et al., 2016). Unfortunately, given the 
skewed incentives of researchers, there is a severe bias in favour of positive 
results (Moonesinghe et al., 2007; Ioannidis, 2005) which distorts scientific 
reporting. A way to bypass these issues would be to promote harmonised 
methods and ensure that relevant metadata describing the samples is available 
to the research community. 
With access to high-throughput analysis methods and structured databases, 
replication studies can be conducted LQ WDQGHP ZLWK RQH¶V RZQ RULJLQDO
research provided that three key criteria are achieved. 
¾ The biological systems under investigation must be sufficiently similar.
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¾ The sample handling and analytical process must yield comparable results. 
¾ There must be a system or an a priori knowledge of the fact that an 
experiment may serve as a replication of previous studies.  
In theory, deep learning techniques (Angermueller et al., 2016) should enable 
researchers to sift through large datasets and identify experiments similar 
enough to be evaluated as replicates automatically. For such an approach to be 
realistic, it is, however, necessary that there is a degree of harmonisation of 
sampling methods and analytical techniques and that sufficient metadata is 
made available for the algorithms to identify functionally similar projects. 
Federated networks of biobanks and analytics oriented service platforms 
would provide such an environment supporting replication studies at an 
unprecedented scale. Hypothesis generation and experimentation by robot 
scientists have already been explored  (King et al., 2004) but a similar 
approach could be feasible on already existing data in a federated network of 
eB3Kits. In such a network, data would systematically be returned to biobanks 
or dedicated databanks. Making data available for hypothesis testing after 
research projects have been published. 
6.4 Bridging the gap between applied research and 
ethics 
There is a historical divide between applied research, bioethics and law as 
described in section 1.5 and 3.3. For researchers this results in frustration, and 
potentially alienation as projects are delayed for reasons beyond their control 
or understanding (Johnsson et al., 2014). 
Embedding researchers with training in life science into collaborative 
projects with ethicists or lawyers can help reduce this frustration and contribute 
to developments in the respective fields. Research on threat modelling 
presented in a context relevant to lawyers and bioethicists could therefore be of 
tremendous value to the respective research communities. High impact articles 
on privacy related issues and emerging threats to the anonymity of donors are 
sometimes published with significant influence on policymaking (Erlich and 
Narayanan, 2014; Gymrek et al., 2013; Homer et al., 2008; Zerhouni and 
Nabel, 2008) but there is also evidence of scaremongering taking advantage of 
information-privacy experts or bioethicist lacking the knowledge necessary to 
evaluate claims in the field (Reardon, 2017). Given the phrasing of consent 
forms and priorities in data protection is unlikely that threat modelling can be 
conducted on samples donated for health research but public datasets and 
aggregated data can provide a sufficient substitute for topics such as the risk of 
genetic discrimination by insurance companies or employers. 
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Since the publication of paper III, Legal & ethical compliance when sharing 
biospecimen, the authors have been invited to write a review in the British 
Medical Bulletin, participated in writing a SURSRVDOIRUWKH(8+FDOO³7KH
ethical dimensions of IT technologies: a European perspective on security and 
KXPDQULJKWVDVSHFWV´DQGGHFOLQHGDQLQYLWDWLRQWRSDUWLFLSDWHLQDFRPSHWLQJ
proposal for the same call. Continuing this research therefore looks like an 
attractive proposition in the intersection between ethics, law and 
bioinformatics. 
6.5 Automated biomolecular research 
If widely adopted MolMeth would have provided a unique opportunity to 
deploy machine learning methods on semi-structured text to develop automated 
parsers able to read and annotate laboratory protocols. A lack of source data 
means that such a project is not yet possible, but the promotion of increasingly 
demanding laboratory standards (Neururer et al., 2016) create increasingly 
powerful incentives to describe the sample management process better. 
Being able to integrate MolMeth features into the compliance process of the 
eB3Kit could thereby resolve many of the limitations of the current website as 
standard operating procedures or protocols could be retrieved directly from the 
document repository of a laboratory following CEN/TS standards for biobanks. 
By accessing published data generated from biobanks and comparing 
variations between protocols it is then possible to identify key parameters 
influencing the quality of samples and confounding factors contributing to 
irreplicable findings in research. A pilot study regarding the factors influencing 
fragmentation of DNA is currently ongoing and will serve as a template for the 
design of quality management workflows in the eB3Kit. 
6.6 Development of a Phenomics platform 
Connecting phenotype data with genotype data is of immense value to 
biobanks and life science in general. It is therefore unfortunate that SLU still 
lacks a system to connect recordings from Lövsta research station or the 
university animal hospital with genomic data generated in the laboratory. 
We have previously collaborated with partners from International Bull 
Evaluation (located at SLU), the European Molecular Biology Laboratory, 
Wageningen University, the University of Bari, the Italian National Research 
Council and University of Manchester to develop such a platform but failed to 
gain funding for the proposed Federated Phenomics Data project for livestock 
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research (FePheD). Renewed attempts based on experience from the eB3Kit 
and the Biobank Cloud project which has developed Hops (Ismail et al., 2017) 
may, however, be approved in the future.  
A phenotype platform built on Hops would be highly extendable and able to 
support pre-processing of resource intensive data from sources such as 3D 
camera imaging for long term storage. Integrating the phenomics platform with 
the eB3Kit would combine the system with a graphical user interface for 
researchers, enabling researchers to identify relevant data from the phenomics 
platform and integrating it with other resources such as laboratory information 
systems using the STATegra experiment management system.  
A pilot project to integrate the eB3Kit with Hops is scheduled for the 
autumn at Karolinska Institutet and will provide valuable experience for a 
potential future implementation of a similar system at SLU. 
6.7 Curing Ebola and other tropical diseases 
Ebola is perhaps the most famous and fear-inducing of tropical diseases. The 
IHDUVRPH VSUHDG RI (EROD GXULQJ VKRUW SHULRGV RI WLPH FUHDWH D ³ERRP DQG
EXVW´HQYLURQPHQWZKHUH LQWHUQDWLRQDO UHVHDUFKHUVDQGPHGLFDO VWDII DUULYHDW
the scene, collect samples, do their work and then disappear almost as quickly 
as they came. Attempting to organise research ad hoc during a major health 
crisis is impossible and the lack of coordinated sample management constitutes  
a biohazard as well as a wasted opportunity to produce long term solutions 
(Abayomi, Katz, et al., 2016). 
With the portability of the eB3Kit and its modular design, the kit is perfect 
for challenges where time is of importance. With the eB3Kit being deployed at 
several locations in Africa many researchers will already have prior experience 
of working with the kit and a new kit can quickly be cloned from an existing 
implementation. At a time of crisis an eB3Kit can therefore rapidly be made 
available and provide an informatics platform for sample management at health 
care institutions during a disease outbreak. Early responders thereby get access 
to a system for structured sample storage which reduces a currently serious 
biohazard in the form of poorly maintained sample collections with potentially 
life threatening content while enabling long term stakeholders to make better 
use of the samples for future research. 
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As humans, we are biased in favour of innovations that allow us to carry out 
our work in the same way as before albeit in a more efficient manner. This bias 
in combination with the inherent difficulties of gaining acceptance for 
solutions to wicked problems contributes to the remarkable resilience of the 
academic system of peer-review and career advancement. At a time when 
global patterns of business and consumption are being disrupted by 
industrialisation, globalisation and digitalisation, the same trends have merely 
accelerated academic communication while leaving the overall structure intact. 
The eB3Kit fits into this conservative environment as it helps researchers to 
collect more data, analyse it faster and register their results in scientific 
journals. At the same time the eB3Kit may enable a more radical 
transformation in how we handle and perceive data. Access to data is not only 
limited by passwords and access rights. With an ever increasing amount of 
publications it is impossible for researchers to keep track of potentially useful 
data unless it is made available in structured and searchable data formats. 
Making structured data from studies more readily accessible for analysis and 
reuse may therefore help to break the current paradigm of one researcher, one 
project, one main author, and significantly increase the productivity as well as 
the quality of research. 
For example, an extensively documented set of samples collected for 
applied biology may generate data that is reused for biomolecular research on 
quality parameters, replication studies for unrelated phenotypes, as a validation 
dataset for the development of new bioinformatics tools and as a resource for 
information about genetic variance in threat modelling.  To make such a future 
possible it is however necessary to ensure that it is rational for researchers to 
share high quality datasets. Researchers are however reluctant to share data if it 
requires a significant amount of time or financing to share it, if it carries a risk 
that they will be scooped to future publications or if it may inadvisable due to 
7 Concluding remarks
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ethical or legal concerns. One way to encourage sharing and efficient sample 
utilisation is by separating the task of sample collection from the analysis of 
samples. Organising samples into biobanks was rated as one of the top 10 ideas 
changing the world right now by Time Magazine in 2009. Such investments 
are however generally restricted to fields and regions where strategic funding 
over long periods is available as the time from start up to measurable results 
spans many years from the establishment of a biobank. Distributing eB3Kits 
provide researchers with access to a cost efficient informatics platform for the 
establishment of biobanks and thereby make such investment feasible in 
regions and fields without access to the strategic funding currently necessary to 
establish a biobank. 
Concerns regarding the replicability and quality of research also make it 
important for research groups to adopt robust informatics platforms. Important 
scientific discoveries may be delayed for long periods of time as researchers 
delay publication over concerns that minor errors may cast doubt on important 
but controversial findings. Many researchers also delay publications as they are 
unwilling to make unique datasets available until they are confident that all 
relevant research opportunities have been exhausted, fearing that they 
otherwise may be scooped by other researcher groups better equipped to 
analyse the data. The eB3Kit enables researcher groups to better manage this 
risk and quickly sift through their data to identify features of scientific interest 
using widely accepted workflows.  
Using the eB3Kit may therefore generate a cascade effect of benefits to 
research groups who adopt it. Improved quality management and data analysis 
enables them to publish their findings more quickly. The published datasets 
may then after publication serve as beacons for the researchers who published 
them as stringent quality measures and relevant metadata improves the 
credibility of results, making the data and results more likely to generate 
secondary publications by other researchers, boosting the scientific impact of 
the original findings. Deployment of the eB3Kit into research institutions can 
thereby significantly contribute to research productivity and enable research 
groups with limited resources to produce competitive results influencing local 
communities as well as global scientific knowledge.  
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New technologies in life science constantly create new opportunities for researchers to 
generate data for analysis. In life science, this increased output has outpaced 
developments in sample collection, processing power, and storage space. As a result 
researchers struggle to keep up to date with new technologies while also struggling to 
handle increasingly complex challenges related to logistics and information technology. 
Research infrastructures such as the Swedish Science for Life Laboratory, numerous 
biobanks and the National Bioinformatics Infrastructure Sweden have been established 
to support researchers in handling these issues. Dedicated infrastructures enable 
researchers to work more effectively but can only offer limited customisation for the 
specific needs of individual researchers. This is especially noticeable in fields such as 
bioinformatics which apart from biological knowledge require an understanding of 
computer science and statistics. In many countries there is also a lack of long term 
funding to establish infrastructures. SLU Bioinformatics Centre therefore works to 
develop networks and tools to empower researchers across the world and leverage the 
capacity of bioinformatics into their research. This thesis describes studies made to 
support the development of the eB3Kit in the B3Africa project. With the eB3Kit 
researcher gains access to a comprehensive informatics platform supporting researchers 
with sample collection, data analysis and data storage in compliance with good research 
practice and laws regarding personal privacy. 
To make technical platforms relevant for researchers it is important that it addresses 
the needs of researchers on an individual level. New technology and the development 
of science makes researchers increasingly reliant on team efforts and collaboration but 
academic achievements are still judged on an individual level. This makes a solution 
like the eB3Kit attractive as it enable researchers to automate work outside their own 
field of expertise. Researchers can thereby quickly establish structured sample 
collections and use bioinformatics in their work while maximising the time available 
for specialisation within their chosen fields of expertise. 
Popular science summary
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Ny teknik skapar hela tiden nya möjligheter för forskare att planera och genomföra 
experiment. Dessa nya metoder gör det möjligt för forskare att producera mer och helt 
nya typer av data än tidigare vilket gör analysarbetet allt mer komplicerat. Inom 
livsvetenskaperna har dessutom förmågan att generera data ökat snabbare än 
kapaciteten för provinsamling, dataanalys och lagring. Eftersom forskare i hög grad är 
specialiserade inom sina respektive ämnesområden skapar detta problem då 
datahantering och logistik blir en allt mer krävande del av arbetet. 
För att stödja forskning har viktiga infrastrukturer såsom Science for Life 
Laboratory, biobanker och den nationella bioinformatikinfrastrukturen NBIS etablerats 
i Sverige för att stödja forskare med krävande delmoment. Sådana infrastrukturer 
kräver långsiktig finansiering och kan bara i mycket begränsad omfattning anpassas 
efter enskilda forskares behov. Det här är särskilt tydligt inom bioinformatik som 
bygger på en blandning av biologi, datavetenskap och statistik. Många andra länder 
saknar även de resurser som krävs för att etablera långsiktigt hållbara infrastrukturer. 
SLU Global Bioinformatics Centre samarbetar därför med forskargrupper i många 
länder i syfte att stödja deras arbete och etablera nätverk med bioinformatiker som kan 
analysera biologiska data. Denna avhandling beskriver arbetet med att studera vilket 
stöd forskare behöver och använda dessa slutsatser för att bidra till utvecklingen av 
SODWWIRUPHQ ´WKH H%.LW´ LQRP UDPHQ I|U %$IULFD-projektet. Målet är att skapa en 
teknisk plattform som ger forskare stöd med provhantering, dataanalys och datalagring 
i enlighet med lagar och riktlinjer för integritetsskydd och kvalitetsarbete. 
Den övergripande slutsatsen från studierna är att ny teknik skapar svårigheter inom 
universitetsforskning då akademisk meritering bedöms på individnivå samtidigt som ny 
teknik hela tiden skapar behov av större team och samarbeten. För att komma förbi 
detta är det viktigt att tekniska lösningar gör det möjligt att automatisera processer 
utanför det egna kompetensområdet och att forskare därigenom ges möjlighet att 
specialisera sig inom det egna forskningsområdet. Med eB3Kit får forskare möjlighet 
att etablera strukturerade provsamlingar även med begränsade investeringar. Vilket gör 
det möjligt att snabbt etablera biobanker vid sjukdomsutbrott och öka produktiviteten 
likväl som kvaliteten hos etablerade forskargrupper då tidsödande arbete utanför det 
egna kompetensområdet minimieras. 
Populärvetenskaplig sammanfattning
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Workshop on laboratory protocol
standards for the molecular methods
database
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Management of data to produce scientiﬁc knowledge is a key
challenge for biological research in the 21st century. Emerging high-
throughput technologies allow life science researchers to produce
big data at speeds and in amounts that were unthinkable just a few
years ago. This places high demands on all aspects of the workﬂow:
from data capture (including the experimental constraints of the
experiment), analysis and preservation, to peer-reviewed
publication of results. Failure to recognise the issues at each level can
lead to serious conﬂicts and mistakes; research may then be
compromised as a result of the publication of non-coherent
protocols, or the misinterpretation of published data. In this report,
we present the results from a workshop that was organised to create
an ontological data-modelling framework for Laboratory Protocol
Standards for the Molecular Methods Database (MolMeth). The
workshop provided a set of short- and long-term goals for the
MolMeth database, the most important being the decision to use the
established EXACT description of biomedical ontologies as a starting
point.
Introduction
The Molecular Methods database (MolMeth) is a
structured database intended to provide
researchers with an efﬁcient resource to create,
develop and publish life science laboratory
protocols. It is available as an early beta version
at http://www.molmeth.org. Using MolMeth, a
researcher should be able to ﬁnd relevant lab
protocols quickly, and to use one or more
protocols to create an individualised workﬂow.
The user should also be able to publish the
protocols through MolMeth to make them
available as peer-reviewed articles via stable
accession numbers. To achieve such a goal, it is
important to have a common schema and
vocabulary to describe laboratory protocols,
along with a common understanding of the
entities in the domain to make descriptions of
those protocols: ontologies are now commonly
used to provide such common understandings
of the entities within a ﬁeld of interest. With the
use of an effective ontology, built using accepted
standards, it becomes easier to create a coherent
environment, where laboratory protocols are
integrated with resources made available by
biobanks, scientiﬁc literature and best-practice
protocols supported by commercial providers.
This workshop, held in Uppsala on November
15th, 2011, served to initiate the effort to create
an ontological data-modelling framework for
MolMeth. It was divided into a series of lectures,
and a session to receive input from experts
regarding the development of MolMeth and its
supporting ontologies. The six lectures were
focused on the development of ontologies,
relevant examples of ontologies, on web services
that could provide examples and standards to
which the MolMeth developers could adhere,
and ﬂexible database implementations for local
laboratories to adopt easily.
Key points from lectures
Agile development of an ontology
The Robot Scientist project presented by Dr
Larisa Soldatova (Aberystwyth University, UK)
aims to develop a computer system capable of
planning and conducting its own experiments as
well as interpreting the results [1,2]. To support
this system the scientists at Aberystwyth
University have created the LABORS and EXACT
ontologies [3] to provide open access to Robot
Scientist experimental data (LABORS) and
laboratory protocols that can be interpreted by a
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fully automated system (EXACT). This fully
computerised environment does not possess the
ability to process and interpret natural language
that we take for granted when writing laboratory
protocols intended for other human beings.
EXACT can therefore be considered an effective
‘upper limit’ on the amount of information
necessary to replicate laboratory experiments as
all information is explicitly recorded (Fig. 1 for an
example comparing natural language and
EXACT instructions). For humans it is, however,
possible to remove excess information as we can
understand many steps implicitly and are likely
to miss important information hidden behind
unnecessary text blocks. It would for example be
highly unfortunate if a researcher read the
‘remove lid’ instruction whilst missing ‘in a fume
hood’. Therefore it is necessary to carefully
evaluate the EXACT ontology and to improve it
according to human needs.
Dr Robert Stevens (University of Manchester,
UK) presented a set of guidelines for the quick
and efﬁcient development of the basic input to
form an ontology. He also reported practical
experience from his work with the Software
Ontology Project [4] and via collaborators from
the Ontology for Biomedical Investigations (OBI)
[5]. This framework consists of several key points
for the agile development of ontologies:
 Iterative and incremental;
 Evolving requirements and solutions;
 Self-organising and cross-functional teams;
 Short time boxes; rapid and responsive
development;
 Doing what is important ﬁrst;
 Users are embedded in the process as ﬁrst
class citizens;
 Test driven; regular and frequent builds.
To achieve this, MolMeth will develop its
ontology out of EXACT by removing ontological
terms necessary to a computer but implicitly
understood by a human researcher. The ontology
will then be iteratively improved according to
input from the users and external developers.
It is not uncommon that such development
leads to unintended defects in the ontology
network as the ontology is remodelled and
extended. Dr Patrick Lambrix (Linko¨ping
University, Sweden) addressed many of these
concerns as he presented the RepOSE
environment for repairing ontologies [6].
Syntactic defects such as misspellings can be
easy to ﬁnd, but issues such as inconsistencies
and missing connections are harder to ﬁnd
because they require extensive domain
expertise and the careful study of the ontology.
RepOSE automates much of this process that
removes much time consuming manual labor
from the process.
Existing web systems with integrated
ontologies
The Embrace Data and Methods (EDAM)
ontology [7,8] presented by Matu´sˇ Kalasˇ
(University of Bergen, Norway) has been
developed to support the categorisation of
bioinformatics resources, such as eventually the
web services collected in Biocatalogue [9].
Integration of MolMeth with ontologies such as
EDAM and with information standards under the
Minimum Information for Biological and
Biomedical Investigations (MIBBI) [10] is also
desirable to enhance the end user experience.
Such integration in combination with the
possibility of collaborating with organisations
such as the Registry of Standard Biological parts
were discussed by Dr Kristian Mu¨ller (University
of Potsdam, Germany), who is part of a team
creating services for laboratory protocols on
smart phones. Their mobile app enables
downloading of preformatted protocols from
the Internet and provides interactive features
such as note taking, barcode reading,
countdown timing, time stamping, and log ﬁle
generation. The protocols are stored in an XML
property list (plist) format and are used by the
iGEM team of the University of Potsdam.
Erik Roos and Dr Morris Swertz (University
Medical Center Groningen, The Netherlands)
presented the MOLGENIS application suite [11].
At its core there is a generic data structure
named ‘Observation Object Model (Observ-OM)’
[12] to capture any phenotypic observation and
the provenance of the protocols used to produce
them, a structure particularly well suited to use
the ontologies above in daily research practice.
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FIGURE 1
Description of how natural language is converted to an EXACT protocol.
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Observ-OM therefore includes extensive use of
ontological references for unambiguous
protocol, protocol-parameter and observed
value deﬁnitions using the OntoCAT framework
[13] to automatically retrieve ontology terms from
resources like BioPortal and OLS, all developed in
collaboration with EU-GEN2PHEN (http://
www.observ-om.org). Many applications have
built on this core with more underway such as:
 AnimalDB for the management and observa-
tion of laboratory animals (http://www.ani-
maldb.org);
 A Next Generation Sequencing LIMS for
resequencing laboratories and the analysis
protocols surrounding this data with an
application to the Genome of the Netherlands
(770 Dutch whole genomes) project (http://
www.nlgenome.nl);
 An International Dystrophic Epidermolysis
Bullosa patient registry, where the model is
used to report protocols and observations for
phenotypic, clinical and genetic features
(http://www.deb-central.org) [14];
 Interestingly, this also includes a computa-
tional framework to capture and run compu-
tational protocols using exactly the same
model as wet lab protocols (should this run
on with the previous bullet point or be a
separate one?);
 The ‘xQTL workbench’ for the observation of
genetic quantitative trait loci in genome wide
linkage and association studies (GWL, GWAS)
in human and model organism populations
(http://www.xqtl.org).
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FIGURE 4
User expectations of the MolMeth database based on input from the Workshop.
FIGURE 2
Information deemed necessary to create a fully reproducible protocol during the ﬁrst workshop session.
During the workshop the information was divided into distinct classes as shown in the ﬁgure.
FIGURE 3
Information deemed unnecessary for creation of a fully reproducible protocol. During the workshop the
information was divided into distinct classes as shown in the ﬁgure.
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Underlying all these applications is the
MOLGENIS automatic software generator that
makes it possible to rapidly generate new
databases with fully functional web user
interfaces from an XML model [15]. In practice
this means that local groups can easily
customise the MOLGENIS + Observ-OM
application suite taking the best components
from the existing applications such as those
listed above.
A great future enhancement would be to
enable exchange of protocol metadata between
each application and MolMeth whilst converging
Observ-OM with MolMeth common data
schema. Moreover, this model driven approach
can be perfectly adapted to the needs of the
MolMeth database to create extensions where
natural language is combined with generic
methods to convert protocols between natural
language and formal languages such as EXACT.
Discussion
The workshop delivered input for the further
development of MolMeth. The discussion
session was divided into three sections to
determine the scope of the supporting
ontologies and expectations of the MolMeth
database itself. The ﬁrst section consisted of a
brainstorming session where researchers
paired up to identify information necessary to
make a laboratory protocol fully reproducible.
The suggested key points were then clustered
and eight key areas were identiﬁed as
necessary to create a fully reproducible
protocol (Fig. 2).
The second session served to identify
information commonly available in laboratory
protocols but not essential to render the
protocol reproducible. Two major classes were
quickly identiﬁed to divide information into
‘beneﬁcial information unrelated to
reproducibility’ and ‘non-beneﬁcial or harmful
information’. These classes were then further
divided to create a clustering similar to that
arising from the ﬁrst session (Fig. 3).
The ﬁnal session was conducted to secure
input from ontologists and wet lab experts
regarding their expectations for the MolMeth
database and how they would like to use it (Fig.
4). To keep in line with the principles of Agile
development these ideas will be implemented
iteratively when the ﬁrst fully functional version
of the database is published.
Conclusions
The workshop provided a set of short term and
long-term goals for the MolMeth database as
well as some highly valuable advice, the most
immediate being the decision to use EXACT as a
starting point for the ontology.
In the Agile development of software and
ontologies, emphasis is placed on quickly
creating a fully functional core platform to
allow early user input into the development.
The platform is then gradually improved as
new functions and modules are added to the
core platform. MolMeth is currently making its
ﬁrst steps through this development process
that can be visualised in Fig. 5. In this ﬁrst
pre-launch iteration of the MolMeth database
the following functionalities will be
implemented:
 A user-friendly environment for the publica-
tion of protocols.
 A user-friendly environment for ﬁnding, read-
ing and downloading protocols.
 Features to ﬁnd and contact protocol authors
or other users with experience of the protocol.
 A back end ontology enabling users to
compare and switch sections of protocols in
silico, to develop protocols suitable for their
own needs.
 A versioning system allowing users to access
referenced protocols, earlier protocols and
later developments of the same protocol.
Further development will then be carried out
based on future workshops, contact with end
users and unsatisﬁed requests summarised in
Fig. 4.
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Scholarly publication in the digital age, an investigation 
into why novel publishing concepts have failed to disrupt 
the market of scientific journals.  
Tomas Klingström, Babette Regierer, Teresa K. Attwood, Erik Bongcam-Rudloff. 
Abstract 
Digital technologies have changed the ways in which society in general, and science professionals in 
particular, communicate. Senior researchers send and receive hundreds of e-mails per day; many 
write or read blogs; many visit social networking sites; many ‘tweet’. Similarly, all major journals use 
the Internet to communicate their latest issues/volumes, landmark articles, etc. Despite all this the 
time-consuming nature of journal publication including tasks like peer-review, separation of articles 
into scheduled issues remains a cornerstone of scholarly communication in the life sciences. The 
persistence of this labour-intensive system of communication suggests that factors other than rapid 
dissemination are crucial to how researchers engage in scholarly communication. 
To gain insights into these factors, and the opportunities offered by digital communication, we have 
developed a framework for evaluating how social networking and other ‘Web 2.0 technologies’ have 
been used to increase the efficacy of scholarly communication and applied it on life science research. 
Of the Web-based services that we surveyed based on the framework, around 15 % have been able 
to maintain active user-bases; by comparing the unique value propositions of those with active and 
inactive user bases, it was possible to identify incentives that motivate researchers to use them. In 
particular, the study showed that web 2.0 technology: 
 Have primarily been used to boost the visibility and efficiency of researchers by increasing 
awareness of their own published work and reducing the time they have to spend finding 
information of relevance to them;  
 have lowered the entry barriers to publishing scientific articles, as search engines and social 
networks have made article discovery much easier, and journal circulation and impact factors 
less important for article visibility; 
 that there is a current trend where innovators in the field develop tools to make scientific 
outputs “citeable” by attaching digital object identifiers to scientific outputs other than 
articles published in peer reviewed journals. 
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Introduction 
Scientific publications are an integral part of academic life: they are used to convey research findings 
to peers, to assert priority, and as quality metrics for academic promotion committees and grant-
awarding bodies (1,2).  
As the number of journals publishing scientific articles increases(3), the more important it becomes 
for individual researchers to stand out and produce ‘good’ articles (i.e., articles that are highly cited 
and/or published in prestigious journals with high impact factors (4–7). In competitive fields, 
researchers may therefore be tempted to ‘game the system (8), by publishing as much as possible, 
while withholding information that provides them with a competitive edge to support further 
publications (9).  
This article focuses on how social-networking and other platforms can support productive and 
constructive publishing strategies for individual researchers, and also support the research 
community as a whole. In this context, many attempts have been made to stimulate social change 
using information technology (10) , to mimic the success with which social networks, and other such 
platforms reliant on user-generated content (hereafter referred to as ‘Web 2.0’), revolutionised 
online behaviour in the early 2000s and subsequently altered the dynamics of the news media 
market (11). The expectation was that a similar revolution might transform the process of scientific 
publishing (5,10,12). However, so far, the norms of scholarly communication have remained 
remarkably resilient to change, and peer-reviewed journals remain the gold standard for measuring 
the ‘quality’ of academic outputs in the life sciences (1). 
Aiming to gain insights into why some platforms have been more successful than others, we studied 
the user incentives offered by 45 Web- or social-networking tools tailored for life scientists identified 
in a peer analysis of the collaborative protocol management website Molecular Methods 
database(13). The initial study was conduct by searching for “social network for scientists” and 
similar terms to identify websites marketing themselves as such or being mentioned as social 
networks for scientists in articles. This initial search was then expanded by searching for articles 
writing about the previously identified websites and mentioning other, not yet identified, websites 
meeting the criteria described below. By differentiating those that have been successful (i.e., with 
active user communities) from those that have not gained traction, we have been able to identify key 
features and incentives that motivate researchers to adopt new scientific communication 
technologies. 
Defining a framework of evaluation 
The theoretical framework underlying the survey and its conclusions is divided into three separate 
segments: 1) a definition of virtual communities (or social networks from communication theory (14); 
2) a view of information sharing as a gift from the field of anthropology (15), and 3) the Garvey-
Griffith model of scholarly communication, which was initially developed for the field of psychology, 
but is also applicable in other fields of research (16). The Garvey-Griffith model was selected as it 
provides a comprehensive overview over the high level tasks of an active researcher but predates the 
development of virtual communities and widespread distribution of data (17), enabling us to use it as 
a baseline to compare what virtual communities have offered to scholarly communication.  
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Defining a social network 
Candidate websites for inclusion were based on an initial Google search for potential competitors 
and/or role models for the development of Molecular Methods database, a website for the 
publication and crowd-sourcing of laboratory protocols (13). The initial aim of the peer-analysis was 
not to write a full scientific paper on the topic. Given the lack of similar studies and our experience of 
developing the Molecular Methods database we do however believe that many entrepreneurs and 
research innovators may benefit from a study on successful motivators for researchers based on 
comparisons between successful and not so successful attempts. Websites and tools described as 
social networks for scientists or as comparable to such a website/tool were considered for inclusion 
in the study. Final inclusion was based on the following criteria used to define virtual communities 
(14): 
(1) the website must offer users an interface for interacting with each other;  
(2) interactions between several communicators must be supported; 
(3) there must be a sustained user-base not affiliated with the founders; and 
(4) there must exist a virtual common-public-space where a significant portion of interactive 
computer-mediated group communication occurs. The existence of such a virtual settlement 
is evidence of the existence of a related virtual community. 
Information sharing as a gift 
Virtual communities are characterised by the exchange of information. The procedure of giving away 
material, texts or advice can be described, in this context, as a gift-giving process based on a mixture 
of altruism and self interest (17). This process of sharing information can be divided into two distinct 
practices (15); the first is usual among explorers or enthusiasts who share information on almost 
anything; the second is dominant among professionals who rely on having information constantly at 
their disposal journalists, freelance artists, and programmers are mentioned in anthropological works 
(15), but researchers in rapidly developing fields, such as the life sciences, also fit this profile. 
Aside from needing social interaction, these professionals require a constant influx of new 
information, which they achieve by creating networks of contacts. Providing information as a gift 
within these networks forms an important step in the establishment of a virtual community. Sharing 
information online comes at very low distribution cost, and usually without control mechanisms to 
limit access (e.g., via a payment system); instead, information is gifted, with an anticipated and 
undetermined future reciprocity (18). 
In research, information in the form of publications and conference presentations is a major carrier 
of value (6,8,19); it is therefore of particular interest to analyse which components scientists are 
willing to “gift away” and what incentives the networks themselves provide to content-producing 
members.  
The Garvey-Griffith model for scholarly communication 
In 1972, Garvey and Griffith outlined a model for scientific communication for the field of psychology 
(16). Figure 1 illustrates the comprehensive picture they devised for how advances in scientific 
research are communicated in scientific papers, in preprints, seminars and conference presentations. 
Peer-reviewed articles are indexed, and comprehensive reviews provide researchers with overviews 
of the state-of-art in various fields of science. 
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Figure 1. The Garvey-Griffith model of scholarly communication. Research is conducted in discrete steps, 
where the results of each (notable) step are communicated in conferences, seminars and, most importantly, 
journal publications. 
A joint model for scholarly communication in a digital environment 
A weakness of the Garvey-Griffith model is that it accurately portrays how people share information, 
but fails to account for why they do so. For many researchers, altruism and idealism serve as major 
motivations to contribute information. But, regardless of such ideals, it is also necessary for 
researchers to work with a rational dissemination strategy to secure their recognition as originators 
of knowledge; in return, this supports the procurement of future funding and their promotion in the 
academic environment. 
Funding, promotion and recognition are rewards necessary for researchers to be able to maintain 
their research activities. Roosendal and Guerts (20) have identified five steps in the academic process 
that must be fulfilled before a researcher is eligible to receive the rewards needed to continue their 
work. These have been summarised by Van de Sompel et al. (21) as follows: 
x registration, which allows claims of precedence for a scholarly finding; 
x certification, which establishes the validity of a registered scholarly claim; 
x awareness, which allows actors in the scholarly system to remain aware of new claims and 
findings; 
x archiving, which preserves the scholarly record over time; and 
x rewarding, the explicit or implicit assignment of funding, promotion or recognition as a 
leading researcher. 
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By assigning these five steps to different phases in the Garvey-Griffith model, we produce a 
framework for assessment of rational incentives for researchers to participate in scholarly 
communication and/or scientific social networks (Figure 2). When comparing the modes of 
communication, it becomes evident how peer-reviewed publication is the mode of communication 
that alone provides registration, certification, awareness building and archiving, which preserves the 
scholarly record over time. Conferences, seminars and colloquia are all important in helping 
researchers raise awareness of their research, but they do not provide a persistent and easily 
accessible form of storage suitable for the registration and archiving of results unless compiled in 
conference proceedings which is common practice in computer science and handled in a manner 
similar to journal articles in other research fields (22). Preprints, on the other hand, make it easy to 
quickly register new discoveries, and make them accessible to a wider community; however, the lack 
of certification makes it hard to distinguish credible results from unsupported claims. 
 
Figure 2. To justify funding, promotion and recognition researchers are expected to contribute to scientific 
progress. As a researcher it is therefore necessary to register new discoveries (1), have them accepted by 
peers (2) and present the results to the wider research community (3) in a format accessible to future 
researchers (4).  Reward metrics may be straightforward (e.g., reward for publishing in the ‘right’ journal, 
with high acceptance in the community) or implicit (e.g., being awarded a promotion based on a successful 
track record of conference presentations and publication of significant articles) but all four criteria are 
necessary to estimate scientific impact and justify the future allocation of resources (5). 
Material & Methods 
In this work, we compiled a list of social networks and Web tools dedicated to using Web 2.0 
technologies (23). By identifying features offered by each, and comparing those with active user-
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bases with those that have failed to attract significant audiences, we gain insights into the 
motivations and incentives that encourage researchers to adopt new technologies and share 
information.  
The relative success of each website has been estimated by commonly used Web metrics used in 
marketing research and current activity. As an external and easily verified metric, we also measured 
the Google keyword search volume for the name of each service, as many users perform keyword 
searches rather than writing out full URLs into the address window (24). 
Key metrics were selected based on tools commonly used in web analytics and used to evaluate 
overall website popularity by Alexa toolbar traffic estimates, Google Pagerank, Compete and 
MozRank. Data were initially collected using MozBar 2.63 and SearchStatus 1.46 on 29 October 2013. 
A repeat measurement was carried out on 25 February 2016 using WebRank SEO 3.3.7. The data 
behind the measurement services are not available to external researchers; therefore, we also cross-
validated each service against the others to minimise the risk of skewed data (see Table 1). In the 
2016 update, metrics from popular social media were also included in the comparison as studies on 
Altmetrics show a strong correlation between citation rate and activity on Twitter/Facebook (25), 
thus indicating that they are used by researchers for research related tasks. 
Alexa toolbar measures Web traffic based on an international panel of Internet users who have 
installed the toolbar. Data are normalised to correct for demographic inaccuracies, and the ranking is 
based on Web traffic in the previous three months, the most popular website is ranked number 1 
(26). 
Compete measures Web traffic based on a panel consisting of more than two million Internet users 
in the United States of America (USA). Data are then normalised to correctly reflect the 
demographics of the USA, and sites are ranked based on their relative popularity, again, the most 
popular website is ranked number 1 (27). 
Page rank estimates site popularity based on the number of inbound links, and popularity of the 
websites hosting the inbound links. Sites are linked on a logarithmic scale from 1-10, 10 being the 
highest possible value. Public Page rank data are no longer provided by Google, and hence ranks 
were not updated between the two surveys (28). 
MozRank is similar to page rank, but provides more granular data (1-100), and is more frequently 
updated. Data are also processed so that links made on pages with a large number of outbound links 
are less valuable (29). Owing to changed terms of usage MozRank data were unavailable in the 2016 
survey. 
Google search is a popular search tool via which many users reach websites, rather than directly 
accessing them by laboriously typing out their URLs (24). Google keywords provide access to the 
average monthly search volume on keywords, and may, in cases where the site names differ from 
popular search terms unrelated to the site, provide an estimate of website popularity. 
Facebook is the largest social networking website in the world with over 1.7 billion monthly active 
users (30). Content is commonly shared on Facebook in the form of links and aggregated statistics on 
how often users share content from a domain therefore provide an estimate of user engagement.  
7 
Linkedin is the largest professional networking website in the world with 106 million monthly users 
(31) sharing or posting content, in a manner similar to Facebook. 
StumbleUpon is a private company  providing a “discovery engine” that finds and recommends web 
content to users based on the preferences of similar users; it does not provide exact usage statistics, 
but was estimated in January 2015 to drive 0.5 % of all website traffic (32). 
Google+ is operated by search-engine giant, Google; user activity is hard to measure, as Google+ 
membership has been bundled with other services provided by Google. In January 2016, it was 
estimated that links provided by members using Google+ generated 0.04% of the total traffic on the 
Web (32). 
Results  
 
Figure 3, Spearman rank correlation on data from 29 October 2013, showing whether rankings are consistent 
throughout the sample: ‘1’ indicates a perfect positive correlation (blue); ‘0’, no correlation; and ‘-1’, a 
negative correlation (red). Squares with a white background indicate that the compared variables did not 
pass the significance threshold (p < .05). The strongest correlation is dark blue  
Comparison by Spearman rank correlation was performed to evaluate whether websites performed 
similarly, based on the selected Web metrics. 17 of the investigated websites were excluded, as the 
social networks had either been removed from the Web or used a business model where the 
network was inaccessible to outsiders. Spearman rank correlation (Figure 3) and scatter plots (see 
Supplementary Material 1) indicate that Google search frequency, the Alexa toolbar and Facebook 
8 
engagement all generate a high correlation, despite relying on different measurement techniques to 
estimate web site popularity. Correlations also remain statistically significant between years (p < 0.5), 
supporting the initial conclusions based on the manual evaluation, indicating that websites with 
activity in 2013 remained the most active in 2016 (Supplementary Material 2, Table 3). 
Manual evaluation of websites was conducted in 2013 and 2016 with user accounts registered on the 
sites for the purpose of evaluation, covering a four-week periods and manually counting the number 
of submissions made to the website by external users. At the end of the period site popularity was 
estimated using the above-mentioned tools. A community was deemed active if users not affiliated 
by the websites submitted content during the four-week periods in October 2013 and February 2016, 
ending at the evaluation date listed above. Manual evaluation was consistent with the quantitative 
data generated using the website analytics tools for large websites. 
Website usage statistics  
In total, 42 platforms were evaluated in the study (Table 1). Out of the 42 platforms only six websites 
maintained active user communities that could be defined as “active” in the sense that members got 
a response from other members not affiliated with the site responding. Out of the six successful 
websites three are focused on helping researchers to access articles of interest and advertise their 
own articles (ResearchGate, Mendeley and Academia.edu) and one obtain members by requiring 
students participating in the International Genetically Engineered Machine (iGEM) competition to 
contribute protocols to the Wikipedia like web page OpenWetWare as a part of the competition. The 
two remaining websites, Biostars and myExperiment are targeting bioinformaticians in line with 
traditions from programming and computer science rather than “wet work” in Life Science – see 
Table 1 for ranking, and Supplementary Material 2, Table 3 for raw data including all the metrics used 
to measure web site popularity. 
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Based on both the tool-based and manual evaluation, three websites clearly stand out from the rest, 
as they dominate the rankings (see Table 1). By evaluating the value proposition(33)offered to 
prospective members, it is possible to assess what each of the host companies considers to be the 
relevant key customer benefits.
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The value propositions offered by the top-ranked websites (as described on each website landing 
page) are: 
Research Gate (34) 
x Research visibility 
x Connect and collaborate 
x Stats and metrics 
Academia.edu (35) 
x Share your papers 
x See analytics on your profile and papers 
x Follow other people in your field
Mendeley (36) 
x Organise your research
x Collaborate with others online
x Discover the latest research
Academia.edu and ResearchGate are almost identical in their customer offer, and similar to 
Facebook or Linkedin in their design. Mendeley is, in its basic form, a bibliography management tool 
but with social-networking features that allow users to discover and track new research, similar to 
Academia.edu and ResearchGate. Based on the Van de Sompel categorisation (21), the interpretation 
might be that two of the most successful platforms (Research Gate and Academia.edu) attract users 
by promising to increase awareness of their work, while Mendeley provides a variant of peer-to-peer 
certification, promoting awareness as friends and associates spread articles of interest to their 
collaborators.  
Apart from these three highly successful platforms, three others have managed to maintain active 
communities in niche areas. These are: 
Open Wetware, a Wiki-style community dedicated to managing laboratory information and sharing 
protocols supported by, among others, the BioBricks Foundation (37) – BioBricks offers a registry of 
standardised (safe, ethical, cost effective, free) biological components, which teams of students use 
in synthetic biology’s iGem competition to build viable biological systems – teams that actively share 
information via Open Wetware are rewarded;  
myExperiment, a website to find, use and share scientific workflows (38); 
Biostars, a question-and-answer website where users can post questions, and casual visitors and 
subscribed members can answer. Questions and answers are voted up or down, which helps users to 
find the best solutions. This sort of website is popular with programmers; Biostars brings this concept 
to bioinformatics audiences. 
Apart from these websites functioning as autonomous virtual communities it should also be noted 
that two websites have active communities but are largely reliant on users affiliated with the 
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founders to provide content, which violates criterion (3) in the definition of a social network (“there 
must be a sustained user-base not affiliated with the founders”). 
Protocol-online, a website that publishes experimental protocols, and hosts a forum where members 
can discuss laboratory techniques and research-related questions. The protocol section sees low 
activity, but the question-and-answer forum is active, a high proportion of answers being provided by 
members affiliated with the website;  
The Science Advisory Board, a community sponsored by Bioinformatics LLC, where users are 
rewarded for answering questions and surveys. The community consists of groups of users who can 
post articles and questions, a significant part of the communication coming from members affiliated 
with the website. 
Discussion 
The major limitation of the study is the difficulty of creating an exhaustive list of social networking 
websites. Few of the surveyed websites have an accompanying marker paper in indexed journals and 
Google searches are not repeatable over time making it hard, if not impossible to evaluate the 
proportion of suitable websites meeting the criteria being included. The nature of Google searches 
with its advanced metrics for prioritising relevant web sites does however mean that websites left 
out of the comparison are unlikely to have been widely popular at the time of the surveys. The 
second survey to evaluate the development between 2013 and 2016 further strengthens this 
conclusion as the relative popularity of websites remained relatively stable throughout the time 
covered by the two surveys. Indicating that widely visited and well known websites remained popular 
while less popular websites were either shut down or remained relatively unknown.  
The majority of scientists are, in one way or another, operating online, surfing, searching for 
information, commenting, rating, and, last but not least, sharing their scientific results with others as 
reflected by the correlation between citation rates and high exposure in social media(25,39). 
Nevertheless, only three out of 40 social networks developed for open scientific communication 
online (see Table 1 and Supplementary Materials 2, Table 1 for full list and features) have achieved 
widespread influence in several research fields of life science, with active user-bases from a variety of 
scientific fields. This is, however, consistent with the typical pattern of what economists label as 
‘winner takes it all markets’ (40). In such markets, it is necessary for companies to make significant 
investments in marketing, as well as infrastructure, in order to gain profits of scale that make it 
unattractive for competitors to fight for a market share (41). From a user perspective, this might be 
reasonable, as the work-cost associated with sharing information online is the same, regardless of 
the size of the audience, but the likelihood of reciprocation is far greater in a community with a 
million users than in a community with small numbers of users. It is therefore of little surprise that all 
three major networks have been highly successful in obtaining financing (Mendeley 2.13 M USD (42), 
ResearchGate undeclared (43) and Academia.edu 2.2 M USD in early funding (44)) for expanding the 
networks at an early stage in their development.  
All three platforms provide a combination of broadcasting capabilities and filtering, as scientists can 
both recommend their own articles and promote awareness of articles written by others. This 
provides an efficient solution to one of the major paradoxes of modern science; for researchers, it is 
important to publish as much as possible in high-impact journals (5,6,8), in order to advance their 
career and to acquire research funding; at the same time, scientists struggle to cope with the 
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information deluge published in their fields, and strive to minimise the time reading less important 
articles (20).  
None of the smaller social networks provide these broadcasting and filtering services as efficiently as 
the larger ones. But, by finding attractive niches, three of the small networks have been able to 
create viable networks, despite the dominance of the larger ones. Open Wetware focus on publishing 
protocols and workflows that would be hard to publish elsewhere – several of the networks that 
failed to gain traction have tried to offer similar services, but Open Wetware is unique as it is an 
integrated part of the BioBricks infrastructure, supported by eager participants in the iGem 
competition, who are rewarded for publishing material in Open Wetware (45) but also remains 
relevant for other researchers accessing the website.  
The two remaining networks (Biostars and myExperiment) are dedicated to bioinformatics, an 
informatics-related sub-field of the life sciences in which computers are used to manage, analyse and 
help interpret biological data (46). The bioinformatics community is strongly influenced by traditions 
in programming where virtual communities are as old as the Internet itself (47), meaning that social 
networking sites for bioinformaticians may be considered an extension of traditions in programming 
rather than a case of technology adoption among life science researchers. 
In general the websites included in the survey had a focus on facilitating interactions between 
researchers, either by directly promoting the creation of virtual communities or by encouraging 
researchers to share material and then use the networking features to discuss the materials 
presented. Indicating that there was a widespread belief in the importance of speeding up 
communications among entrepreneurs in the field starting companies at a time when social 
networks such as Facebook and Twitter rose to prominence among a mainstream audience.  
In comparison more recent ventures seem to follow a different path with entrepreneurs investing 
efforts into systems that allow researchers to register their findings and make them more easily 
citeable to a wider audience. This development is closely related to the development of digital object 
identifiers (48) or “DOI-numbers” which are nowadays ubiquitous for scientific journals and 
reference management systems (including Mendeley) use them to automatically retrieve metadata 
for citations and generate bibliographies. There is however no technical limitations restricting DOI-
numbers to traditional journals and entrepreneurs in scholarly communication now provide websites 
making it possible to register scientific outputs other than journals using these identifiers and 
associating them with relevant metadata. In 2016 Crossref announced that they would provide DOI 
numbers to preprints (49) and other forms of research outputs can now also easily be published in an 
easily referenced manner using DOI numbers using websites such as Protocols.io (50) for laboratory 
protocols, datasets at Zenodo (www.zenodo.org) and any kind of “research output” at Figshare 
(www.figshare.com).  
It is yet too early to evaluate which ones of these may become significant contributors to the system 
of scholarly communication, but it is clear that while the websites covered by our survey aimed to 
change communication, this newer generation of websites is more oriented towards helping 
researchers integrate new kinds of research outputs into a very traditional system of academic 
recognition. 
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Implications for future development and research 
Creators of social networks for scientists have often found that participation rates are lower than 
anticipated. Leading to most web sites covered by the study either being shut down or languishing 
with empty or inactive communities (51,52). This survey is to our knowledge the first of its kind and 
provides an insight into how technology has been adopted in life science which as a field appears 
more conservative in its means of communication than for example physics and data science. 
From the survey it is evident that the most successful social networks have been the ones helping 
researchers to achieve the four criteria necessary for qualifying scientists for academic recognition 
(registration, certification, awareness and archiving). In environments where traditional 
communication is restricted to print media or verbal presentations, scientists need to publish in 
widely distributed and well-known journals in order to be recognised and rewarded. But access to 
dedicated social networks and communication platforms has increased the accessibility of scientific 
results and knowledge (53). However, in order to become eligible for promotions or to receive 
funding, this notoriety must be coupled with publication in scientific journals(1,2).  
 
Figure 4. Current status of scientific publishing in life science. Publication in peer reviewed journals remains 
the only method to achieve certification, awareness and archiving, but search engines and scientific social 
networks provide new channels for researchers to raise awareness of new articles. This makes scientists less 
reliant on the popularity of the journal to reach potential readers.  
Journals have so far maintained a position as the mainstay of scientific communication, as they 
provide a ‘one stop service’ in scientific communication. The value of this contribution is evident as, 
relative to other sectors of the publishing business (e.g., novels and weekly news magazines), profit 
margins and returns on equity are 5-15 % higher, (54). The profitability of this market has so far not 
been significantly threatened, as open-access journals (e.g., PLoS One), and currently successful 
scientific social networks, have built their success by adhering to the traditional academic recognition 
process; at the same time, they provide other advantages, such as faster review and support for 
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researchers to raise awareness of their work, thereby sustaining a system in which the value they 
contribute can be converted into considerable profit margins.  
This conservatism is also evident when looking at engagement levels on social networking websites. 
Nature has launched ambitious projects such as Nature Networks (discontinued) and Scitable  
(http://www.nature.com/scitable), providing high-quality material to the public, but without 
achieving major user engagement. But even early adopters to new platforms such as PeerJ (a 
publisher offering extremely low-cost open-access publishing in return for providing at least one 
peer-review per year) (55) display a similar unwillingness to step outside the traditional structure of 
scholarly communications. Apart from its revolutionary approach to review, with life-time users and 
low costs, PeerJ still functions mainly as a traditional scientific journal, despite offering Web 2.0 
features, such as a Q&A section, modelled on the popular Stack Overflow system. In its first 14 
months of existence, the Q&A section only received questions from 15 members, and answers from 
49 members, despite being highly visible on a website where 1,512 members had registered and 410 
had participated as non-anonymous reviewers in the traditional peer-review process (a more time-
consuming task than responding to questions in the Q&A section). By 18 May 2016, the number of 
members had grown to 33,052 (an increase by over 2,000 %), but the number of members who had 
responded in the open Q&A forum had only increased to 52 (+6 %), suggesting that adapting to new 
ways of communication is not high on the list of priorities of new members. 
Based on the evaluation of platform success and other factors described in this article, we can see 
that there has been no Web 2.0 revolution, and new technology has only been successful when used 
to support the current system of scholarly communication. There may yet be a significant upheaval in 
the publishing business, as new methods for building awareness and certification allow researchers 
to bypass publication in scientific journals and still achieve all four requirements to be eligible for 
academic rewards, such as funding or career promotion (Figure 5). However, for such an upheaval to 
take place, it is necessary that systems are put in place to enable external funding bodies and 
academic review boards to evaluate these metrics just as they review publication metrics today 
For researchers, this means that new technologies, at the moment, are most readily useful in the 
‘awareness building’ stage of scholarly communication. By sharing information about interesting 
articles with colleagues online, we gain acceptance within communities, we gain access to relevant 
articles efficiently, and have opportunities for promoting our own articles. 
The long-term effects of new technologies are harder to predict and the development of websites 
making it possible to register scientific output other than articles for citations may yet generate 
significant shifts in scholarly communication. Journal publication is optimised for a different era of 
communication, and the rapid pace of research, combined with a limited pool of reviewers, has put 
the system under serious strain (1,56).  
Openness is a core value of science (57) but our results indicate that researchers are unwilling to 
commit the time and effort to openly sharing data online unless it contributes to the already 
established norms for scholarly communication. With publication metrics already being considered 
an important factor by many researchers (58) and many researchers being open to alternative 
metrics as well to expand their resumes (59) it may be increasingly attractive for researchers to 
register and archive their researcher in unconventional ways without going through the established 
process of pre-publication review. 
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Evidence of this is still limited to individual cases and even the decision by a single researcher to not 
commit to journal publication for a pre-print accepted as valid by peers has been deemed 
newsworthy enough to cover in a Nature editorial (60). Such a development would however be a 
logical conclusion based on our model integrating the Garvey-Griffith model with the 5 steps to 
scientific reward by Roosendal and Guerts. 
The lack of a controlled environment makes it hard to draw definite conclusions. But our model 
provides a logical explanation for the current lack of radical transformation of scholarly 
communication despite how electronic communication has disrupted and radically changed other 
traditionally printed media (11). Furthermore it provides the foundation for a theory that will be 
tested over the coming years as we see the effect of preprints and other citeable media play out in 
the research community. Based on our model we suggest that: 
x Preprints and other data will be increasingly cited as infrastructure enabling researchers to 
both find and cite alternative means of publication of data is readily available. 
x As a result external or alternative certification bodies conducting peer review (10,61) will 
become increasingly important. 
Without external certification bodies, it will be virtually impossible for academic institutions to 
properly reward scientific material published outside traditional journals. Citeability in itself does 
however create renewed opportunities for entrepreneurs to challenge traditional journal 
publications and if external certification outside of the established journal system become widely 
recognised by academic institutions, then a revolutionary change in scholarly communication could 
disrupt scientific journals and their profitability just as news media is currently changing. 
   
 
Figure 5. A future scenario where publication in scientific journals is no longer the single gold standard as 
articles can obtain the steps of registration (1), certification (2), awareness (3) and archiving (4) without 
18 
 
publication in traditional scientific journals. In such a scenario peer review moves into the hands of formal 
accreditation bodies, external committees like Peerage of science, or scientific social network platforms, 
such as PubMed Commons, Paper Critic (Mendeley) or ResearchGate, providing relatively reliable 
certification regardless of the status or reputation of the archive hosting the article. 
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Abstract
When obtaining samples from biobanks, resolving ethical and legal concerns is a time-consuming task where researchers need
to balance the needs of privacy, trust and scientiﬁc progress. The Biobanking and Biomolecular Resources Research
Infrastructure-Large Prospective Cohorts project has resolved numerous such issues through intense communication between
involved researchers and experts in its mission to unite large prospective study sets in Europe. To facilitate efﬁcient communica-
tion, it is useful for nonexperts to have an at least basic understanding of the regulatory system for managing biological samples.
Laws regulating research oversight are based on national law and normally share core principles founded on international
charters. In interview studies among donors, chief concerns are privacy, efﬁcient sample utilization and access to information
generated from their samples. Despite a lack of clear evidence regarding which concern takes precedence, scientiﬁc as well as
public discourse has largely focused on privacy concerns and the right of donors to control the usage of their samples.
It is therefore important to proactively deal with ethical and legal issues to avoid complications that delay or prevent sam-
ples from being accessed. To help biobank professionals avoid making unnecessary mistakes, we have developed this basic
primer covering the relationship between ethics and law, the concept of informed consent and considerations for returning
ﬁndings to donors.
Key words: ethics; biobank; sample access; genomics; DNA
Introduction
The Biobanking and Biomolecular Resources Research
Infrastructure-Large Prospective Cohorts project has provided
valuable experience on the issues of sample access through its
open calls to provide funding for accessing biobanked samples.
For the cohorts who did participate in various projects, attaining
ethics approval and sorting the legal issues were time-
consuming but not insurmountable tasks because of intense
communication between involved researchers and experts.
The risk of biobank samples being used in an inappropriate
manner has received increasing attention in scientific dis-
course. In comparison, the threat of under-utilization of sam-
ples or an inability to return the benefits of research to donors
has received relatively little attention, despite also being among
the chief concerns of interviewed donors [1]. Furthermore, the
genomic revolution means that pretty much any sample can be
considered to contain potentially identifiable personal data in
the form of DNA. Researchers therefore face an intricate extra-
legal regulatory system complete with steering documents
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(ethics guidelines), overseeing bodies (research ethics commit-
tees) and formal procedures (informed consent) [2] when at-
tempting to access samples.
Although laws regulating research oversight have been im-
plemented differently in every country, there is a similarity of
core principles founded on international charters such as the
Helsinki Declaration. International consortia have translated
these core principles into policies, procedures, tools and govern-
ance that facilitate interoperability between biobanks across na-
tional borders in a manner acceptable to national law makers
[3–5], thereby enabling the scientific community to operate des-
pite a lack of clarity and international agreements that may pro-
vide a stable and enabling environment for international
collaboration [6, 7].
As biobanks mature, priorities tend to shift [8], and it is not
uncommon that biobanks find themselves prevented from pro-
viding samples due inappropriate decisions taken several years
earlier. These complications are often the result of requests
with unforeseen requirements causing uncertainties if given
consents are sufficient and how or if information from new re-
search projects should be returned to the donors. The primer
therefore covers how these obligations are governed under
international agreements and national law, the practice of es-
tablishing this relationship by the concept of informed consent
and the difficulties on deciding when and what information
should be provided to sample donors.
Hard and soft law, the key to
international collaboration
The national legal framework of biobanking is often substan-
tially different even between countries of comparable jurisdic-
tional systems [9]. To accommodate international collaboration,
it is therefore necessary to rely on ‘soft law’ or extra-legal
means to bridge the gap between the national legal systems,
which operate on a ‘one nation, one law, one project’ approach
[10].
When dealing with such matters, it is therefore important to
understand and recognize how research is regulated by a com-
bination of ‘hard law’ and ‘soft law’ where the terms can be
defined as follows:
Hard law: Binding legal instruments, either in the form of
international law (conventions, treaties or agreements) or na-
tional law (statutory law). International law is often drafted in a
more general form and subsequently implemented in national
law. For the individual researcher, it is most often the national
statutory law that regulates the legality of actions.
Soft law: Nonbinding instruments such as guidelines and
codes of conducts that may lay down suitable and commonly
accepted ways to deal with a matter. Soft law in different forms
varies in form from openly phrased to rather strictly defined
rules, bearing close resemblance to hard law.
Hard law is codified in legal text, which makes it relatively
straightforward for a trained expert to access and identify the
relevant laws. Soft law is on the other hand more flexible but
makes it harder to find and understand the regulatory mechan-
isms, as it allows governmental and nongovernmental experts
to update regulations and standards without requiring active
engagement of law-making bodies, and often these experts may
be specified in hard law as bodies tasked with providing legally
binding regulations and decisions. Funding bodies are becoming
an increasingly important source of soft law by enforcing
contracts requiring certain guidelines or procedures to be fol-
lowed by researchers to be eligible for funding.
For European researchers, an important source of this kind
of regulation is the European Union (EU) funding programs
managed by the European Commission. It requires applicants
to state in their proposal that they will conform to specific
standards [11] where failure to comply mean that the researcher
will not be eligible to receive the funds provided by the grant.
Similar approaches are not only used for international pro-
jects but are also a way for national agencies to harmonize
activities in nations where legislation is done at a regional or
state level. For example, in the United States, the National
Research Council stipulates the following for the international
transfer of embryonic stem cells:
If a U.S.-based investigator collaborates with an investigator in an-
other country, the ESCRO committee may determine that the pro-
cedures prescribed by the foreign institution afford protections
consistent with these guidelines, and the ESCRO committee may
approve the substitution of some of or all of the foreign procedures
for its own. [12]
These guidelines are defined by one selected group of experts
(the National Research Council) who delegate decisions to an-
other group of experts [the Embryonic Stem Cell Research
Oversight (ESCRO) Committee], which is charged with deciding
if there is a comparable set of checks and balances in the part-
ner country in the form of a, yet to be identified, third group of
experts. These guidelines are a good example of how a soft law
approach with several layers reduces transparency in return for
increased flexibility, as guidelines, review committees and re-
search practitioners make up an ever-changing system of stake-
holders. Under such circumstances, collaboration is
substantially more likely to be accepted between nations where
the respective authorities have had the possibility to become fa-
miliar with each other’s customs and traditions, and above all,
where the legal requirements applicable to the matter have
been enacted as a result of international agreements. A lack of
trust, harmonization or the local preferences of the committee
may therefore significantly affect the outcome of an application
for the transfer of data or samples. Decisions by judicial author-
ities covering one of the partners in a collaboration may also
have an immediate impact on international collaboration, as
certain procedures are deemed to be in conflict with national
law. The EU has, for example, chosen a high standard for data
protection, as seen in the recent Safe Harbor-ruling from the
Court of Justice of the European Union (C-362/14), where the US
level of protection was found not to uphold an adequate
protection.
However, most modern national laws are based on an ambi-
tion to adhere to a common set of core principles derived from
the declaration of human rights and international declarations
such as the Declaration of Helsinki [13]. This means that even if
there is yet little legal harmonization between countries. There
is a strong case for researchers to argue that institutional review
boards should take into account decisions from review boards
in other countries, in a soft version of a principle of mutual
recognition.
Consent as the basis of
international collaboration
The signed consent form provides a receipt that verify that the
donor has been provided with sufficient information to make
an informed consent when donating his or her samples.
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Modern regulations regarding informed consent were codified
in an international setting by the Helsinki declaration and
Nuremberg code [14] as a result of the horrors in World War II
and subsequent development. Respect for the autonomy of re-
search subjects and their right to refuse participation in re-
search does however have a much longer history in research
[15] even if modern researchers may find certain practices trou-
bling or even barbaric. For example, in the mid-19th century in
America, it was considered acceptable for a slave owner to ob-
tain consent for invasive experimental surgery from slaves [16].
While it for a modern person is hard, if not impossible to accept
slavery or the concept of ‘a consenting slave’. From an academic
context, this intuitive protest can be interpreted as an example
of how we instinctively respect that a person in a position of de-
pendence cannot make a truly autonomous decision [17]. The
concept of donors as autonomous agents is one of the key con-
cepts of modern research, and the question of identifying what
information and freedom is necessary before a person can
make an autonomous decision is therefore central to all forms
of biobanking and genomic research with human participants.
When establishing a new biobank, it is important to rely on
forward-looking consent procedures to ensure the future viabil-
ity of the sample collection. A large number of different forms
of consent have been proposed in scientific literature. But in
practice, consent forms likely available to a biobank would need
to result in a presumed, broad or specific kind of consent
(Table 1). In bioethicist literature, concepts such as ‘tiered’ or
‘dynamic’ consent are suggested as compromises between spe-
cific or broad forms of consent. In practice, these forms of con-
sent can either be broad or specific depending on whether the
components of the consent are widely or narrowly specified.
It is however not always possible or feasible to obtain informa-
tion from a known, informed and willing donor. In some cases,
a presumed consent is necessary, and several ethicists also
argue that a consent can never be truly informed unless strict
requirements are met [18–20].
When looking at large biobank infrastructures, a broad
consent is favored among the major infrastructures [21–23]
even if there still is debate among ethicists on how broad a
consent can be while still maintaining the autonomy of the
donor [24]. The dominance of broad consent in infrastruc-
tures based on soft law is in this context a good example of
how soft law solutions allow society to adapt more quickly
to new possibilities and risks compared with hard law
where important laws may be debated for years before
implementation [7].
Specific consent is by its nature reactive, as it is impossible
to request specific consent for purposes not yet foreseen. As a
response to this issue, proponents of specific consent have
made numerous proposals where modern communication tech-
nology makes it possible to repeatedly (or dynamically) ask
donors for consent [25]. Thus, initial consent only needs to
cover foreseeable research, while new projects are made pos-
sible by a renewed consent, thereby, in the opinion of its pro-
ponents, creating a balance between maximizing the value of
samples and the necessary safeguards to ensure that consent is
truly informed.
However, research rarely takes place in clearly defined mod-
ules, and there is often a continuum where it is hard to define
the acceptable threshold for clarity, which requires new consent
[26]. In practice, this means that a biobank will require a similar
independent ethics review board, regardless of if the biobank
operates under a legislation requiring specific, broad or any
other form of consent.
Recent research further underlines the support for a broad
consent among biobank experts [20], but even a broad consent
is limited in how much freedom may be given to researchers to
initiate new projects. That an administrative framework re-
mains in place for the sample collection and that the new re-
search does not change the overall aims or governance
structure are core conditions and may be regarded as a minimal
set of regulations for a broad consent to remain valid [27]. For
European needs, Carlo Petrini at the Bioethics unit of the
Presidenta˜ s office in Italy has conducted a bibliographical study
of the requirements necessary to operate a biobank under a
broad consent in Europe [28], suggesting that the following
requirements must be met:
• Adequate sample coding procedures are used.
• Adequate procedures for personal data protection are used.
• The importance of the research aim is sufﬁcient to justify con-
ducting the study and is evaluated on a case-by-case basis by an
ethics committee.
• The sensitivity of the data is evaluated on a case-by-case basis.
Genetic information varies in sensitivity based on its signiﬁ-
cance, ranging from stringent protection to a lesser degree of
protection.
• Generic research results are always released without speciﬁcally
identiﬁcation of individual subjects.
• ‘Opt-out’ consent is allowed for subsequent or secondary studies.
Every subject must be guaranteed the possibility of withdrawing
consent at any time.
• Participants must have adequate means of involvement, such as
encouraging participant consultation or communicating infor-
mation through the mass media before project initiation. The
multiple modes of involvement should be complementary as
opposed to mutually exclusive. It is especially important that
forms of direct participation also be available, for example, by
having population representatives serve on the ethics commit-
tees that will decide on the approval of the research before it
begins.
• Measures to ensure transparency and supervision must be in
place. Adequate supervisory, procedural and technical systems
are necessary to guarantee information protection. Further, it is
highly advisable to have external and independent supervisory
bodies monitoring procedural correctness.
The reporting of planned or incidental findings
Another controversial subject with far-reaching consequences
for sample availability is whether researchers should be obliged
to return information on findings to the donor [29]. There is cur-
rently no overall consensus on when to tell and when not to tell
participants of incidental findings [30]. Careful planning of pro-
cedures to satisfy local or national expectations is therefore ne-
cessary to ensure that donor interests are managed properly. In
cases where a study is based on samples, not yet collected, re-
searchers can, and should, plan ahead to ensure that donors are
properly informed at the time of consent on reporting proced-
ures. For studies on samples already collected or where clinic-
ally relevant findings are incidental in nature, it instead
becomes necessary for study manager to base their reporting
procedures on their own judgment or guidelines provided by
local experts or governing boards suited to the task.
Based on the conflicting opinions described by researchers
conducting systematic reviews of the field, it would be fool-
hardy to claim that practitioners and ethicists are anywhere
near a consensus in the field [21–23, 29]. It may however be
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possible to break down disclosure into two dimensions to separ-
ate situations where researchers are closer to consensus from
areas where there still is severe disagreement (Figure 1).
Given this four-field breakdown and preceding information,
ethicists are at least approaching a consensus on the lower left
and upper right corners. Which mean that incidental findings
with a high level of actionability and clinical validity should, if
possible, be reported back to the donor [31] and findings of low
validity and actionability should not be reported to the donors
(2, upper right corner) ahead of [31] and (3, lower left corner).
There is however no consensus on whether it is a moral neces-
sity to actively look for such genes in genetic data, and many re-
searchers also feel uncertain when judging if specific markers
are actionable and clinically valid [31]. To support clinicians, the
American College of Medical Genetics has taken initiatives to
support researchers to reduce these difficulties with lists of
Table 1. Forms of consent described in literature
Generalized category Type of consent Definition Authors Disagreement
No consent given Presumed Consent is presumed to have been given
by donors to use their samples and in-
formation for all research unless they
actively choose to opt out
Master et. al. and
Hofman
Passive/tacit/silent
consent
Presuming that the persons object if they
do not consent
Hofman
Hypothetical consent Consent under the presumption that a
person would have consented to the
treatment or research were she or he
able to consent
Hofman
A broad or speciﬁc consent Future/deferred consent Postponing the consent procedure Hofman
An extremely broad consent General/blanket/open
consent
Donors can actively consent once for the
current study and all future research
involving the general use of their sam-
ples and information
Master et. al.,
Hofman and
Salvaterra et al.
Salvaterra refer to
this as broad consent
May be either
broad or speciﬁc
depending on how the
consent is formulated
and the deﬁnition used
by the reviewers
Broad Donors can actively consent once for the
current study and all future research
within a broad ﬁeld, e.g. cancer, dia-
betes or heart disease
Master et. al.,
Hofman and
Salvaterra et al.
Salvaterra refer to
this as partially
restricted consent
Delegated trustee Donors can transfer consent to a trustee
who is at arm’s distance from the bio-
bank and consents on behalf of donors
Master et al.
Third-party oversight Donors can actively consent to a general,
broad or other model, but an ethics
board must approve the study before
the commencement of research using
stored samples and information. This
approach is emerging as a common
component of biobanking governance
schemes
Master et al.
Tiered Donors can actively consent once for the
current study and choose one or more
broad ﬁelds of research or other op-
tions, i.e. whether they would be willing
to have their samples used in research
that result in commercialization. Other
terms: line item or multilayered
consent
Master et al.
Re-consent Donors are informed and are required to
consent to the current study and to
each future research study involving
the use of their samples and
information
Master et al.
Speciﬁc informed
consent
Allows the use of biological specimens
and related data only in immediate re-
search; forbids any future study that is
not foreseen at the time of the original
consent
Salvaterra et al.
Note: Terms used in literature are not always univocal and may also be used with different levels of speciﬁcity. In the table, the speciﬁc deﬁnitions described by the au-
thors have been clustered into more general of consent described in accordance with this article. The more speciﬁc deﬁnitions are listed in the column ‘Deﬁnition’, and
the terms used to name them are outlined in ‘Type of consent’ and ‘Disagreement’.
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valid and actionable genetic biomarkers [32], which can be con-
sulted by clinicians to determine if incidental findings should
be reported. The procedures for how and if findings are to be re-
ported to the donor should be outlined to the donor at least by
the time of consent, thereby helping to set donor expectations
and define their future relationship with their donated samples.
This means that the researchers, when developing the con-
sent form, must take care to ensure the long-term viability of
the biobank and balance their obligations to donors with the
scientific needs of the project. A high level of reciprocity cannot,
for example, be offered in a biobank where a large portion of the
research is expected to be conducted by external researchers
limited to anonymized data to maintain privacy. It is therefore
necessary that researchers make important decisions such as
coding [33] versus anonymization before contacting potential
donors for consent. Failure to do so may otherwise result in
major issues in the future, as national laws on privacy or obliga-
tions outlined in the consent form may prevent the efficient
usage of biospecimen.
Concluding remarks
International collaboration relies on soft law connecting na-
tional legal systems, which creates an environment that is in-
consistent, unfair and often lacking in transparency. But
replacing the soft law with hard law may be even worse, as a co-
dification of overly restrictive standards into law may stifle or
outright halt scientific progress in regions within the jurisdic-
tion of such laws [7]. Furthermore, it is unlikely that hard law
solutions would be able to possess the necessary flexibility to
keep up the pace with the rapid advancement of research and
genomics.
As a researcher, it is easy to become frustrated and avoid
engaging in such a complex, and ever-changing field of work.
But despite calls for harmonization, it is unlikely that issues will
be solved in the immediate future. There are significantly differ-
ent legal traditions [34–37] as well as variation in public percep-
tion [38, 39] of research. Taken together, this makes it a perhaps
insurmountable task to reach harmonization of national laws
regarding biological samples and data protection. The legal obli-
gations of biobank professionals concerning consent and reci-
procity are therefore likely to change over time and remain
areas associated with a high risk of interfering with the individ-
ual goals and aims of researchers.
In this context, adhering to best practices contributes to the
long-term value of samples, as new implementations of soft
law instruments and codified law are likely to take established
best practices in consideration. Guidance and templates pro-
vided by international organizations such as International
Society for Biological and Environmental Repositories (ISBER,
www.isber.org), Global Alliance for Genomics and Health
(http://genomicsandhealth.org), the Asian Network of Research
Resource Centers (http://anrrc.org), the Biobanking and
BioMolecular resources Research Infrastructure-European
Research Infrastructure Consortium (www.bbmri-eric.eu) and
the Human Heredity and Health in Africa (http://h3africa.org),
here, form a platform for harmonization as well as generating
the opportunities to build the mutual trust necessary to enable
the transfer of samples or data. The role and function of these
soft law tools must however take into account the constitu-
tional aspect of the bioethical framework involving several
human rights. Traditionally, these rights, and especially the
limiting of the rights, are usually thought to be best regulated
by democratically elected parliaments [40]. These international
soft law tools do thus not supersede national authorities and
courts, but their status as internationally recognized authorities
may provide considerable support in achieving approval from
institutional review boards acting under mandate from national
laws.
It is therefore in the best interest of researchers to respect
and promote core principles codified by international conven-
tions and organizations. Connecting local interpretations on
law to an international context also makes it easier to compare
decisions and encourage the development of trust that is neces-
sary for collaboration using sensitive genomic data. It is there-
fore advisable for biobank builders to adopt a system of
governance where:
• The ethical standards set forth by the Global Alliance for
Genomics and Health are upheld [5].
• Samples are stored and managed in accordance with the inter-
nationally recognized ISBER standards for best practice [41].
• Sharing is handled in a manner compliant with the International
Charter of principles for sharing bio-specimens [42].
This does not preclude researchers from having to abide by
the national law of each state involved in international research
collaborations and is far from an exhaustive list of tools to sup-
port international sharing of samples. But it may provide an
international research project with a common foundation and
framework, which make the project more easily acceptable to
the national authorities charged with reviewing projects.
The inherent adaptability of soft law also mean that interna-
tional collaboration through soft law mechanisms may steadily
improve, as experience is gained among stakeholders and thus
alleviate the need for global governance via codified hard law
solutions within the field. If given time to adapt, researchers
and associated organizations might instead be able to contrib-
ute to a bottom-up harmonization of a soft global bioethical
framework.
Figure 1. A breakdown of potential situations encountered when conducting
genetic analysis on collected samples and practical examples of cases clearly be-
longing to each quarter. Support for returning information to the donor is strong
when a ﬁnding is both reliable (possessing a high level of clinical validity) and
actionable (the donor can act on the given information) as in the example given
in Square 2 and, there is little support for providing information that is neither
reliable nor actionable (Square 3). Decisions are harder and in greater need of
consideration when the reliability of ﬁndings is low (Square 4) or when there is
little the donor can do about the situation (Square 1).
Legal and ethical compliance | 5
Key Points
• To accommodate international collaboration, it is ne-
cessary to bridge the gap between national legal frame-
works. This is usually done by designated experts and
organizations who determine if material transfer agree-
ments are able to protect the rights of the donors in ac-
cordance with what they could expect when giving
their consent for samples to be stored for future usage.
• Collaboration is substantially more likely to be ac-
cepted between nations where the respective author-
ities have had the possibility to become familiar with
each other’s customs and traditions. Identifying suc-
cessful precedents by other researchers participating in
collaborative projects can therefore greatly reduce the
time necessary to access samples.
• Different institutions deﬁne terms such as consent, in-
formed consent and broad consent differently. This
mean that an ‘informed consent’ at one institution may
not be accepted as truly informed by another. Under
such circumstances, researchers are likely to face a
situation where the strictest interpretation in terms of
data protection or privacy becomes the governing one.
• There is a conﬂict between reciprocity, anonymity and
the right to not know. Research must therefore be
planned and conducted in accordance with what the
donors could reasonably expect when donating their
samples and giving their consent.
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Abstract: Biobanks are an organized collection of biological material and associated 
data. They are a fundamental resource for life science research and contribute to the 
development of pharmaceutical drugs, diagnostic markers and to a deeper 
understanding of the genetics that regulate the development of all life on earth. 
 Biobanks are well established in High Income Countries (HIC) and are rapidly 
emerging in Low and Middle Income Countries (LMIC). Surveys among biobanks 
operating in a LMIC setting indicate that limited resources and short term funding 
tied to specific projects threaten the sustainability of the biobanks. Fit-for-purpose 
biobanks targeting major societal challenges such as HIV and Malaria provide an 
excellent basis for integrating biobanks with the available research communities in 
LMIC regions. But to become sustainable for the future it is important that biobanks 
become an integrated part of local research communities. To achieve this, the cost of
operating biobanks must be lowered, templates must be developed to support local 
ethics committees and researchers must be given the opportunity to build experience 
in successfully operating biobank based research projects. 
The B3Africa consortium is based on these conclusions and set up to support 
biobank based research by creating a cost efficient Laboratory Information 
Management System (LIMS) for developing biobanks and also contribute to the 
training and capacity building in the local research community. The technical 
platform called the eB3Kit is open source and consists of a LIMS and a 
bioinformatics module based on the eBiokit that allow researchers to take control 
over the analysis of their own data. Along with the technical platform the consortium
will also contribute training and support for the associated infrastructures necessary 
to regulate the ethical and legal implications of biobank based research.  
Keywords: biobank, low- and medium-income countries, biobank and cohort 
building, eInfrastructure, open source open source software, ethical, legal and social 
issues, bioinformatics. 
Introduction 
A biobank is a collection of biologic material and associated data obtained from a 
population or cohort of individuals/subjects and stored in an organized system. The 
associated data (which can be linked back to the subject who provided the sample) include 
epidemiologic, clinical, and lifestyle data. Biobanks are increasingly considered an 
important platform for medical and scientific research. They provide key resources for 
studying the etiology and molecular mechanisms of diseases and for developing potential 
diagnostic biomarkers. Biobanking also contributes significantly to the development of 
personalized drug treatment through translational research.
 Biobanking facilities are well established in High Income Countries (HIC) with 
efforts from international organisations such as the International Society for Biological and 
Environmental Repositories (ISBER), the European, Middle Eastern & African Society for 
Biopreservation & Biobanking (ESBB), the Biobanking and Biomolecular resources 
Research Infrastructure (BBMRI-ERIC), the US National Institute of Health-National 
Cancer Institute (NIH-NCI) and the International Agency for Research on Cancer (IARC). 
These organisations have developed international guidelines and protocols which have 
contributed to this development[1], [2]. However, in many Low and Middle Income 
Countries (LMICs) the uptake of the available resources has moved at a slower pace. In 
many of these settings, standard guidelines and protocols to regulate the collection, 
management, sharing and use of biological samples for research purposes are not being 
utilized.
IARC launched the LMIC Biobank and Cohort Network (BCNet) in 2013[3] with 
the overall objectives to promote capacity-building in LMIC biobanks and to increase 
opportunities for training and funding. BCNet aims to raise awareness among stakeholders, 
communities, and decision-makers about the benefits of biobanking as an important 
infrastructure for research. 
 A situational analysis of infrastructures and facilities was conducted, in order to 
gather information on biobanking activities, research infrastructures and resources. Twenty 
seven institutions from sixteen LMICs participated, including twenty-two institutions from 
eleven African countries.  
 Results from the survey showed that, although information on biobanking activities 
in Africa is limited, biological resource management infrastructure is being developed[4]. 
Biobanks were introduced through specific programmes targeted at major health issues 
affecting the populations of these countries (e.g. HIV treatment programmes) and their 
sustainability is seriously threatened after the project ends.  
 Lack of access to electronic record management systems and organised databases 
has made it difficult for the linkage of biobank records to other health related services. In 
cases where electronic databases are available, they are not harmonised with locally used 
software to allow direct linkage to associated databases such as cancer registries, clinical 
and treatment records databases, etc.  
 The lack of harmonization amongst databases and procedures limits opportunities 
for research collaborations and less than 30% of the centres are involved in scientific 
research collaboration. 
Technical consideration in selecting and maintaining databases and cost implications with 
respect to acquisition, installation and management of Laboratory Information Management 
Systems (LIMS) were limiting factors affecting progress. Many do not have access to 
dedicated facilities to support the biobank LIMS or personnel with the relevant expertise. 
 On the other hand, biomedical research is producing a huge amount of big data 
generated from high-throughput experiments associated to biobanked samples. The lack of 
infrastructures and software platform supporting storage and analysis of this data is creating 
a bottleneck in biomedical research[5].  
The challenge of ethical, legal and social issues (ELSI) related to biobanking was 
also highlighted in this survey, as well as in previous reports[6], [7]. Although the different 
ethics and scientific committees have established various mechanisms to deal with ELSIs in 
scientific research, in most cases, the committees lack the experience and the regulatory 
framework to adequately review applications specific to biobanking or biobank projects. 
This situation creates a barrier for the effective use of biobank samples in these countries as 
well as international collaboration. 
  There is also the need to increase the level of participation of African 
researchers within Africa in a fair and transparent manner.  
 To address these anomalies, the Human Heredity and Health in Africa (H3Africa) 
Initiative project has developed a policy framework to promote fair collaboration between 
scientists in Africa and with the international community[8]. This policy particularly 
highlight key areas to focus on such as sample and data sharing as well as the importance of 
a data and biospecimen access committee. 
 In this article we present the solutions that are being proposed by the EU-H2020  
B3Africa project. The project builds on the conclusions from the BCNet and other projects 
such as the H3Africa Initiative[8]. It proposes an innovative solution, integrating available 
open-source software, services and tools for biobanking, bioinformatics, ethics, regulation 
and training. 
 The main goal of the project is to create a collaboration framework that bridges 
European and African biomedical research and provides a technical platform (eB3Kit) that 
implements and integrates the necessary components of this framework including: 
biobanking, bioinformatics,  education, training and dissemination.  
Defining an ethical and regulatory framework 
There are two basic notions of bioethics that can be considered universally accepted, the 
need for informed consent and ethical approval to allow a safe and legitimate handling of 
biological samples and data within research[9]. The B3Africa project builds upon these two 
notions as well as through a Model Data Management Policy (MDMP) based on the legal 
framework. The MDMP will provide a set of formal rules, criteria and priorities that should 
guarantee a consistent ascertainment of all requirements that should be fulfilled by the 
platform and by the users of the B3Africa platform. 
Four main risks have been identified within the project; a) The B3Africa project 
encounters a complex legal landscape which is difficult to navigate. This creates a risk that 
the legal tools used are incorrect. b) Some of the prospective users of the B3Africa platform 
may be situated in states with underdeveloped bioethical legislation, where procedures that 
would be considered unethical elsewhere, remain legal. c) In states with underdeveloped 
bioethical legislation, it is likely that the governing infrastructure is also underdeveloped, 
for example institutional control and audit of biobanks, research ethics boards, etc. d) If the 
bioethical regulations are too strict, research in itself may be hampered, especially if all 
national laws of the participating states must be upheld in practice. The potential limitations 
for the future use of research data according to ethical regulation and guidelines, for 
example the (African Union) AU convention on cyber security and personal data 
protection, could lead to global national control, unless there is specific provision for data 
access for future scientific research. 
Legal framework 
All processing of biomedical data within the B3Africa project should adhere to two basic 
principles, informed consent and ethical approval, both in regards to processing within a 
state and for cross-border sharing. The legal implementations of the principles are carried 
out within each national legal order, by national authorities enacting administrative 
decisions applicable within the state. For sharing data between two states, there is a need to 
find a model for connecting the ethical approval from the sending state to the receiving 
state[10]. International administrative law provides two approaches that can be applied[11].
First, a common rule can be established for all entities to apply, together with an obligation 
for all to accept each other decisions (home state control). Secondly, the collaboration can 
be built on a conflict of law-approach, leaving each state to decide for themselves how to 
govern the issue at hand and to develop tools to connect to other administrative orders, for 
example via agreements in each individual case. 
 The B3Africa project will employ both strategies to safeguard compliance with 
relevant law set out above, the home state control approach and the conflict-of-law 
approach, in a model adapted to the project. A common understanding of the principles of 
informed consent and ethical approval will function as threshold-principles, basic 
requirements that all parties must follow in their internal work. These requirements should 
thus be upheld by all and will be implemented in the project via the Model Data 
Management Policy (MDMP) and the Data Model, explained below. When collaboration 
cross-borders, each transfer of data must be governed by an individual legal tool, for 
example a data transfer agreement. Standard versions of data transfer agreements, 
especially targeting transfer of medical data, may be drafted in the project, for the parties to 
use or to adapt according to their own needs. In developing of this part of the framework, 
inspiration will be taken from other relevant international research projects and 
infrastructure, such as the work within the common service ethical, legal and societal issues 
of BBMRI-ERIC (http://bbmri-eric.eu ), IARC (http://www.iarc.fr) the H3Africa project 
(http://h3africa.org ) and the RD-Connect project (http://rd-connect.eu ).
Model Data Management Policy (MDMP)  
The MDMP is based on the B3Africa legal framework and will provide a set of formal 
rules, criteria and priorities that should guarantee a consistent ascertainment of all 
requirements that should be fulfilled by the platform and by the users of the B3Africa 
platform. This policy will be implemented as part of the B3Africa final product, the eB3Kit 
and will pave the way for managing the use of the eB3Kit in control and regulated 
environments beyond the project’s life time. 
The model will be based on common standards regarding informed consent and 
ethical approval. The definition of the concepts will be determined by the applicable law on 
site. If the applicable law does not regulate these issues, the minimum requirements set out 
within the legal framework of the project will be applied. For all the European users it will 
be based on the EU Data Protection Directive (and in due time, the General Data Protection 
Regulation). Central features of the MDMP are an Adoption Committee that is tasked with 
evaluating adoption requests from potential users. In order to enter the platform, each user 
needs an Organization membership as well as Individual membership for the person 
conducting the analysis. An application for an organizational membership is done via a 
standardized application form in which the requester provides information regarding the 
organization, (contact information, aim and purpose, if the organisation is private or public, 
means of funding, forms of supervision over the organisation, etc.). Once the B3Africa 
platformeB3Kit has been adopted by an organization or group, the individual requesters is 
also asked to provide information. Only accepted members can request store, management 
and analysis services. Before data is uploaded, standardized documents with the approvals 
by ethics committee or institute research boards for the research project, consent 
information from sample donors whose samples have generated the data, and, if applicable, 
for authorization of use of non-consented data must be uploaded.  
Technology Description
B3Africa will provide a curated platform for open-source software in the biobank domain 
built upon the BiBBoX (biobank software in a box). Within BiBBoX software components 
are pre-installed and configured ready to go with minimal IT effort. The BiBBoX core 
module will cover the core functionality necessary to operate a biobank and the repository 
will also contain docked software tools such as a bioinformatics module based on the 
eBiokit[12]. In addition APIs and interfaces will be specified to integrate open source 
software solutions in the areas electronic health records (EHR), patient and study 
management, imaging and data integration and analysis. The first version of BiBBoX is 
already accessible at http://bibbox.org/.
BiBBoX architecture 
The BiBBoX system architecture is built on top of a virtual machine and docker containers, 
see figure 1. A lightweight central component (green part in figure 1) will provide 
functionality for the deployment of software tools, a central ID und user management and a 
user interface based on the Liferay portal (www.liferay.com).
Figure 1: The BiBBoX System Architecture, central component in green, integration 
software in blue and docked software in white. 
Data exchange between software tools and ID management will follow the MIABIS 
recommendations.  
The Minimum Information About BIobank data Sharing (MIABIS) was developed 
in 2012 by the Biobanking and BioMolecular Resources Research Infrastructure of Sweden
(BBMRI.se). In 2013 a working group was formed under BBMRI-ERIC to continue the 
development of MIABIS through a multi-country governance process. MIABIS is the “de 
facto” biobank information standard for BBMRI-ERIC community and has been widely 
accepted within Europe and beyond.  
The minimum information guidelines consist of a collection of components with 
associated attributes representing relevant concepts from biobanking and biomedical 
research and can be used to integrate the most relevant building blocks of the biomedical 
research ecosystem (https://github.com/MIABIS/miabis/wiki).  
 MIABIS has been implemented in several projects and e-infrastructures as 
BiobankCloud (http://www.biobankcloud.com/), RD-Connect (http://rd-connect.eu/), 
BioMedBridges (http://www.biomedbridges.eu/), BCNet Catalogue 
(http://bcnetcat.iarc.fr/), BBMRI-ERIC Directory (http://bbmri-eric.eu/bbmri-eric-
directory-2.0), among others.  
B3Africa platform will implement MIABIS as part of the data model for 
representing and sharing biobank and research data which will lead to a wider and more 
efficient use of valuable bio-resources. 
Based on previous requirement analysis work [13], [14], we specified core 
functionality for the BiBBoX and identified an initial set of core modules for the first  
BiBBoX release.  
BiBBoX core module 
The BiBBoX core module consists of software tools for the organization of samples and 
related data in the context of a collection / study protocol. It includes functionalities for 
sample acquisition and sample metadata management, sample processing, sample storage, 
sample and data retrieval/distribution (provided by BIKA http://www.bikalabs.com/) as 
well as data integration and cataloguing. In particular the following functionality will be 
supported: 
Organize Collections, Studies and SOPs: Each collection has to be based on a 
specific study design, follow well-documented rules, and describe responsible stakeholders 
(including their roles), sample types, data formats, ontologies and business processes. The 
BiBBoX core module will provide functionality to handle all this information in a version-
controlled manner and will provide a user management system that defines users and what 
actions they are entitled to perform in the system.   
Sample Acquisition and Sample Metadata Management: Each sample and 
aliquot in a collection is related to a specific patient / donor and to a medical / study event. 
Basic information about patient / donors and medical / study data objects will be available 
in the BiBBoX core module, at least global unique identifiers for patients and medical/study 
events will be provided for each sample and aliquot. For sample acquisition in the field we 
plan to integrate the ILRI monitoring system as software component[15].  
Sample Processing: In a typical biobank environment various kinds of procedures 
are carried out on samples, e.g. preservation procedures, generating aliquots and more 
complex processing such as deviation of the original material. To ensure that the fate of all 
of the sample material is known, each aliquot and sub-sample will be tracked and their 
relationship to the parent sample will be recorded. Even if all of the sample material has 
been consumed, this needs to be recorded, so that the processing history is known.  
Sample Storage: After processing and validation samples are moved to a (long 
term) storage. The BiBBoX core module will assist users to organize shelf spaces and to 
find stored samples again when they need to retrieve them. The system will track sample 
locations and monitor freezing and thawing cycles, as well as disposal of them. For bigger 
biobanks automated systems and storage robots will be supported. 
Data Integration and Cataloguing: The BiBBoX core module will provide 
functionality to import and integrate external data objects and generate a catalogue of 
physical and data objects available in the biobank. A catalogue will include metadata 
elements collected in the sample acquisition process including sample availability and 
access conditions.  In addition biobanks metadata describing storage and quality parameters 
will be included. We plan to implement the catalogue functionality based on the Molgenis 
platform[16] providing both sample level and aggregated information as well as search 
functionality.  
Sample / data retrieval and shipping, retention and destruction: The BiBBoX 
core module will provide functionality to manage samples in transit between source and 
destination, for both receiving samples and redistributing them to authorized recipients. 
Shipping is related to the whole chain of custody and storage inventory and the sample 
access management.  In addition also a retention schedule for samples and data defining 
how long samples and associated sample records will be supported.  
Administrative, business and management support: The BiBBoX core module 
will support administrative tasks of the biobank operation, including workflow and 
customer management.  For this we will provide functionalities, which allow managers and 
auditors to monitor the biobank operation.   
Docked bioinformatics module 
The BiBBoX integrate a bioinformatics modules based on the eBiokit[12] which is a
self-contained computing platform providing users with access to popular bioinformatics 
software and services. The local storage allows researchers to conduct advanced data 
analysis in a user friendly environment and access local copies of commonly used 
databases. Combined with extensive in-built tutorials this system allows non-specialists to 
process data generated from a biobank collection. 
Data analysis is often a significant bottle neck in modern life science and the 
bioinformatics component in the eB3kit provides research institutions with the means to 
more efficiently distribute the work load. Junior researchers can perform routine operations 
and screening while simultaneously learning the basics of bioinformatics. Research 
institutions can then either use the eB3kit bioinformatics toolkit as a foundation for further 
specialization in bioinformatics or use the data produced as a basis for collaboration with 
research groups specialized in bioinformatics.
Education and capacity building
The eB3kit will contribute to establishing an open-innovation ecosystem in Africa 
and Europe. In doing so it is important that researchers in Low and Middle Income 
Countries have the infrastructure and know-how to participate in the co-creation and 
exploration of ideas. To bring a real added-value to the institutes and countries in which it 
will be implemented, the eB3Kit will therefore be supported by an extensive education and 
capacity building effort where different enabling factors have been considered.  
First, the project recognizes the paramount importance of having the B3Africa 
concept validated by biobanks from both continents. This implies an active involvement of 
a different range of actors from involved biobanks, providing complementary technical, 
scientific, ethical, legal and political perspectives. Different actions are planned to engage 
those actors: ethics and legal issues meeting, stakeholder forums, technical jamborees. 
In addition, the eB3kit will be installed and tested in real-life settings (use case), 
using a step-wise approach. Three centers involved in H3Africa were first selected to take 
part of the use case work package.   
x National Health Laboratory Services - Stellenbosh University Biobank, Cape Town, 
South Africa 
x Institute of Human Virology, Abuja, Nigeria 
x Makerere University College of Health Sciences, Kampala, Uganda 
The involvement of those three centers represents a great added-value for both the B3Africa 
and the H3Africa projects, as it reinforces synergies and complementarities. Since the 
beginning of the B3Africa project, the International Livestock Research Institute (Nairobi, 
Kenya) already partner of the project, has also volunteered to act as use case for non-human 
biobank setting.  
BCNet, from which the B3Africa project could largely draw on, has also been 
identified as an important source for use case centers. With twenty-one members from 
seventeen countries (seventeen centers from thirteen African & Middle East countries, 
along with centers from two European countries and two Asian countries), this dynamic 
network represents great opportunities for testing and dissemination of the eB3kit. Equally, 
the eB3kit will provide a concrete solution to some of the challenges reported by BCNet 
members. Initially, four BCNet members will be take part in the use case work package:  
x Breast Care International, Peace and Love Hospital, Kumasi, Ghana 
x Medical Research Council, International Nutrition Group, Banjul, The Gambia  
x National Cancer Institute, Vilnius, Lithuania 
x Wroclaw Research Centre, EIT+ Biobank, Wroclaw, Poland  
Furthermore, key professionals involved in the implementation of the eB3Kit will be 
trained. Courses and tailored learning materials will be developed based on a detailed 
learning needs assessment. Inputs from B3Africa partners in charge of developing the 
eB3Kit will be requested in order to take into account the specificities of the various tools 
included in the kit (technology and various components, required knowledge and skills, 
available learning resources, etc.). Professionals at use case institutions will also be 
consulted in order to take into account the various profiles of those responsible for the 
implementation of the eB3Kit (“focal points”), as well as end users of the kit. Besides 
knowledge and skills specific to eB3kit components (tool-specific), other competencies 
(core competencies) will be considered for an effective and sustainable use of the eB3Kit.  
Available learning resources/opportunities within B3Africa and related partners (i.e. 
H3Africa, ESBB, ISBER, BBMRI, etc.) will be identified, in order to maximise synergies 
between existing laboratory capacity building initiatives. Over the first years of the project, 
training initiatives will target the use case institutions listed above.   
Finally, learning materials developed throughout the implementation of the project 
will be produced as standalone generic resources organised as a standardized learning 
environment such as the eBioKit used in the Pan African Bioinformatics Network for 
H3Africa (H3ABionet). Resources will be more widely disseminated through awareness 
raising actions on project activities and results, as well as dissemination of project 
deliverables and outcomes to relevant stakeholders, including at the policy level. Besides 
communication activities of the B3Africa project, a course will be organised towards the 
end of the project and will target professionals from other biobanks interested in the use the 
eB3kit.  
All the above will enhance the ability to conduct training for new and/or developing 
biobanks and therefore strongly contribute to create a sustainable network of biospecimen 
repositories infrastructures interacting and sharing  knowledge between Europe and Africa. 
Maximizing the social and economic impact of biobanks in Africa
The surveys among biobanks operating in a LMIC environment show that biobanks
have so far mainly been created to support specific programmes targeting major health 
issues in the countries hosting the biobank[4]. Such programmes may be successful in 
achieving their aims and also set a precedent for effective biobank management in the 
region. But experience in the field show that these benefits may quickly be lost unless the 
biobanks evolve into a sustainable infrastructure embedded in the local research community 
(figure 2).  
Figure 2, the life cycle of a biobank if sustainability is not achieved.
To ensure sustainability it is important for projects like the B3Africa project to take 
a holistic perspective towards biobanking and its role in research. Research is not a 
continual flow of progress from point A to point B but rather an endless number of research 
cycles where ideas are conceived, tested and hopefully contribute to the shared 
knowledgebase of society. Biobanks contribute to this process by facilitating the efficient 
management of biological samples and associated data. In a fit-for-purpose biobank this 
task is well defined and the project justifying the creation of a biobank can be expected to 
handle the research tasks outside simple storage and management. 
For a biobank to become sustainable it must strengthen the local research 
community enough to justify its costs. The B3Africa project achieves this by not only 
focusing on a technical solution for tracking samples and associated information but also to 
support researchers all the way from the ideation stage to knowledge generation. Such an 
integration into a local research community cannot be limited to technical solutions but 
must also incorporate social and legal factors in order to ensure its integration into the local 
community into the program. The B3Africa project therefore consist of a combination of 
the open source software package called the eB3Kit and a social integration program aimed 
towards enabling communities adopting the software(figure 3).  
Figure 3,the B3Africa project is built upon a technology platform in the form of the eB3Kit  (blue) and social 
components (green).Together the components contribute to strengthen African and European research 
communities in LMIC by reducing the thresholds in the research cycle..
The successful completion of the B3Africa project will therefore not only be reliant on 
production and availability of a high quality open source LIMS in the form of the eB3Kit,
but also on its successful integration into local research communities across the Europe and 
Africa. Major initiatives such as H3Africa and BCNet provide a valuable opportunity to 
embed biobanking as a natural component of research in a LMIC setting. But smaller local 
initiatives serve as a complement to major programs as they can draw upon earlier 
experience and implement them in local research communities[17]. The eB3Kit provide the 
information technology necessary to provide the services of a biobank in a robust and cost 
efficient management. Combined with the training and ELSI components this allows the 
small scale creation of biobanks that can be integrated into the global biobanking networks 
through the regional networks initiated by H3Africa and BCNet.
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Abstract 
There is a severe shortage of statisticians and bioinformaticians available in research. As universities 
fail to cover the increasing need of graduates with the necessary skills, ad hoc training and 
workshops have become commonplace but are insufficient to cover the needs. Technical solutions 
that distribute the workload more efficiently between researchers with a different education 
background (e.g., computer scientists and biologists) are therefore necessary to cover some of this 
shortage.  
Galaksio provides a workflow-centric graphical user interface for the Galaxy Workflow Management 
system easy to use for biologists and medical researchers who need to run routine tasks in 
bioinformatics. Combined with back end tools such as BioBlend, CloudMan and Pulsar, Galaksio 
provides a novel, layered approach to Galaxy making it easier to divide research tasks to researchers 
depending on their skills in interdisciplinary subjects such as bioinformatics and computational 
science. 
Galaksio is developed by the B3Africa project for the eB3Kit but functions as a stand-alone server 
that can be configured for to be connected to any Galaxy server using the Galaxy API. Galaksio can be 
downloaded at: https://github.com/fikipollo/galaksio. 
Key points 
x Galaksio is built to provide a more layered approach to Galaxy, providing a simplified user 
interface based on workflows. 
x Galaksio reduces the workload of bioinformaticians as routine tasks can be performed with 
minimal training.  The presentation of workflows also provides a comprehensive overview of 
necessary input data as well as methodological changes to the end user. 
x Galaksio can be used to rapidly deploy new services. Public Galaxy servers are a powerful 
tool to support collaborative research and Galaksio provides a more lightweight user 
interface for researchers who wish to make a specific project or workflow available. 
Introduction 
Galaxy is a widely supported workflow management system used in bioinformatics (Goecks et al., 
2010; Leipzig, 2016; Tastan Bishop et al., 2015; Atwood et al., 2015) to facilitate accessible and 
reproducible research. One of the main aims of Galaxy is to provide access to bioinformatic analysis 
tools for experimentalists with limited expertise in programming (Atwood et al., 2015; Blankenberg 
et al., 2010).  Nevertheless, our experience with Galaxy, gained by implementing it in the eBiokit 
(Hernández-de-Diego et al., 2017) and by using Galaxy in several training and capacity building 
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projects (Fuxelius et al., 2010; Atwood et al., 2015; Mulder et al., 2016) shown us that many potential 
Galaxy users find themselves in a bit of a conundrum when trying to use Galaxy. Researchers skilled 
enough in bioinformatics to install and configure tools prefer command line tools, whereas less 
advanced users are left on their own struggling to find and combine tools using the user interface 
provided by Galaxy. Therefore, many research groups remain reliant on in-house scripts maintained 
by a small number of bioinformaticians spending significant time on providing ad hoc support to 
other researchers in the group. To provide an attractive technology platform for researchers it was 
therefore deemed necessary to provide a more simplified, workflow-centric model of operations. In 
the workflow-centric model researchers with limited bioinformatics training are provided with 
prepared workflows and default input parameters, while more advanced users can create and modify 
workflows using the normal Galaxy GUI. This allows research teams to work in a more efficient way. 
Trained bioinformaticians can adapt and develop tools and then provide the finished workflows for 
routine analysis to lab researchers. 
In standard Galaxy all users rely on the same GUI, despite significantly different education 
background and expertise. Trained bioinformaticians often rely on a set of skills dependent on 
education decisions taken by students several years ahead of enrolling at a university (Wightman and 
Hark, 2012) while other researchers may have little or no formal training. Given the complexities of 
training needs, influential stakeholders such as the US National Research Council has therefore 
concluded that bioinformatics research is likely to be carried out by two disparate groups of 
researchers: quantitative biologists, who work at the interface of mathematical/computer science 
and biology, and research biologists, who need familiarity with a range of mathematical and 
computational concepts without necessarily being an expert (National Research Council (US) 
Committee on Undergraduate Biology Education to Prepare Research Scientists for the 21st Century, 
2003) 
We therefore present Galaksio, a solution based on the Galaxy API and a Python web server, that we 
have developed to provide a layered access to Galaxy functions that facilitate the work of research 
biologists through an easy-to-use web interface, while the default Galaxy interface is used by 
bioinformaticians to create new workflows and systems administration tasks that are facilitated by 
packages created by other researchers such as BioBlend (Sloggett et al., 2013), CloudMan (Afgan et 
al., 2010) and Pulsar (Afgan et al., 2015).   With Galaksio, all data is managed within the normal 
Galaxy workflow management system and user credentials are passed on to the Galaxy server to 
manage user privileges, meaning that Galaksio can be used to access all workflows created on a 
normal Galaxy server using the command line tools implemented on the server.  
Thanks to Galaksio, the Galaxy user’s experience can be managed at three different levels: 1) a layer 
suited to research biologists (i.e., users using tools); 2) a layer suited to bioinformaticians (i.e., users 
developing tools); 3) a layer suited to computer scientists (i.e., users developing the environment 
tools work in) (Figure 1). 
This approach is currently being implemented in the B3Africa project using the eB3Kit which includes 
Galaksio and relies on these resources to connect the relatively light weight Mac Pro Server, 
commonly hosting the eB3Kit, to external computing resources (Klingstrom et al., 2016).  
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Figure 1. This figure shows the layered approach used by Galaksio and implemented in the eB3Kit to divide labour more 
efficiently between researchers with different background. 
Materials, methodologies and techniques 
Galaksio has been designed as a multiuser web application and is divided in two components: the 
server side application and the web interface for users. 
The server side, which is built on Python Flask server(http://flask.pocoo.org/), is responsible for 
accessing the Galaxy data using the tools provided by the Galaxy application programming interface 
(API) (Blankenberg et al., 2010; Goecks et al., 2010). The Galaksio web interface has been developed 
using AngularJS(https://angular.io) and Bootstrap(http://getbootstrap.com), both popular HTML, 
CSS, and JavaScript cross-browser frameworks for developing responsive and user-friendly web 
applications. The exchange of the data between clients and the server is handled using asynchronous 
JavaScript and XML (AJAX) communication. 
Results 
Galaksio is free to use and is distributed under the GNU General Public License, Version 3. A public 
copy of the application is hosted at the SLU facilities as part of the eBioKit platform 
(http://ebiokit.eu/) and source code is available at GitHub(https://github.com/fikipollo/galaksio), 
allowing other laboratories to browse, propose code reviews, and download the code in order to set 
up their own instance of the application. Additionally, Galaksio can easily be installed using 
Docker(https://www.docker.com), an open-source virtualisation software that provides a 
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lightweight, stand-alone, portable, and ready-to-execute package that includes the software and all 
the dependencies necessary to run the application independently of the operating system installed 
on the server. Documentation for the project can be found at the ReadTheDocs 
platform(https://galaksio.readthedocs.io). 
 
Figure 2. The figure shows the graphical interface for the workflow selection in Galaksio. 
 
Figure 3. The figure shows the Galaksio web interface that is presented to the user after  the selection of a workflow. 
Figure 2 shows the Galaksio’s GUI for biologists. Using this interface users can run any workflow 
implemented in the associated Galaxy instance in just few clicks and get a clear image of the analysis 
steps included in the selected workflow (Figure 3). The user interface allows the user to customise 
the execution of pre-selected tools, the uploading of the necessary files, the downloading of the 
results, and the execution of several workflows simultaneously in the background.  
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Table 1 provides an overview of all the developed features in the current Galaksio version. As all 
interactions with Galaxy are managed through the Galaxy API, the Galaksio implementation can be 
hosted independently as a separate server sending commands to any available Galaxy server. This 
includes public servers such as the popular usegalaxy.org website(https://usegalaxy.org/). 
Information on the connected server is provided when logging in via the Galaksio interface. It should 
however be noted that Galaksio, while light-weight in itself, is completely dependent on the speed of 
the Galaxy server when returning workflows and any user restrictions defined by the Galaxy server.  
Feature Category Implemented Planned 
User sign-in/out Users X  
User sign-up Users X  
Workflow listing Workflows X  
Workflow importing Workflows X  
Workflow execution Workflows X  
Workflow creation Workflows  X 
Simultaneous execution of 
workflows 
Workflows X  
Recovering previous executions Workflows X  
Help and description for tools in 
workflow 
Workflows X  
Input selection and parameter 
configuration 
Workflows X   
History selection History X  
History creation History  X 
History deletion History  X 
Dataset uploading Dataset manipulation X  
Dataset downloading Dataset manipulation X  
Dataset deletion Dataset manipulation X  
Dataset collection creation Dataset manipulation X  
Dataset collection deletion Dataset manipulation  X 
Tool execution Tools  X 
Table 1. Implemented and planned features for Galaksio. 
Use case 
Due to delays in achieving approval for tool wrappers created by the Galaksio team, an alternative 
use case has been created with much appreciated support from Marius van den Beek at the Institut 
Curie, Paris, France. The test dataset is available from the Zenodo data repository (Freeberg and 
Heydarian, 2016) but all data can also be imported from usegalaxy.org. 
History containing dataset collections: https://usegalaxy.org/u/tomkl/h/galaksio-use-case-mouse-
chip-seq-data. 
Main workflow: https://usegalaxy.org/u/tomkl/w/copy-of-imported-parent-workflow-chipseq 
Subworkflow: https://usegalaxy.org/u/tomkl/w/copy-of-imported-chipseqtutorialchild1 
The workflows can be imported inside Galaksio by any users logged into a Galaksio server connected 
to https://usegalaxy.org. Other use cases will be added with the addition of “Galaksio use case” in 
the name of the workflow to make them easy to be identified in the Galaksio’s repository. Issues are 
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tracked using the Galaksio repository on GitHub (https://github.com/fikipollo/galaksio/issues) and 
external contributions are welcome.  
Discussion 
Compared to the clearly defined classes of “research biologist” and “quantitative biologist”, 
proposed by the US National Research Council, bioinformatics has developed into a field where its 
practitioners share a number of characteristics, but none of which are essential enough to 
characterise what a bioinformatician truly is (Vincent and Charette, 2015). Many people may 
therefore be highly skilled and productive researchers in bioinformatics, despite very limited skills in 
one or more of the core competencies associated with being a bioinformatician (Smith, 2015). Due to 
the shortage of comprehensive university programmes in the field (Williams and Teal, 2017; Atwood 
et al., 2015), most researchers currently active in bioinformatics have participated in a number of 
courses, workshops and self-learning sessions that, step by step, has taken them to a skill level where 
they may be considered qualified bioinformaticians or quantitative biologists. Such a self-organised 
curriculum encourages bioinformaticians to obtain exactly the skills necessary to complete their own 
projects but with limited consideration for auxiliary skills such as code documentation and a deeper 
understanding of computer science.  
As a result of this self-motivated style of learning, significant delays occur when new technologies 
emerge if they require significant retraining of practitioners before becoming fully competitive with 
the new solution. This is perhaps most evident in the slow adoption of distributed computing 
systems such as Hadoop(http://hadoop.apache.org/). While significant investments in large Hadoop 
infrastructures has been made, the production of bioinformatics tools to use them has been delayed 
as bioinformatics tools are developed by bioinformaticians focused on high-level languages which, 
until recently, had limited support for Hadoop. Thereby delaying the adoption of distributed 
computing in bioinformatics (Oliphant, 2016). 
The Galaksio interface itself is tailored towards enhancing user friendliness for biologists and medical 
researchers with limited IT-skills. The implementation of such a tool is a necessary step towards a 
multi-layered approach to Galaxy which allows distribution of labour not only between biologists and 
bioinformaticians, but also between “scripting” bioinformaticians and bioinformaticians with a strong 
background in computer science. Enabling researchers with the latter form of education background 
to provide access to more advanced computation tools by creating  tools such as BioBlend (Sloggett 
et al., 2013), CloudMan (Afgan et al., 2010) and Pulsar (Afgan et al., 2015) connect the Galaxy 
workflow management system to more powerful computation resources. 
A common objection to user-friendly and automated systems such as Galaksio is the fear that 
automation can increase the error rate or can reduce the willingness of researchers to learn 
bioinformatics properly. Automation is however one of the core concepts of advanced research ever 
since the introduction of the automated sequencing (Smith et al., 1986). Indeed, without the 
automation of routine tasks even the sequencing and analysis of a single genome would be an 
impossible task (Ewing et al., 1998). The relevance of automation within specific research tasks is 
perhaps best demonstrated by the common reliance on FASTQ files, with automatically assigned 
phred-quality scores, rather than the more expansive sequence read format (SRF) when working with 
large volumes of data (Clarke et al., 2012; Van der Auwera et al., 2013).  With Galaksio automation is 
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moved from a per-tool basis to a per-workflow basis and it is therefore appropriate to not only look 
at the risks that a further automation of tasks can bring, but also to evaluate how the current state of 
automation is facilitated in bioinformatics and other IT heavy fields. As an example, in healthcare the 
data management is seen as a way to reduce error rates and three key factors to success have been 
proposed for automation to be beneficial (Nolan, 2000): 
x the system should prevent errors; 
x procedures must be transparent so that they may be intercepted; 
x procedures should be designed to mitigate the adverse effects of errors when they are not 
detected and intercepted. 
Current practices in research are far from optimal when considering these three criteria for 
automation of bioinformatics. When dealing with bioinformatics tasks beyond their expertise, 
biologists may prefer commercial software that provides a more comprehensive, but also expensive 
platform with a dependency on proprietary software (Pabinger et al., 2014; Smith, 2015b). As an 
alternative they may rely on outsourcing computing tasks to collaborators. Other biologists take the 
course of establishing their own curriculum of training as previously discussed. Some of these 
researchers may, over time, become proficient bioinformaticians but even in the best case scenario 
researchers are likely to produce a number of papers based on ad-hoc scripting with low 
transparency and potentially serious errors, unlikely to be caught by reviewers. In comparison, 
prepared workflows accessed in Galaxy or Galaksio limits the time spent on ad-hoc scripting and 
provide a comprehensive file history with source data and the individual steps used to generate the 
final results that greatly improve the reproducibility of the results (see Figure 4).  
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Figure 4. The figure displays a report generated by Galaxy by exporting a workflow after running a 
ChIP-seq use case.  
 
 
The downside of Galaksio is that it does not provide a natural exposure to the command line 
environment. However, Galaksio provides a comprehensive overview of any workflow available in 
the Galaxy system. If used properly Galaksio can therefore also serve as a training tool to explain 
theoretical concepts prior to coding exercises and function as a road map for researchers aiming to 
improve their skills in bioinformatics and build their own workflows step-by-step using the command 
line. 
Conclusions 
Galaksio does not replace the role of trained bioinformaticians in a research environment. It does 
however allow bioinformaticians to automate routine tasks and promote transparency in research as 
researchers with limited, or no, bioinformatics training can run best practice procedures and 
automatically generate the data necessary for others to evaluate their work. Such automation of 
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routine tasks have contributed positively to the productivity and to the reduction of error rates in 
other information heavy fields (Horsfall, 1992; Leek and Peng, 2015; Nolan, 2000). Automation can 
thereby reduce the work load of expert bioinformaticians and provide them with the freedom to 
target more challenging tasks as well as develop a curriculum for the evaluation and training of 
colleagues with basic or intermediate training (Peng, 2015). 
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